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Abstract
Obesity has been associated with impairment in most cognitive domains, but the nature of this
relationship is unclear. Most studies have examined the relationship between cognitive
impairment and current obesity and/or history of obesity-related medical conditions. However, a
number of “lower-level” obesity factors (e.g., increased adipokines, low grade inflammation,
chronic mild hypoventilation) are present even among the otherwise healthy obese population,
and it is possible that many of these factors have differential impact on cognition according to
magnitude and duration of exposure. Knowledge of a person’s weight history, which may serve
as a proxy for a number of lower-level obesity variables that cannot otherwise be measured, may
provide additional utility in predicting cognitive functioning. Of the cognitive domains,
processing speed is particularly important to study in this context, as its decline plays a large role
in driving cognitive aging. Despite this, little is known about the impact of weight history on
processing speed in old age. The present study added to the scientific body of literature by using
data from the 1999–2000 and 2001–2002 NHANES cycles to examine the relationship between
weight history and current processing speed among young-old adults (i.e., adults aged 65–74)
using data at three timepoints: young adulthood, late mid-life, and young-old adulthood. A
statistically significant relationship between persistent obesity in young adulthood and late
middle-age and processing speed in young-old adulthood was identified, but it was found to be
fully mediated by vascular health history. Additionally, slow processing speed was associated
with the weight trajectory pattern of obesity in late middle-age coupled with the absence of
obesity in both young adulthood and young-old adulthood. In regard to study implications, it
may be possible that efforts toward prevention of new onset obesity during mid-life, if
successful, would protect against slowed processing speed in young-old adulthood.
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Introduction
Statement of the Problem
The prevalence of obesity, a leading cause of preventable death, has nearly tripled among
adults in the United States since the late 1970s, and it was estimated that 35.0% and 40.4% of
American men and women were obese in 2016, respectively (Sassi, Devaux, Cecchini, &
Rusticelli, 2009; Zylke & Bauchner, 2016). At the same time, the percentage of the United
States population who are elderly (i.e., 65+ years old) has grown from approximately 9.9% in
1970 to an estimated 14.9% in 2015, with projections to reach 22.1% by 2050 (He, Goodkind, &
Kowal, 2016; United States Census Bureau, 2017; United States Department of Health & Human
Services, 2014a). Cognitive decline is normative with increasing age, but there is growing
evidence that obesity (or obesity-related factors) accelerate this decline (Harada, Natelson Love,
& Triebel, 2013; Sabia, Kivimaki, Shipley, Marmot, & Singh-Manoux, 2009; Xu et al., 2011). It
follows that America will most likely see an increased number of obese elderly, elderly with a
history of obesity, and elderly with greater cognitive decline than what is typically found in
normal aging in the coming decades. This has highlighted the importance of understanding the
unique cognitive challenges elderly individuals might face as a consequence of obesity or obesity
history. It also underscores the importance of understanding the unique value of each obesity
index in predicting cognitive functioning in the elderly; this is an especially salient topic given
that the most widely used obesity index, body mass index (BMI), underestimates adiposity in the
elderly (Heo, Faith, Pietrobelli, & Heymsfield, 2012). Furthermore, it also raises larger
questions of (a) whether current and/or history of obesity may be considered independent risks
for cognitive dysfunction, and (b) what processes might underlie the relationship between
obesity and cognitive dysfunction.
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To briefly address the first question, obesity is associated with impairments in attention,
processing speed, memory, and executive functioning, although many of the relationships
between obesity and cognitive domains appear to vary according to age and sex, and there is
conflicting evidence regarding whether these associations are independent or can be sufficiently
explained by mediating variables (e.g., hypertension, diabetes). Recently, there has been more
focus on lower-level obesity-related factors that may impact cognition (e.g., low grade
inflammation, increased circulation of adipocyte hormones, endothelial dysfunction). For
example, one recent population-based study of the elderly found that circulating biomarkers of
two phenomenon typically seen in obesity (namely, low-grade inflammation and endothelial
dysfunction) were associated with impairments in processing speed and executive functioning,
and controlling for vascular risk factors only slightly attenuated their relationships (Heringa et
al., 2014). It may be that these obesity-related factors that contribute to cognitive decline have
an increased effect if the individual is exposed to a greater magnitude (e.g., more hormones
released from adipose tissue) and/or over a greater time period (e.g., chronic low-grade
inflammation in the chronically obese person, chronic endothelial dysfunction, chronic mild
cerebral hypoxia due to chronic mild hypoventilation).
Therefore, rather than studying the relationship between current weight status and
cognition, it may be more informative to study long-term weight history and cognition. Indeed,
there does appear to be a relationship between weight history and cognitive functioning. For
example, obesity during midlife appears to be an independent risk factor for vascular dementia
(VaD) and Alzheimer disease (AD) onset in later-life (Xu et al., 2011). Individuals who go on to
develop dementia are more likely to have lost a significant amount of weight between midlife
and late-life compared with individuals who remain free of dementia (Stewart et al., 2005).
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Therefore, the combination of obesity in midlife and weight loss between midlife and late-life,
the latter of which is likely to be unintentional, may indicate especially elevated odds of
developing dementia.
In addition to those with dementia, many have asked whether body weight history is also
related to cognitive functioning both among those without dementia and among the general
population. Most of this work has focused on older adults, which is likely due to (a) the idea that
older adults will have a greater time period to have experienced impact of weight-related
processes on their cognitive functions, and (b) the simple fact that older adults are at greater risk
for cognitive decline than any other age group. As expected, preliminary evidence suggests that
body weight history is also related to cognitive functioning among those without dementia and in
the general population. For example, long-term underweight or obese status during adulthood
has been associated with impaired memory and executive functions in late midlife after
controlling for sex, age, and education (Sabia et al., 2009). Furthermore, the extent of weight
loss or weight gain in middle-aged and older men and women has been associated with poorer
performance on visual memory tasks and poorer overall cognitive performance (Brubacher,
Monsch, & Stähelin, 2004; Lo, Pachana, Byrne, Sachdev, & Woodman, 2012). However, this
area of study is in its infancy, and findings have not been adequately synthesized. There are a
myriad of potential mediating and moderating factors that have not yet been accounted for in
current research, and very little is known about the potential impact of weight history on
processing speed, a domain many consider to be foundational to other cognitive processes (e.g.,
Vance, 2009).
Processing speed is an especially important cognitive domain in the elderly for many
reasons, including the following: (a) In normal cognitive aging, processing speed (along with
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spatial ability) declines more rapidly with age than other cognitive abilities (e.g., memory, verbal
abilities; Finkel, Reynolds, McArdle, & Pedersen, 2007). Many consider processing speed to be
a foundational resource for other cognitive processes, and, according to the processing speed
theory of aging, reduced processing speed in old age restricts other cognitive processes to the
extent that these cognitive processes rely on processing speed (Finkel et al., 2007; Salthouse,
1996; Vance, 2009). Therefore, processing speed may be a main driver of cognitive aging. (b)
Of the cognitive domains, only processing speed appears to be independently associated with
longer time to complete everyday tasks in the elderly (Owsley, Sloane, McGwin, & Ball, 2002).
(c) Processing speed and spatial abilities, but not memory or other cognitive domains, appear to
predict greater life satisfaction prospectively in the very old (Enkvist, Ekström, & Elmståhl,
2013). (d) Greater processing speed has been linked to longer survival time in the elderly,
independent of other cognitive impairments and medical conditions (Iwasa et al., 2014). These
reasons highlight the need to understand contributors to processing speed in the elderly.
Study Aims
The present study added to the body of scientific literature in this area by examining the
relationship between weight history (beginning in early adulthood) and current processing speed
among men and women aged 65–74, a population typically referred to as the young-old (e.g.,
Chen, Tsai, Lee, & Lee, 2014; Zizza, Ellison, & Wernette, 2009). The period of early adulthood
to young-old adulthood greatly extends the length of weight history in any published study on
the relationship between weight history and processing speed. Furthermore, because the present
study used data from the 1999–2000 and 2001–2002 cycles of the National Health and Nutrition
Examination Survey (NHANES), it was in a unique position to examine the impact of a great
number of variables (e.g., current and past medical conditions, blood work, physical activity,
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blood pressure, diet, nutrition) that may impact the relationship between weight history and
processing speed in a large sample of elderly individuals. While it was hypothesized that weight
trajectory would play a role in processing speed in old age, other factors were expected to be
very important, and NHANES data provided bountiful opportunity to explore them. The present
study made several hypotheses regarding the relationships among NHANES variables and
culminated with creation of a model to explain poor processing speed among those with longterm obesity.
It should be noted here that the NHANES is an ongoing study designed to assess the
health and nutrition among a sample representative of the United States population, and it
involves a number of components, including interviews, laboratory work, and physical
examinations. NHANES and other research projects were created by the National Center for
Health Statistics (NCHS) in order to collect and provide information to the Centers for Disease
Control and Prevention (CDC) for the purposes of guiding public health action and policy
(NHANES Plan and Operations, 1999–2010). The 1999–2000 and 2001–2002 NHANES cycles
were chosen for the present study due to their inclusion of a processing speed measure, whereas
subsequently completed cycles have not.
A secondary aim of the present study was to examine the relationship between various
obesity indexes (e.g., body mass index [BMI], percent of total body mass that is comprised of fat
as measured by dual energy x-ray absorptiometry [% total fat DEXA], percent of trunk mass that
is comprised of fat as measured by DEXA [% trunk fat DEXA], waist circumference [WC],
waist-thigh ratio [WTR], waist-height ratio [WHtR]) and processing speed, and determine
whether there is an interactive effect of obesity indexes on processing speed. Most studies on the
relationship between weight and cognition have relied on BMI to define obesity; however, there
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is reason to believe that regional body composition is also important in impacting cognition. In
fact, a community study of the elderly found BMI and waist circumference to interact such that
high BMI only predicted poor performance on a brief screener for cognitive impairment when
abdominal obesity was present (Jeong, Nam, Son, Son, & Cho, 2005). Unfortunately, little more
is known due to the paucity of such studies. The present study sought to determine the
relationship between processing speed and multiple obesity indexes, as well as determine the
best combination of indexes in predicting processing speed.
Overweight and Obesity Trends and Prevalence
The prevalence of overweight and obesity in adults aged 20 years or older in 2011–2012
in the United States was estimated with NHANES data using standard World Health
Organization (WHO) BMI cut-offs to be 68.5% and 34.9%, respectively (Ogden, Carroll, Kit, &
Flegal, 2014). This obesity prevalence represents almost a three-fold increase compared with
12.6% in 1978 (Sassi et al., 2009). A number of other countries, such as Australia, Canada, and
England, are nearly as affected by the epidemic, as they have seen their obesity rates more than
double in recent decades (Sassi et al., 2009). Although the U.S. may now finally be nearing a
stabilization of obesity rates, those countries with historically low rates of obesity (e.g., South
Korea, France) are expected to show significant increases in the coming years (Flegal, Carroll,
Ogden, & Curtin, 2010; Sassi et al., 2009).
Rates of estimated overweight and obesity vary by age, sex, and race/ethnicity. In the
United States, men have higher estimated rates of overweight, but women have higher estimated
rates of obesity (Ogden et al., 2014). Overweight rates are also elevated in adults aged 40–59
years (75.3%) and 60+ years (71.6%) compared with adults aged 20–39 years (60.3%; Ogden et
al., 2014). Furthermore, Hispanic women and non-Hispanic Black women are estimated to have
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higher rates of overweight at each of the above age ranges compared to their non-Hispanic Asian
and non-Hispanic White counterparts (Ogden et al., 2014).
Elderly Trends and Prevalence
Similar to obesity, the prevalence of the elderly (adults aged 65+) in the United States has
climbed significantly throughout the past century. For example, approximately 8.1%, 9.9%,
12.6%, and 13.0% of the population was elderly in 1950, 1970, 1990, and 2010, respectively
(United States Department of Health & Human Services, 2014a). The latest available data
indicates that approximately 14.9% of the US population was elderly in 2015 (United States
Census Bureau, 2017). Elderly prevalence is expected to climb dramatically in the upcoming
decades, partly due to the aging of the baby boomer generation; it has been projected that 22.1%
of the U.S. population will be elderly by 2050 (He et al., 2016). Taken together with the
aforementioned obesity prevalence data, these data suggest that there will be dramatic increase in
the number of obese elderly individuals and elderly individuals with a significant history of
obesity in the coming decades in the United States.
Assessing Obesity in the Elderly
To examine the impact of obesity and history of obesity on the elderly, it is first
necessary to examine the utility of obesity assessment methods. In doing so, it is also useful to
understand how body composition and these indexes typically change with age.
Body mass index. The most commonly used method of assessing obesity among adults
is the body mass index (BMI), which is calculated by dividing weight in kilograms (kg) by
height in meters squared (m²). The WHO uses BMI as its standard unit for obesity statistics for
adults and recommends the following set of international cut-offs for researchers: underweight <
18.50 kg/m²; normal 18.50–24.99 kg/m²; overweight ≥ 25.00 kg/m²; obese ≥ 30.00 kg/m²; obese
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class I 30.00–34.99 kg/m²; obese class II 35.00–39.99 kg/m²; and obese class III ≥ 40.00 kg/m²
(WHO, 2010).
Although BMI is the most widely used method for estimating adiposity, there are several
known problems with its use. BMI, which relies solely on height and weight, cannot distinguish
fat from bone, muscle, and other lean body mass. Given this deficit, it is not surprising that BMI
tends to overestimate body fat percentage in those with muscular builds (e.g., athletes) and to
underestimate body fat percentage in those who have lost muscle or bone density (e.g., the
elderly; NIH, 2010). Indeed, researchers routinely consider types of body fat estimation methods
that do not rely solely on anthropometric measurements (e.g., hydrostatic weighing, dual energy
X-ray absorptiometry [DEXA]) to be more accurate than BMI (e.g., Duncan, Duncan, &
Schofield, 2009; Kupusinac, Stokić, & Doroslovački, 2014). Furthermore, percentage of body
fat, when ascertained by these more accurate methods, in individuals with the same BMI value
has been shown to vary significantly across age, ethnic, and racial populations (Deurenberg,
Yap, & van Staveren, 1998). For example, the elderly have significantly more body fat than
young and middle-aged adults at a given BMI (Heo et al., 2012). Moreover, Asians have
significantly more body fat than Whites at a given BMI, and White and Hispanic women have
significantly more body fat than Black women at a given BMI (Deurenberg, Yap, & Guricci,
2002; Rahman & Berenson, 2010). These findings suggest the potential for underestimation of
body fat in Asians and the elderly as well as overestimation of body fat in Black individuals.
Another weakness of BMI is its inability to provide data on body fat distribution or body shape,
factors which carry additional information regarding various health risks (Després, 2012). As a
result, many researchers continue to advocate for the use of alternative measures of body fat in
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research and/or use of BMI cut-offs specific to the population served (Burkhauser & Cawley,
2008; Kagawa, Uenishi, Kuroiwa, Mori, & Binns, 2006).
Central obesity indexes. Many other obesity indexes have focused on abdominal
adiposity (e.g., waist circumference [WC], waist-to-hip ratio [WHR], waist-thigh ratio [WTR],
waist-height ratio [WHtR], % trunk fat DEXA). Interest in these central obesity indexes are
related to findings that they predict increased risk for certain obesity-related diseases beyond that
conferred by BMI classification and, in fact, are even better predictors of hypertension,
dyslipidemia, metabolic syndrome, and type-2 diabetes mellitus (T2DM) than BMI (GuaschFerré et al., 2012; Janssen, Katzmarzyk, & Ross, 2002, 2004; Radzevičienė & Ostrauskas, 2013;
van Dis, Kromhout, Geleijnse, Boer, & Verschuren, 2009; Yusuf et al., 2004). Reasons for
advantages of these central obesity indexes have been theorized to include differences in
metabolic activity of visceral and subcutaneous adipose tissues, shared genetic influences
between waist circumference and T2DM, and findings that larger hip and thigh circumferences
are associated with decreased risk of T2DM (Conway et al., 2011; Mamtani et al., 2014; Power
& Schulkin, 2008; Snijder et al., 2003). It should be noted that, although these are called central
obesity indexes, WHR, WTR, and WHtR each reflect information about one’s body proportion
that goes beyond waist only.
Optimal cutoffs in predicting health risks using the aforementioned central obesity
indexes have been found to vary by sex, race/ethnicity, and age (Dobbelsteyn, Joffres, MacLean,
& Flowerdew, 2001; Lear, James, Ko, & Kumanyika, 2010). The most common cutoffs for
central obesity in men include WC of ≥ 102 centimeters (cm) and WHR of ≥ 0.95, whereas the
most common cutoffs for women include WC of ≥ 88cm and WHR of ≥ 0.8 (Lear et al., 2010).
However, these cutoffs are primarily based on studies of Caucasians of European origin, and
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there is some evidence to suggest that optimal WC cutoffs for Asians are lower than those of
European Caucasians (Lear et al., 2010; Obesity in Asia Collaboration, 2008). There is less
conclusive evidence regarding specific central obesity cutoffs for other groups, including
African-American, Hispanic, and Middle Eastern populations (Lear et al., 2010). In regard to
age, higher cutoff points for WC and WHR appear to be more appropriate for older aged
populations up to age 65, at which point the appropriate cutoffs appear to lower slightly
(Dobbelsteyn et al., 2001). One study found optimal WC cutoffs in individuals aged 60–74 to be
similar to the aforementioned commonly used cutoffs (Gouveia, Marucci, Lebrão, & Duarte,
2014). More research is needed to better understand appropriate central obesity cutoffs for
predicting health risks in all age ranges within the elderly populations, particularly in those
above 75 years of age.
There is no clear consensus regarding which of the central obesity indexes is most useful
in predicting medical outcomes, although one recent systematic review and meta-analysis
concluded that WHtR is better in predicting hypertension, T2DM, dyslipidemia, and metabolic
syndrome among adults than WC or BMI (Ashwell, Gunn, & Gibson, 2012). Among the elderly,
WHtR and WC appear to predict metabolic diseases about equally as well, both surpassing BMI
(Guasch-Ferre et al., 2012). WC, but not WHR, is associated with hypertension among the
elderly, and WC has been found to predict mortality better than WHR and BMI in this
population (de Hollander et al., 2012; Visscher et al., 2001; Woo, Ho, Yu, & Sham, 2002).
Relatively less has been published about the value of WTR or % trunk fat DEXA as central
obesity indexes, but preliminary data suggest that WTR may be a better predictor of peripheral
vascular disease than WC and a better predictor of T2DM in men than WC, WHR, and WHtR
(Li, Ford, Zhao, Kahn, & Mokdad, 2010; Lu, Zhou, Waring, Parker, & Eaton, 2010). Taken
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together, these results suggest that WTR, WHtR, and WC have great potential as health
screening tools. More system comparisons (especially those involving WHtR and WTR) are
needed to determine the best index to use to screen for each medical condition.
Other obesity indexes. Methods typically considered to be more accurate in estimating
adiposity than BMI and the aforementioned central obesity indexes include DEXA,
computerized tomography (CT), magnetic resonance imaging (MRI), bioelectrical impedance
analysis (BIA), hydrostatic weighing, total body electrical conductivity (TOBEC), and skinfold
thickness measurements (Moyad, 2001). These methods tend to be costly, not widely available,
and/or necessitate administration by trained technicians, and thus are often not practical to
implement in large studies. The NHANES, however, is an ongoing large epidemiological study
that does obtain body composition data using one of these methods, namely DEXA. This
method uses two x-ray beams of differing wavelengths to analyze body composition.
Information on bone mineral content, bone mineral density, and fat-free mass can be yielded
with this technique, and estimates of percent body fat can be calculated indirectly from this
information (Clasey et al., 1997). Standard DEXA cut-offs for obesity are fat mass ≥ 25% for
men and ≥ 35% for women (Donini et al., 2013). Advantages of DEXA include ability to
differentiate between fat and lean mass, validity in determining percent body fat within obese
and elderly populations, ability to yield regional body composition measurements (e.g., arm,
trunk), and good reproducibility in estimates of abdominal fat and lean mass (He, Li, & Kung,
1999; Salamone et al., 2000; Tallroth, Kettunen, & Kujala, 2013). Disadvantages include
measurement error introduced by variations in hydration in fat-free mass across individuals and
lack of consistency of DEXA scan mode used in research (Clasey et al., 1997; Salamone et al.,
2000).
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Changes in body composition and obesity indexes with age. Aging is associated with
significant changes in body composition, including those involving total adiposity, distribution
of adiposity, and fat-free mass, the latter of which includes muscle mass, bone mass, and other
nonfat parts of the body (Obisesan et al., 2005; Oldroyd, Stewart, Truscott, Westmacott, &
Smith, 1998). Total fat mass and percentage of body fat generally increase with age (Jackson,
Janssen, Sui, Church, & Blair, 2012; Kyle, Genton, Slosman, & Pichard, 2001). Some data
suggest that total fat mass and body fat percentage stabilizes after about age 80, but other
research suggests that they continue to increase well into the 90s in healthy individuals (Jackson
et al., 2012; Kyle et al., 2001). Subcutaneous fat (e.g., on arms and legs) decreases begin in late
midlife and continues until at least one’s 80s, whereas fat in the viscera and other areas (e.g.,
organs, muscles) increase during midlife (Oldroyd et al., 1998; WHO Expert Consultation,
2008). Declines in fat-free mass (FFM) and fat-free mass index (FFMI) typically begin during
one’s 50s and become significant by ages 65–69 in Black men, 70–74 in Black women and
White men, and 75–79 in White women (Obisesan et al., 2005). Bone loss begins even sooner at
approximately 30 years of age and is accelerated in the early post-menopausal period in women
(Ahlborg et al., 2001; Nuti, Martini, & Gennari, 1995). Furthermore, significantly more lean
mass is lost during weight loss in the elderly than is gained during weight gain in this population
(Newman et al., 2005). These body composition changes explain why the elderly are prone to
both sarcopenia, an age-related loss of muscle tissue, and sarcopenic obesity, the combination of
sarcopenia and high fat mass (Evans & Campbell, 1993).
Obesity indexes also tend to vary with age. The obesity indexes of BMI, WHR, and WC
increase up to age 64; in the decade thereafter, BMI declines in both sexes, WC increases slightly
for men but declines slightly among women, and WHR shows no significant change
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(Dobbelsteyn et al., 2001). Currently, there appear to be no published studies specifically on
changes in WHtR or WTR throughout adulthood into old age. It should be cautioned that
changes in obesity indexes are not necessarily consistent with body composition changes in the
elderly. For example, BMI typically declines in old age, but total fat mass does not appear to do
so. Likewise, WC decreases slightly among women after age 64, but visceral fat mass is actually
thought to increase in this population. For these reasons, care should be taken when selecting
obesity indexes to assess adiposity or related health risks in the elderly. In regard to the present
study, it was hypothesized that age would be positively associated with percent body fat
estimated by DEXA but would show a slight negative correlation with BMI. It was also
hypothesized that WC would show little change with age, but visceral adiposity estimated by %
trunk fat DEXA would increase with age.
Obesity Comorbidity/Mortality
Obesity is associated with reduced quality of life, financial burden, and increased risk for
many medical and psychological disorders, certain types of cognitive decline, and mortality. The
present section summarizes the relationships between obesity and these comorbidities, focusing
on relationships within the elderly population when data are available.
Medical. Overweight/obesity has been named one of the five leading global risks for
mortality by the WHO and is associated with three of the other four identified risks:
hypertension, high blood glucose levels, and physical inactivity (WHO, 2009). Also a risk factor
for hypercholesterolemia and raised triglyceride levels, obesity is associated with increased
prevalence of cardiovascular diseases (CVDs), the worldwide leading cause of death (Mendis,
2010; WHO, 2003). Obesity is also a primary risk factor for T2DM, as excess adipose tissue can
have a contributory role in increased insulin resistance, resulting in increased blood glucose
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levels (Amini et al., 1997). Other potentially life-threatening events or conditions with wellestablished links to obesity include several types of cancers, chronic kidney disease, obstructive
sleep apnea, gallstones, asthma, micronutrient deficiencies, and complications following certain
types of surgical procedures (Arif, Rohrer, & Delclos, 2005; Dowsey, Liew, Stoney, & Choong,
2010; Must et al., 1999; Whaley-Connell, Pavey, Afroze, & Bakris, 2006; Xanthakos, 2009).
Moreover, obesity is associated with many non-life threatening medical conditions, including
osteoarthritis, stress incontinence, gout, gastroesophageal reflux disease, and polycystic ovary
syndrome, all of which have been shown to negatively impact health-related quality of life
(Jeong, 2008; Roddy, Zhang, & Doherty, 2007; Tincello et al., 2010; Yildiz et al., 2010).
Given this, it is not surprising that obesity has been repeatedly linked to impaired healthrelated quality of life and disability (e.g., Alvarez-Blasco, Luque-Ramírez & Escobar-Morreale,
2010; Corica et al., 2006; Strain et al., 2010). Those with class III obesity appear to suffer
greater health-related limitations in performing physical activities (e.g., walking one mile,
walking up steps) than those with class I–II obesity (Castres, Folope, Dechelotte, TournyChollet, & Lemaitre, 2010). Furthermore, there is a well-documented association between
obesity and chronic pain in individuals of diverse ages, ranging from children to the elderly
(McCarthy, Bigal, Katz, Derby, & Lipton, 2009; Wilson, Samuelson, & Palermo, 2010). Obesity
has also been found to have a negative mediating effect on pain outcomes of various procedures,
including knee arthroscopy, knee arthroplasty, and hip arthroplasty (Gandhi, Razak, Davey, &
Mahomed, 2010; Harrison, Morrell, & Hopman, 2004; Núñez et al., 2009).
Obesity in midlife has been linked to shorter life span, which is consistent with its
association with a number of life-threatening conditions (Peeters et al., 2003). In contrast,
obesity among the elderly, when measured by BMI, has been associated with survival (Auyeung
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et al., 2010; Lee et al., 2014). The origins of these discrepant findings are unclear but are
theorized to be related to health risks and conditions in normal weight elderly, including illness,
smoking, and normal weight obesity, the latter of which is a condition marked by a normal BMI
but a high level of body fat (Richman & Stampfer, 2010). More specifically, a variety of clinical
or subclinical illnesses (or related medical treatments) that are more common in the aging
population, such as dementia and cancers, often directly or indirectly lead to weight loss (Stewart
et al., 2005; Tisdale, 2003; Wannamethee, Shaper, Whincup, & Walker, 2000). The extent of
weight loss is associated with worse prognosis in many of these illnesses, and weight loss
amongst the elderly is predictive of mortality (Bamia et al., 2010; Martin et al., 2013; Thivat et
al., 2010). Therefore, an elderly population sampled at a particular time point will include many
who have recently lost weight unintentionally and may have subclinical or clinical illness that
put them at greater risk for mortality. Furthermore, elderly individuals who smoke, a behavior
which carries a well-documented mortality risk, tend to have a lower BMI and a lower risk of
obesity than the elderly who do not smoke (Sulander, Rahkonen, Nissinen, & Uutela, 2007;
United States Department of Health & Human Services, 2014d; Wilson, Habib, & Philpot,
2002). Finally, the elderly demonstrate increased cases of normal weight obesity, which is
associated with cardiovascular mortality independent of BMI and central fat distribution in the
elderly (Batsis et al., 2013). It has been hypothesized that although normal BMI predicts greater
mortality in the elderly, the aforementioned factors associated with normal BMI in the elderly,
rather than the normal BMI itself, are likely to cause mortality (Richman & Stampfer, 2010). At
present, it continues to be debated as to whether there are any true benefits of obesity in old age,
or whether this idea is simply an artifact of bias in our research due to reverse causation (Flegal,
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Graubard, Williamson, & Cooper, 2011; Richman & Stampfer, 2010). More research is needed
to better answer these questions.
Psychopathology. Obesity is associated with psychopathology, including depressive
disorders, social phobia, panic attacks, agoraphobia, binge eating disorder, attention deficit
hyperactivity disorder, and history of alcohol use disorders (Barry & Petry, 2009; Herpertz et al.,
2006; Mather, Cox, Enns, & Sareen, 2009; Pagoto et al., 2009). These associations vary
according to a host of factors, including age and gender. Generally, women and younger adults
evidence greater associations between BMI and psychiatric disorders than men and older adults,
respectively (Mather et al., 2009; McCrea, Berger, & King, 2012). Age and gender may also
interact. For example, one study found that the probability of a young woman having a common
psychiatric disorder (e.g., depressive disorders, anxiety disorders) increases between
approximately BMI 20–30 kg/m2 with a relative stabilization thereafter (McCrea et al., 2012). In
contrast, the association between BMI and common psychiatric disorders takes a “U shaped”
pattern in young men, such that both underweight and obesity increases the probability of a
common psychiatric disorder (McCrea et al., 2012). The relationship between BMI and
common psychiatric disorders attenuates significantly by age 60 in both men and women
(McCrea et al., 2012).
Financial burden. Economic costs of obesity have been conceptualized on the
following three basic levels: individual (e.g., lost opportunities), employer (e.g., lost
productivity, higher insurance premiums), and government (e.g., Medicare and Medicaid
spending; Runge, 2007). Obesity-related medical costs, which are shared by all three of these
levels, are estimated to be approximately $147 billion per year, accounting for 9.1% of the
nation’s total medical spending (Finkelstein, Trogdon, Cohen, & Dietz, 2009). Obese
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individuals tend to use more health care resources, which may be due to increased prevalence of
conditions for which obesity is a risk factor, such as T2DM and asthma, as well as other factors
including reduced physical activity, lower quality of life, increased depressive symptoms, and
increased risks and costs of surgery (Ahn, Smith, Matthew Lee Dickerson, & Ory, 2012; Kirk,
Kuhle, Ohinmaa, Colman, & Veugelers, 2012; Rosemann, Grol, Herman, Wensing, & Szecsenyi,
2008; Trakas, Lawrence, & Shear, 1999). Little has been published on the financial impact of
obesity on the elderly, but one study used simultaneous equation system modeling to estimate
that individuals who are overweight or obese at age 65 have 6–17% greater health care
expenditures during the rest of their lifetimes than those who are normal weight at age 65 (Yang
& Hall, 2008).
Cognition. There is growing evidence that obesity is associated with impaired cognition
and may even have a contributory role in its development in some cases. Associations have been
found between obesity and impairments in attention, processing speed, memory, and executive
functions, as detailed below.
Attention. Attention is fundamental to virtually all cognitive tasks, and research suggests
obese adults have specific deficits in both automatic and controlled processing within this
domain. More specifically, obese adults have been found to have reduced capacity in perceiving
or attending to negative facial expressions compared to healthy-weight controls (Cserjési,
Vermeulen, Lénárd, & Luminet, 2011). Additionally, Gunstad et al. (2007) found significant
negative correlations between body mass index (BMI) and performances on tests requiring
attentional processing, including those of working memory, choice reaction, and visual memory
span. Higher BMI has also been associated with poorer selective attention and greater rate of
decline in selective attention abilities among middle-aged women; however, the same
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relationship was not found among men (Cournot et al., 2006). Most recently, Stanek et al.
(2013) reported an independent association between elevated BMI and poor performance on a
composite of tasks designed to assess attention and processing speed among both men and
women.
Processing speed. Middle-aged obese adults demonstrate impaired performance on tests
of processing speed. In addition to the aforementioned findings by Stanek et al. (2013), another
recent study reported higher BMI to be independently associated with poorer performance on the
Digit Symbol Substitution Test (DSST), a traditional measure of processing speed, among
middle-aged adults without dementia after adjusting for a number or potentially confounding
variables (Cournot et al., 2006). Furthermore, Sanz and colleagues (2013) found higher BMI to
predict worse performance on the DSST after adjusting for age, sex, education, occupational
status, income, smoking, alcohol use, physical activity, psychotropic drugs, and metabolic
syndrome variables (i.e., hypertension, dyslipidemia, vascular disease, C-reactive protein) among
middle-aged individuals. In contrast to these findings among middle-aged adults, Kuo et al.
(2006) reported healthy elderly obese individuals to perform similarly to their normal-weight
counterparts on the DSST and to have better performance on the Useful Field of View (UFOV),
which relies more heavily on visuospatial speed of processing and less heavily on motor
demands, indicating that the relationship between obesity and reduced processing speed may
shift with age. In regard to the present study, which includes both healthy and unhealthy
volunteers, DSST scores were not expected to be significantly related to current BMI. The
extent to which impairment in fine motor speed, which has been found among obese adults, may
impact these findings is unclear, although one study did not find evidence for fine motor speed to
be a significant contributor to DSST score (Joy, Fein, & Kaplan, 2003; Stanek et al., 2013).
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Graphomotor coordination, which could potentially contribute to DSST score, has not been
found to differ between normal-weight and obese children (Mond, Stich, Hay, Kraemer, &
Baune, 2007). It is unclear if graphomotor coordination or speed differs among the elderly
population according to weight category.
Memory. Results of several studies indicate the presence of auditory and visual memory
deficits in obese adults (Gunstad et al., 2007; Gunstad, Paul, Cohen, Tate, & Gordon, 2006;
Wolf, Beiser, Elias, Vasan, & Seshadri, 2007). There is, however, a lack of clarity regarding
whether these memory deficits are independently associated with obesity. For example, Gunstad
and colleagues (2006) reported an independent association between higher BMI and a variety of
memory deficits (as evidenced by poorer performance on immediate and delayed recall and
recognition tasks) among obese adults across the adult lifespan. However, Stanek et al. (2013)
failed to find an independent association between BMI and memory functioning in a similar
study that controlled for a slightly different set of potentially confounding variables.
It is not clear which variables, if any, significantly affect the relationship between BMI
and memory. This relationship has not been found to vary with age, but results of studies
investigating whether this relationship varies by sex have been inconsistent (Gunstad et al., 2006;
Smith, Hay, Campbell, & Trollor, 2011; Stanek et al., 2013). Two studies found higher BMI to
be associated with poorer immediate and delayed recall abilities among men without dementia,
independent of educational level, blood pressure, diabetes, and other potential confounds, but
only one of these studies found such a relationship among women (Gunstad et al., 2006; Smith,
Hay, Campbell, & Trollor, 2011; Stanek et al., 2013). Another study found memory deficits in
both obese men and women and reported that the relationship between obesity and memory
function did not vary significantly by sex (Gunstad et al., 2006).
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Executive functioning. Executive functions are complex capabilities that can be used to
initiate, manage, and coordinate the use of other mental processes, and allow for complex goaloriented thought and behavior (Lichtenberger & Kaufman, 2009). Deficits in executive
functioning in obese adults have frequently been reported, with most work being published on
young and middle-aged adults (Boeka & Lokken, 2008; Fergenbaum et al., 2009; Gunstad et al.,
2007; Lokken, Boeka, Yellumahanthi, Wesley, & Clements, 2010; Smith et al., 2011). Among
two comprehensive studies that controlled for a host of potentially confounding variables across
the adult lifespan, one found an independent association between higher BMI and impaired
executive functioning, but the other failed to do so (Gunstad et al., 2007; Stanek et al., 2013).
Interestingly, the study that did not find an independent association between BMI and executive
dysfunction reported a significant age by BMI interaction, suggesting that obesity-related
executive dysfunction may increase with age (Stanek et al., 2013). The finding that long-term
obesity during adulthood is associated with greater executive dysfunction in later midlife is
consistent with this idea (Sabia et al., 2009). Regarding older adults, fewer studies have
examined the relationship between obesity and executive dysfunction, but the majority of these
studies support the existence of this relationship (Benito-León, Mitchell, Hernández-Gallego, &
Bermejo-Pareja, 2013; Gunstad et al., 2007; Kuo et al., 2006; Walther, Birdsill, Glisky, & Ryan,
2010).
Weight trajectory and risk of cognitive dysfunction and dementia. In addition to current
obesity (as detailed above), dramatic weight change and long-term obese status are also linked to
cognitive dysfunction. For example, one study found long-term obesity and the extent of weight
gain between early adulthood and late middle-age to be associated with executive dysfunction,
though this study did not assess processing speed (Swabia et al., 2009). Another study of elderly
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subjects (mean age 69.4 years) found that the extent of weight gain or weight loss over the
previous 10-year period was associated with poorer performance on a neuropsychological battery
(Brubacher et al., 2004). Regarding the present study, it was hypothesized that similar
relationships would be found with processing speed. It should be noted here that although
weight changes during specific ages may be linked with cognitive impairment and mortality risk,
weight cycling itself has not been conclusively linked to either (Stevens et al., 2012). Stevens
and colleagues (2012) point out that most studies on the impact of weight cycling do not evaluate
whether weight loss was intentional, which may differentiate between weight loss due to illness
and weight loss due to active attempts to improve one’s health or appearance. Regarding the
present study, it was hypothesized that individuals endorsing significant past-year unintentional
weight loss, which may reflect an underlying disease process, would perform worse on the
processing speed measure than those who achieved significant past-year weight loss that was
intentional and those who were weight-stable in the past year.
The relationship between dementia and body weight is complex. There is some evidence
to suggest that obesity during midlife is an independent risk factor for VaD and AD onset in
later-life (Xu et al., 2011). However, individuals who go on to develop dementia are more likely
to have lost a significant amount of weight between midlife and late-life compared with
individuals who remain free of dementia; this weight loss is likely to be unintentional (Stewart et
al., 2005). Therefore, the combination of obesity in midlife and unintentional weight loss
between midlife and late-life may indicate especially elevated odds of developing dementia.
Obesity indexes and cognition. Little is known about which obesity indexes are most
closely associated with cognition in the elderly. Most studies examining the link between
obesity and cognition use BMI as their sole obesity index, making comparisons impossible (e.g.,
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Kuo et al., 2006; Sabina et al., 2009). It may be the case that other obesity indexes, or
combinations of indexes, predict cognition better than BMI among the elderly. For example, a
community study of the elderly found BMI and waist circumference to interact such that high
BMI only predicted poor performance on a brief screener for cognitive impairment when
abdominal obesity was present (Jeong et al., 2005). However, little more is known due to the
paucity of such studies. The present study sought to determine the relationship between
processing speed and multiple obesity indexes. DSST scores were not expected to be
significantly correlated with the overall obesity indexes (i.e., BMI, % DEXA total body fat);
however, they were expected to show significant negative correlations with the central obesity
indexes (i.e. WC, WTR, WHtR, and % DEXA trunk fat). The theoretical importance of central
obesity in predicting cognition is due to the aforementioned differences between metabolic
activity in visceral and other fat tissue, as well as the superior ability of central obesity indexes to
predict a number of health conditions that may impact cognition (e.g., metabolic syndrome,
T2DM) relative to BMI. Furthermore, among those who are centrally obese (defined here as
WC ≥ 102 cm for men and 88 cm for women), it was hypothesized that individuals meeting BMI
obesity criteria (i.e., BMI ≥ 30 kg/m2) and/or DEXA obesity criteria (fat mass ≥ 25% for men
and ≥ 35% for women) would perform worse on the DSST. This hypothesis was based on the
aforementioned study by Jeong and colleagues (2005). Finally, the best combination of obesity
indexes to predict DSST score was explored. It was expected that the best combination would
involve % DEXA trunk fat due to the aforementioned theoretical importance of central obesity,
as well as it being a more accurate indicator of visceral fat than the other central obesity indexes
in this study.
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Hypothesized Origins of Impaired Cognitive Functioning in Obese Adults
Given the findings that obesity is associated with impairment in virtually all cognitive
domains and may exacerbate age-related cognitive decline, it may prove beneficial to identify the
processes that account for this relationship. This section reviews the relationship between
obesity and processes that are thought to contribute to cognitive decline.
Medical etiological factors in impaired cognitive functioning in obese adults.
Disrupted oxygen flow. Obesity and physical inactivity, which is more prevalent in the
obese population, adversely impact heart and lung functioning, key organs that are responsible
for ensuring an adequate supply of blood and oxygen throughout the body (Chlif, Keochkerian,
Mourlhon, Choquet, & Ahmaidi, 2005; Sharp, Henry, Sweany, Meadows, & Pietras, 1964). For
example, an increased body mass requires the heart to pump a greater volume of blood, thereby
placing additional strain on the heart. Furthermore, breathing can become difficult due to the
additional upper body compressing the lungs. If the heart and the lungs cannot fully meet the
body’s demands for blood and oxygen circulation, the brain may receive inadequate blood and
oxygen supplies, conditions respectively known as cerebral hypoperfusion and hypoxia. These
conditions may cause neuronal death and decreased brain metabolism, which may lead to
impairments in cognition; this idea is supported by animal model studies of cerebral
hypoperfusion (Kim et al., 2012). Decreased blood flow in the prefrontal cortex and temporal
pole have been found in otherwise healthy overweight and obese adults, and this decreased blood
flow appears to be associated with various cognitive deficits (Willeumier, Taylor, & Amen,
2011). Thus, it could be hypothesized that chronic mild hypoxia could have a deleterious impact
on cognition in otherwise healthy obese individuals.

24
Cerebral hypoperfusion and/or cerebral hypoxia is also thought to be a main contributor
to cognitive dysfunction in a number of pathological conditions that are associated with obesity,
including heart failure (HF), ischemic stroke, vascular dementia (VaD), and several respiratory
diseases (Azagra-Calero, Espinar-Escalona, Barrera-Mora, Llamas-Carreras, & Solano-Reina,
2012; Baena-Diez et al., 2010; Strazzullo et al., 2010). Among adults with HF, cerebral
hypoperfusion is associated with poorer performance on tests of attention, memory, and
executive functioning (Alosco, Spitznagel, et al., 2012). Interestingly, one recent study
concluded that deficits in cognitive functioning associated with cerebral hypoperfusion are
exacerbated by elevated BMI (Alosco, Spitznagel, et al., 2012).
In regard to ischemic stroke and VaD, interrupted blood supply to the brain is a hallmark
of these conditions and appears to be the result of multiple etiological factors. Among those who
experience cognitive impairment after a stroke, the most common areas affected appear to be
attention, processing speed, and executive function (Cumming, Marshall, & Lazar, 2013). The
occurrence of one or more strokes raises an individual’s risk of developing dementia
considerably; for example, one study found that 30% of individuals who did not exhibit dementia
prior to suffering a stroke developed dementia within three months (Barba et al., 2000). Changes
in white matter, including white matter hyperintensities, lesions, and diffusity in the frontal and
parietal regions, are associated with worse cognitive performance in stroke survivors and may
play a role in the progression from cognitive deficits during the acute period following stroke to
subsequent progressive cognitive decline and dementia (Dufouil et al., 2009; Rasquin, Verhey,
Lousberg, & Lodder, 2005; Williamson et al., 2010). Reductions in grey matter in the thalamus
have also been associated with cognitive impairment following ischemic stroke and may
contribute to cognitive impairment in that population (Stebbins et al., 2008).
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Respiratory diseases associated with obesity that have the potential to adversely impact
cognition include obstructive sleep apnea syndrome (OSAS), obesity hypoventilation syndrome
(OHS), chronic obstructive pulmonary disease (COPD), and chronic asthma (Guo et al., 2013;
Murugan & Sharma, 2008). In regard to OSAS, individuals affected by this condition
experience multiple episodes of upper airway obstruction while sleeping and, therefore,
intermittent deprivation of oxygen (Carlucci, Smith, & Corbridge, 2013). Obese individuals are
more likely to experience sleep apnea, which is thought to be at least partly due to a greater
amounts of adipose tissue on the neck and soft palate (Azagra-Calero, Espinar-Escalona,
Barrera-Mora, Llamas-Carreras, & Solano-Reina, 2012). Adults diagnosed with OSAS have
demonstrated cognitive dysfunction in several areas, most notably executive functioning (Daurat,
Huet, & Tiberge, 2010; Gale & Hopkins, 2004). Reduced blood oxygen saturation resulting
from the intermittent deprivation of oxygen caused by the upper airway obstructions may
represent a significant contributor to the cognitive dysfunction in this population. Indeed, animal
models of OSAS, which are created through intermittent deprivation of oxygen, implicate the
presence of oxidative stress and neuronal cell death via increased oxygen-derived free radicals
known as reactive oxygen species (ROS) (Wang, Zhang, & Gozal, 2010). Furthermore, many
OSAS neuroimaging studies have reported reduced hippocampal volume, and there is a
significant positive correlation between hippocampal volume and blood oxygen saturation in
patients with OSAS (Gale & Hopkins, 2004; Lal, Strange, & Bachman, 2012). It is also worth
noting here that daytime sleepiness associated with OSAS can impair performance on cognitive
tests, although there appears to be a pattern of impaired executive functioning in individuals with
OSAS even after controlling for this variable (Daurat et al., 2010).
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Compared to OSAS, much less is known about OHS, an often-misdiagnosed syndrome
defined as the combination of obesity, abnormal blood levels of carbon dioxide in the daytime,
and sleep-disordered breathing in the absence of a known cause (Basoglu & Tasbakan, 2014;
Marik & Desai, 2013). Preliminary evidence suggests that OHS, which often presents with
OSAS, high C-reactive protein (CRP) levels, and vitamin D deficiency, may result in multiple
organ system dysfunction and can be fatal (Marik & Desai, 2013). Observations of mental
deterioration have been noted in cases of OHS, but future research is needed to determine
specific cognitive changes that occur as a result of this syndrome (Troester, Palfner, Kovacs, &
Olschewski, 2013).
COPD, a progressive disease that adversely impacts airflow, typically involves both
chronic bronchitis and emphysema (Poulain et al., 2006). Smoking is the leading cause of this
disease (United States Department of Health & Human Services, 2014c). It is unclear if obesity
is a risk factor for COPD, but obesity appears to be more prevalent in those with COPD and is
thought to exacerbate COPD symptoms (Franssen, O’Donnell, Goossens, Blaak, & Schols,
2008). Although many studies have reported cognitive dysfunction in COPD, a specific
cognitive profile has not been consistently identified. Some research has indicated a diffuse
pattern of cognitive impairment in this population, whereas as other research has only found
impairments in memory (De Carolis et al., 2011; Fioravanti, Nacca, Amati, Buckley, & Bisetti,
1995; Incalzi et al., 1993). It has been hypothesized that COPD contributes to cognitive
dysfunction via chronic hypoxia (De Carolis et al., 2011). Furthermore, a recent longitudinal
study found COPD and asthma in midlife to be associated with an increased risk of mild
cognitive impairment (MCI) and dementia in late life (Rusanen et al., 2013). In regard to the
present study, current or history of respiratory disease was expected to contribute to processing
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speed impairment. Duration of respiratory disease was also expected to be negatively correlated
with processing speed task performance.
Oxidative stress and nutrition. Oxidative stress can be described as a disturbance in the
balance between free radicals derived from oxygen known as ROS and antioxidant defenses on
the cellular level (Betteridge, 2000; Wang et al., 2010). Increased amounts of ROS are thought
to contribute to tissue damage and cognitive dysfunction (Betteridge, 2000; Wang et al., 2010).
Oxidative stress has been found to increase after consumption of high fat foods, and
chronic consumption of high fat foods has been linked to cognitive impairment (Bloomer &
Fisher-Wellman, 2009; Winocur & Greenwood, 2005). Additionally, there is an inverse
relationship between oxidative stress and fruit and vegetable consumption, which may be related
to the high vitamin and antioxidant-rich carotenoid content of these foods (Vetrani, Costabile, Di
Marino, & Rivellese, 2013). Indeed, deficiencies in B vitamins and thiamine have been linked to
cognitive impairments and Alzheimer disease (Lu’o'ng & Nguyen, 2011; Selhub, Bagley, Miller,
& Rosenberg, 2000).
A number of pathological conditions for which obesity is a risk factor (e.g., OSAS, CVD,
various types of cancers) are associated with oxidative stress (Vetrani et al., 2013). Even
otherwise healthy obese individuals may be at greater risk for oxidative stress than their normal
weight counterparts. This idea is supported by studies that have found significant associations
between obesity and the dietary characteristics of lower fruit and vegetable consumption and
higher total fat consumption, though it should be noted that these associations have not been
consistent across studies (Davis, Hodges, & Gillham, 2006; Tohill, Seymour, Serdula, KettelKhan, & Rolls, 2004).
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In addition to increasing the risk for oxidative stress, obesity and poor nutrition may also
contribute to cognitive dysfunction via an increase in free fatty acid plasma concentration (DaliYoucef, Mecili, Ricci, & Andres, 2013; Haltia et al., 2007). There are at least two mechanisms
by which this impairment may occur. First, free fatty acids may contribute to altered brain fat
metabolism and elevated fat accumulation in brain white matter (Haltia et al., 2007). This
hypothesis is consistent with the findings of greater white matter volume in several basal brain
areas in obese individuals relative to healthy-weight controls (Haltia et al., 2007). Second, free
fatty acids may contribute to impaired insulin signaling, which may in turn contribute to
cognitive impairment via processes discussed later in this document (Dali-Youcef et al., 2013;
Haltia et al., 2007).
Endothelial dysfunction. Oxidative stress may also contribute to endothelial
dysfunction, which refers to a pathological state of the inner lining of blood and lymphatic
vessels, known as the vascular endothelium (Münzel, Sinning, Post, Warnholtz, & Schulz, 2008).
Biological markers of endothelial dysfunction have been associated with a number of conditions
that may lead to impaired cognition, including hypertension, dyslipidemia, and insulin resistance,
and these associations may be bidirectional (Münzel et al., 2008). Interestingly, circulating
biomarkers of endothelial dysfunction and low-grade inflammation (as discussed below) were
associated with impairments in processing speed and executive functioning in a population-based
study of the elderly, and accounting for vascular risk factors only slightly attenuated their
relationship (Heringa et al., 2014).
Chronic low-grade inflammation. Obesity is characterized by increased number and
size of fat cells, known as adipocytes, which secrete proinflammatory (e.g., interleukin 6) and
anti-inflammatory (e.g., adiponectin) cell-signaling proteins called cytokines (Alexaki et al.,
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2009; Tsatsanis et al., 2006; Visser, Bouter, McQuillan, Wener, & Harris, 1999). An increase in
adipose tissue, visceral adipose tissue in particular, has been suggested to result in a higher ratio
of proinflammatory to anti-inflammatory cytokines (Trujillo & Scherer, 2005; Tsatsanis et al.,
2006). Reduced production of adiponectin, an anti-inflammatory cytokine, in response to greater
adipose tissue, and visceral adipose tissue in particular, may have a large contributory role in this
process (Tsatsanis et al., 2006). This proinflammatory cytokine imbalance is thought to lead to
peripheral inflammation, and, indeed, waist circumference is positively correlated with
peripheral inflammation markers and negatively correlated with adiponectin (Ackermann et al.,
2011). Moreover, obese individuals demonstrate elevated levels of CRP, a general marker of
peripheral inflammation, independent of other known sources of inflammation, such as health
and smoking status (Visser et al., 1999).
Inflammation is a protective process performed by the body in order to clear damaging
stimuli and assist with tissue repair (Michaud et al., 2013). The biological benefit of obesitycaused peripheral inflammation appears to be increased energy expenditure, with inflammation
thereby acting as an energy balance mechanism (Ye & Keller, 2010). However, there are a
number of negative consequences to chronically heightened inflammation that could contribute
to the processing speed and executive functioning impairments that are found in this population
(Heringa et al., 2014). First, results from animal studies suggest that peripheral inflammation is
able to evoke central neuroinflammatory response, and this appears to be especially true in older
age animals (Barrientos, Hein, Frank, Watkins, & Maier, 2012; Godbout et al., 2005). Second,
inflammation resistance may develop over time, causing a greater build-up of proinflammatory
cytokines in the bloodstream (Ye & Keller, 2010). These proinflammatory cytokines may
interact with free fatty acids to impair insulin signaling (Dali-Youcef et al., 2013; Haltia et al.,
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2007). Conditions involving insulin-resistance (as described below) are strongly linked with
cognitive impairment. Finally, there is evidence to suggest that central inflammation
(specifically, in the hypothalamus) may be triggered by high fat diet in addition to being
triggered by the metabolic consequences of excess adipose tissue (Boitard et al., 2014; Velloso,
Araujo, & de Souza, 2008). Regarding the present study, higher levels of chronic peripheral
inflammation (as suggested by a history of obesity and high level of CRP) were expected to be
associated with cognitive impairment.
Impaired insulin production or signaling. Insulin, a hormone primarily produced in the
pancreas, is important for regulation of carbohydrate and lipid metabolism, as well as neuronal
survival and synaptic plasticity (van der Heide, Ramakers, & Smidt, 2006). Peripheral insulin is
generally thought to be able to travel through the blood-brain barrier to the brain, although there
is some evidence to suggest that central production may occur (Woods, Seeley, Baskin, &
Schwartz, 2003; van der Heide et al., 2006). Obese individuals are more likely to experience
peripheral impairments in insulin signaling, which may be due, at least in part, to increased
systemic inflammation, oxidative stress, and high fat diet in this population (Dali-Youcef et al.,
2013; Greenwood & Winocur, 2005; Henriksen, Diamond-Stanic, & Marchionne, 2011).
Peripheral insulin resistance or insufficient insulin production is a hallmark of T2DM, and postmortem studies have shown central insulin resistance to be greater in T2DM patients than agematched controls (Liu, Liu, Grundke-Iqbal, Iqbal, & Gong, 2011). The relationship between
T2DM and deficits in processing speed, memory, and executive functioning among older adults
have been well-established (Blanco et al., 2012; Ryan & Geckle, 2000; van den Berg et al., 2008,
2009; Yaffe et al., 2012; Yeung, Fischer, & Dixon, 2009). Mechanisms for cognitive
dysfunction in T2DM are not well understood, but some evidence suggests the role of
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hippocampal neuron damage due to inadequate supply of glucose to the brain, reduced central
cholinergic activity, decreased functionality of glutamate receptors, oxidative stress, and
disruption of the hypothalamic-pituitary adrenal (HPA) axis, in addition to central insulin
resistance (Kodl & Seaquist, 2008; Raber, 1998; Shonesy et al., 2012; Vijayakumar, Sirisha,
Begam, & Dhanaraju, 2012). Decreased frontal glucose metabolism and impaired neuronal
integrity have also been related to BMI and poorer memory and executive function in adults
without T2DM but who may be somewhat insulin-resistant (Gazdzinski et al., 2010; Volkow et
al., 2009).
Insulin-resistance may also lead to cognitive dysfunction other ways. For example,
insulin-resistance, along with other cardiometabolic syndrome symptoms, has been implicated in
the pathogenesis of chronic kidney disease, which, in turn, is associated with impaired
psychomotor efficiency and processing speed (Jassal, Roscoe, LeBlanc, Devins, & Rourke,
2008; Whaley-Connell et al., 2006). Insulin-resistance may also cause cognitive impairment via
promotion of the build-up of beta amyloid (Aβ) plaques found in AD, and in fact, insulinresistance has been proposed as the primary precipitating event of this disease (Kodl & Seaquist,
2008; Salkovic-Petrisic & Hoyer, 2007). Indeed, autopsies performed in patients with AD show
central insulin resistance, and there is considerable similarity between pathology of experimental
inducement of central insulin resistance in animal studies and AD pathology in humans (Liu,
Liu, Grundke-Iqbal, Iqbal, & Gong, 2011; Shonesy et al., 2012). Such findings have led to the
proposal of the term type 3 diabetes to describe this mechanism of neurodegeneration (Steen et
al., 2005).
As per the current literature, the potential contributory role of peripheral insulin
resistance in impaired processing speed is unclear. Among middle-aged individuals without
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diabetes mellitus, two biological markers of peripheral insulin-resistance (i.e., hyperinsulinemia
and homeostasis model assessment of insulin resistance [HOMA-IR]), have been associated with
poor performance on tests of processing speed; however, the only study that appears to have
controlled for BMI when testing the relationship between insulin resistance and poor processing
speed to-date reported that it became insignificant after doing so (Sanz et al., 2013; Young,
Mainous, & Carnemolla, 2006). This suggests the possibility that peripheral insulin resistance,
itself, may not contribute to processing speed decline in a middle-aged population. The
relationship between central insulin resistance and AD pathology, however, raises the question of
whether insulin resistance would be associated with processing speed decline among the elderly
independent of BMI. The present study investigated this question as part of its exploratory
analyses.
Hyperglycemia/hypoglycemia. Blood glucose level and peripheral insulin resistance are
closely related, but distinct, concepts. Insulin is needed to reduce blood glucose levels, and the
pancreas of an individual developing insulin resistance typically produces extra insulin in order
to compensate for the insulin resistance. The individual can eventually develop hyperglycemia if
this extra insulin is no longer adequate to reduce blood glucose levels to a normal range.
Therefore, peripheral insulin resistance onset precedes peripheral hyperglycemia onset (United
States Department of Health & Human Services, 2017). Once an individual’s fasting glucose
level reaches 100–125 mg/dl or HbA1c, a marker of average glucose level in the past 2–3 months,
reaches 5.7% to 6.4%, prediabetes is diagnosed (American Diabetes Association, 2014). When
fasting glucose level reaches ≥ 126 mg/dl or HbA1c reaches ≥ 6.5%, diabetes mellitus is
diagnosed (American Diabetes Association, 2014).
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Hyperglycemia in the diabetic or prediabetic range may have an adverse impact on
processing speed. Hyperglycemia has been identified as the major contributor to the relationship
between metabolic syndrome and impairment in tasks requiring fast perceptual speed among a
sample of elderly individuals (Dik et al., 2007). Furthermore, HbA1c levels in the prediabetic
range have been linked to impaired processing speed independent of BMI in middle-aged
individuals (Sanz et al., 2013). It is unclear as to how hyperglycemia might contribute to
cognitive impairment, although specific biological pathways in the brain have been proposed
(Kodl & Seaquist, 2008). More broadly, Dik and colleagues (2007) noted that those with
diabetes mellitus also show perceptual speed deficits, and suggested that similar glucose
intolerance pathology in fronto-subcortical structures may be present in both those with diabetes
and prediabetes. There is also strong evidence that hyperglycemia increases the risk for
atherosclerosis, possibly via endothelium damage, oxidative stress, and inflammation (Aronson
& Rayfield, 2002).
In regard to the present study, it was hypothesized that participants with fasting glucose
or HbA1c levels in the prediabetic range would perform worse on the processing speed task than
would those with fasting glucose and HbA1c levels in the normal range; individuals diagnosed
with diabetes mellitus or on antidiabetic medication were excluded from the sample investigated
by this hypothesis. In addition, it was hypothesized that those with diabetes mellitus would
perform worse on the processing speed task than the prediabetic and the non-diabetic groups.
Hypoglycemia has also been hypothesized to contribute to worsening cognition in those
with diabetes mellitus (Kodl & Seaquist, 2008). Namely, repeated episodes of severe
hypoglycemia have been linked to worse cognition in a variety of domains within this
population, although findings are mixed and most work has focused on type 1 diabetes, a
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condition for which obesity is not a risk factor (e.g., DCCT/EDIC Study Research Group, 2007;
Northam et al., 2001). Hypoglycemia history is not included in the NHANES database;
therefore, no hypotheses were made regarding history of this condition.
Adipose tissue hormones. It has been proposed that differential levels of adipose tissuederived hormones, including adiponectin and leptin, may have a complex role in cognitive
dysfunction pathology (Gustafson, 2010). Adiponectin (discussed above) has proinflammatory
effects that may contribute to the development of cognitive impairment. Circulating levels of
leptin, a neuroprotective hormone which is also thought to assist in the regulation of food intake
and body weight by acting on the hypothalamus to signal satiety and increase energy
expenditure, tend to be elevated in the obese, and obese individuals are also more likely to show
peripheral leptin resistance, central leptin insufficiency, and brain atrophy (Harvey, 2007; Heini
et al., 1998; Rajagopalan, Toga, Jack, Weiner, & Thompson, 2013). In addition to the
hypothalamus, leptin also has receptor sites in several other areas of the brain, including the
cerebellum and hippocampus (Funahashi, 2003; Savioz et al., 1997). It has been proposed that
leptin deficiencies and leptin resistance in lean and obese individuals, respectively, are related to
cognitive dysfunction (Labad et al., 2012). In line with this argument, rats with dysfunctional
leptin receptors were found to perform poorly on spatial memory tasks (Li et al., 2002). Another
study found higher levels of leptin to be associated with poorer mental flexibility and executive
functioning among a group of primarily obese men with T2DM (Labad et al., 2012).
Hypertension. Over 70% of obese adults suffer from hypertension, a condition that is
associated with cognitive dysfunction and is linked to deficits in attention, memory, executive
functioning, psychomotor functioning, and motor speed among those with heart failure
independent of medication status (Alosco, Brickman, et al., 2012; Bramlage et al., 2004; van den
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Berg, Kloppenborg, Kessels, Kappelle, & Biessels, 2009). Hypertension has also found to be
significantly associated with cognitive dysfunction independent of obesity among men, although
the same relationship was not found among women (Elias et al., 2003). There is some evidence
to suggest that, among the general population, only those with long histories of hypertension and
those not on antihypertensive medications evidence these cognitive deficits (Farmer et al., 1990;
Power, Tchetgen, Sparrow, & Schwartz, 2013).
Prolonged hypertension may impair cognition through disturbed cerebral blood flow
distribution and alterations to small cerebral blood vessels, which may lead to inadequate blood
supply to brain tissue, blood-brain barrier alterations, and eventually lesions, white matter
changes, silent strokes that do not yield any outward symptoms, stroke, and VaD (Elias, Elias,
Sullivan, Wolf, & D’Agostino, 2003; Pantoni & Simoni, 2003). Hypertension has also been
associated with exacerbated morphological changes that occur during the natural aging process,
particularly in the prefrontal cortex, as well as in the temporal and occipital lobes and underlying
white matter (Raz, Rodrigue, & Acker, 2003; Strassburger et al., 1997).
Hypertension in midlife is a risk factor for VaD and AD development (Kivipelto, Laakso,
Tuomilehto, Nissinen, & Soininen, 2002; Sharp, Aarsland, Day, Sønnesyn, & Ballard, 2011).
Interestingly, among those with midlife hypertension who go on to develop dementia, blood
pressure tends to decline near the time cognitive functioning starts to decline (Hajjar, Keown, &
Frost, 2005). This may result in many individuals with dementia no longer meeting criteria for
hypertension. Nevertheless, if hypertension is present in an individual with dementia, it may
accelerate cognitive decline (Hajjar et al., 2005).
Dyslipidemia. Dyslipidemia (e.g., unhealthy levels of total cholesterol, high-density
lipoprotein [HDL] cholesterol, low-density lipoprotein [LDL] cholesterol, and/or triglycerides) is
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a risk factor for cardiovascular diseases, which in turn are risk factors for cognitive decline, latelife dementia, and AD onset in carriers of the ApoE4 allele (Eriksson, Bennet, Gatz, Dickman, &
Pedersen, 2010; Reiner, Muacevic-Katanec, Katanec, & Tedeschi-Reiner, 2011). For example,
60–70 and 70–80-year olds with plasma cholesterol levels of ≥ 8 mmol/L demonstrate a coronary
heart disease (CHD) risk that is 2.3 and 1.6 times greater than those with cholesterol levels of < 5
mmol/L, respectively (Iversen, Jensen, Scharling, & Schnohr, 2009). The link between plasma
lipids and CHD is thought to be primarily due to atherosclerosis, a thickening of artery walls that
limits blood flow (Elwood, Pickering, Bayer, & Gallacher, 2002; Iversen et al., 2009).
Atherosclerosis itself has also been associated with slower processing speed in the elderly, which
may be due to decreased blood flow to the brain (Vinkers et al., 2005). It has been theorized that
plasma lipids, including low HDL cholesterol and high LDL cholesterol, may also contribute to
cognitive impairment via the build-up of amyloid plaque deposits in the brain (Reed et al., 2014).
Given these theoretical etiological factors, it was hypothesized that dyslipidemia would be
related to worse processing speed in the present study.
Some studies have already linked dyslipidemia with cognitive impairment, although
findings have been mixed. For example, there is some evidence that high triglycerides are
related to executive dysfunction in elderly without dementia after controlling for age, gender,
education, LDL cholesterol, ApoE4 allele status, and a rating of clinical dementia (Parthasarathy
et al., 2014). Low HDL cholesterol may be independently related to memory dysfunction and
decline in middle-aged adults and has been associated with reductions in grey matter volume in
regions associated with neurodegenerative disease, such as the parahippocampal region (SinghManoux, Gimeno, Kivimaki, Brunner, & Marmot, 2008; Ward et al., 2010). Overall, however,
studies of the relationship between dyslipidemia and cognitive functioning have yielded
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inconsistent results, which may be related to the common pattern of favorable body weight
changes prior to dementia onset (Stewart, White, Xue, & Launer, 2007; van den Berg et al.,
2009). Unfortunately, the present study did not include a direct measure of dementia.
Other factors. Obesity appears to be a risk factor for alcoholic fatty liver disease and
non-alcoholic fatty liver disease, conditions which appear to be causally linked to cognitive
impairment (Lee et al., 2006). For example, those with end-stage liver disease can experience
hepatic encephalopathy, which is thought to be caused by a build-up of toxins in the bloodstream
and may involve inattention, confusion, and disorientation (Rahimi & Rockey, 2014). Cognition
appears to return to a normal state after hepatic encephalopathy is treated; however, recent
evidence suggests that learning deficits may continue after treatment (Umapathy, Dhiman,
Grover, Duseja, & Chawla, 2014). Less severe stages of liver disease may also be linked to
impaired cognition in certain domains. For example, one study that compared those with mild
liver disease and hepatitis C virus (HCV) to controls demonstrated that the former group had
worse concentration and memory speed after controlling for depression and fatigue, although
DSST scores were not significantly different (Forton et al., 2002). The authors of this study
suggested that an impact of chronic HCV on the central nervous system or preexisting individual
differences may account for these findings (Forton et al., 2002, 2005). Others have suggested
that substance use history accounts for some of the relationship between HCV and cognitive
impairment. For example, Huckans et al. (2009) reported impairments in processing speed, as
estimated by the DSST, in a group with HCV and SUD history but not in a group with HCV and
no SUD history. Nevertheless, deficits in verbal learning, auditory attention, reasoning, and
mental flexibility persisted even in the absence of SUD history in those with HCV. The
NHANES database used in the present study contains yes/no questions on history of “any liver
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condition” and whether those who endorsed this item still have “any liver condition.”
Unfortunately, this did not allow for identification of specific liver conditions nor did it allow for
specific hypotheses to be made in the present study. Nonetheless, the relationship between “any
liver condition” and current processing speed was investigated as part of the present study’s
exploratory analyses. Based on the above information, history of “any liver condition” was not
expected to be significantly related to processing speed task performance, though this was not a
formal hypothesis.
It should also be noted here that hypothyroidism has been linked to subtle cognitive
deficits when left untreated, whereas less evidence is available for an adverse impact of
hyperthyroidism (Lillevang-Johansen, Petersen, Christensen, Hegedüs, & Brix, 2014; Samuels,
2008, 2014). Hypothyroidism has been associated with obesity; however, the direction of this
relationship is unclear (Verma, Jayaraman, Kumar, & Modi, 2008). The NHANES data used in
the present study contains yes/no questions on history of “thyroid disease.” Unfortunately, this
did not allow for differentiation between types of thyroid disease. In regard to the present study,
thyroid disease was not expected to be significantly linked with impaired processing speed
unless it was not treated. That being said, upon implementation of the present study, it was
discovered to be impossible to determine whether thyroid disease had been treated, as the
NHANES data does not include information on history of many of the treatments for thyroid
diseases, such as those of radioiodine and surgery (Abraham & Acharya, 2010).
Combinations of risk factors. The above subsections have included information on the
potential interactive effects of various health conditions on cognition. Some researchers have
also attempted to study the relationship between cognition and clusters of risk factors for
diseases/events, most notably stroke and cardiovascular disease. In doing so, most of these
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studies use full or modified versions of the Framingham Stroke Risk Profile (FSRP) or the
Framingham Risk Score (FRS) for general cardiovascular disease (CVD; e.g., Bangen et al.,
2010; Elias et al., 2004; Joosten et al., 2013; Kaffashian et al., 2011; Llewellyn et al., 2008).
Both the FSRP and FRS for general CVD were developed using data from the Framingham
Study, an ongoing cohort study in Framingham, Massachusetts (Boston Medical Center, 2014).
In regard to the FSRP, the following stroke risk factors were identified based on the incidence of
stroke over a 10-year period among participants aged 55–84 without a history of stroke at
baseline: age, systolic blood pressure, antihypertensive medication, diabetes, smoking status,
atrial fibrillation, left venticular hypertrophy, and history of CVD (defined as one or more of the
following: myocardial infarction, angina pectoris, coronary insufficiency, intermittent
claudication, congestive heart failure [CHF]; D'Agostino, Wolf, Belanger, & Kannel, 1994;
Wolf, D'Agostino, Belanger, & Kannel, 1991). In regard to the FRS for general CVD, the
following CVD risk factors were identified based on the incidence of CVD (defined as one or
more of the following: heart failure, coronary insufficiency, myocardial infarction, angina
pectoris, ischemic or hemorrhagic stroke, transient ischemic attack, peripheral artery disease, or
coronary death) over a 10-year period among participants aged 30–74 without a history of CVD
at baseline: age, total cholesterol, HDL cholesterol, systolic blood pressure, antihypertensive
medication, smoking, and diabetes (D'Agostino et al., 2008). FSRP and FRS for general CVD
scores can be calculated by assigning points to each of these risk factors using sex-specific
formulas that can be found within their respective publications (D'Agostino et al., 1994, 2008).
As mentioned above, many studies have used full or modified versions of the FSRP and
FRS for general CVD to assess the relationship between these groups of risk factors and
cognition. Modified versions appear to be used due to availablity of data in a study rather than
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theoretical differences. For example, Llewellyn and colleagues (2008) calculated FSRP scores
without left venticular hypertrophy and used a different definition of history of CVD (i.e., CHD,
CHF, and peripheral vascular disease [PVD]). Llewellyn and colleagues (2008) found that the
modified FSRP was related to worse performance in a number of cognitive domains, including
processing speed, in their United Kingdom population sample of individuals aged 50 years and
older. Research has also shown high FRS for general CVD scores to be associated with worse
cognition in a number of areas, most notably executive functioning (Joosten et al., 2013;
Kaffashian et al., 2011). The relatonship between FRS for general CVD scores and processing
speed has not been reported to date. In regard to the present study, it was hypothesized that
scores yielded by modified versions of the FSRP and FRS for general CVD would be inversely
associated with processing speed performance. The present study calculated FSRP scores
without left venticular hypertrophy and atrial fibrillation, and it used a different definition of
CVD (i.e., CHF, angina pectoris, heart attack). The present study calculated FRS for general
CVD scores in the same manner as the full version but used a different definition of CVD (i.e.,
CHF, angina pectoris, heart attack, stroke).
Psychological etiological factors in impaired cognitive functioning in obese adults.
Depression. Impaired ability to think, concentrate and make decisions are among the
symptoms of major depressive disorder (MDD; American Psychiatric Association, 2013). Not
surprisingly, research indicates that MDD is associated with impairment in a variety of cognitive
domains, including attention, processing speed, memory, and executive functioning (Luo et al.,
2013; Marazziti, Consoli, Picchetti, Carlini, & Faravelli, 2010). Obese adults are more likely to
experience depressive disorders compared to their non-obese counterparts, with stronger
associations among those with greater obesity severity (Castres, Folope, Dechelotte, Tourny-
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Chollet, & Lemaitre, 2010; Mather et al., 2009). The connection between depression and obesity
is not fully understood, but longitudinal evidence suggests a bidirectional relationship (Luppino
et al., 2010). Body image dissatisfaction, reduced levels of social and physical activity, and use
of psychotropic medication appear to mediate this relationship (de Wit et al., 2010; Gavin,
Simon, & Ludman, 2010; Smits et al., 2010). Additional factors accounting for the relationship
between elevated body weight and depression may include HPA-axis dysregulation,
hypercortisolemia, unhealthy diet, emotional eating, carbohydrate craving, binge eating, and
social stigmatization (Carels et al., 2010; Gibson, 2012; Hawkins & Stewart, 2012; Ouwens, van
Strien, & van Leeuwe, 2009; Peterson, Latendresse, Bartholome, Warren, & Raymond, 2012;
Wurtman & Wurtman, 1995). Among the elderly, it has been proposed that physical functioning
might be a particularly important mediator between obesity and depression, whereas factors
important in explaining this relationship in young adults (e.g., body image) may become less
important in old age (McCrea et al., 2012).
Anxiety. Anxiety has been strongly linked to attentional bias toward threatening
information and increased distractibility, which in turn may contribute to short-term memory and
executive dysfunctions in this population (Lapointe & Blanchette, 2013). Elevated rates of pastyear and lifetime anxiety disorders and symptoms, particularly social phobia and panic attacks,
have been documented in the general obese population (Mather et al., 2009). The nature and
direction of the relationship between anxiety and obesity is not well understood, but it has been
hypothesized that more frequent stress exposure predisposes obese individuals to anxiety
disorders (Pickering, Grant, Chou, & Compton, 2007). Additionally, longitudinal evidence
suggests that severe anxiety may predispose one to increases in waist circumference and
decreases in HDL cholesterol, both of which are predictive of CVD risk and cognitive
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impairment (Bombelli et al., 2013; Reiner et al., 2011; Singh-Manoux et al., 2008; van Reedt
Dortland, Giltay, van Veen, Zitman, & Penninx, 2013; Yoon et al., 2012). Other potential
factors accounting for the relationship between anxiety and higher BMI include unhealthy diet,
HPA-axis dysregulation, hypocortisolemia, and psychotropic medication (Boyer, 2000; Hawkins
& Stewart, 2012; Smits et al., 2010).
Attention-deficit/hyperactivity disorder. Persistent pattern of inattention, difficulties
with organization, and impulsivity are among the symptoms of attention-deficit/hyperactivity
disorder (ADHD), and each of the three subtypes of this disorder (i.e., predominantly inattentive,
predominantly hyperactive/impulsive, and combined) is associated with executive dysfunction
(American Psychiatric Association, 2013; Pagoto et al., 2009). Adults with ADHD also exhibit
elevated rates of obesity (Pagoto et al., 2009). The relationship between ADHD and obesity is
not well understood, but three main theories have been proposed. First, effects of obesity-related
comorbidities (e.g., decreased alertness as a consequence of obstructive sleep apnea syndrome)
may be mistaken for ADHD symptoms (Cortese & Vincenzi, 2012). Second, cognitive deficits
common to ADHD may interact with environmental factors to predispose individuals with
ADHD to overeat or make unhealthy food choices (Davis, 2010). This idea is partly supported
by findings that impulsivity and/or impaired inhibitory control are positively correlated with
external eating, taste-preference driven food choices, and quantity of ready-to-eat and awayfrom-home foods consumed (Appelhans et al., 2012; Jasinska et al., 2012). Third, it has been
hypothesized that deficits in dopaminergic activity in reward centers of the brain underlie both
ADHD and obesity and drive their association (Campbell & Eisenberg, 2007; Liu, Li, Yang, &
Wang, 2008). For example, individuals with reduced dopaminergic activity in these reward
centers may attempt to compensate via behaviors that promote dopaminergic activity, including
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overeating and consumption of unhealthy foods (Davis, 2010; Wang et al., 2001). The finding
that binge eating disorder, which may be associated with downregulation of the dopamine
receptor D2 in the striatum, partially mediates the association between ADHD and obesity is
consistent with this hypothesis (Johnson & Kenny, 2010; Pagoto et al., 2009).
Intellectual disability. Intellectual disability (ID) is a neurodevelopmental disorder that
involves impairment in both intellectual and adaptive functioning (American Psychiatric
Association, 2013). Although there is not a strict IQ criterion for diagnosis, individuals with this
disorder typically obtain IQ scores of 65–75 or less (American Psychiatric Association, 2013).
Adults with ID demonstrate increased prevalence of obesity and earlier age of obesity onset
compared with the general population (de Winter, Bastiaanse, Hilgenkamp, Evenhuis, & Echteld,
2012; Melville, Hamilton, Hankey, Miller, & Boyle, 2007). The nature of the association
between ID and obesity is uncertain. One longitudinal study found lower IQ at age 11 to predict
weight gain and obesity at age 42, a relationship which was partly mediated by education level
and diet quality (Chandola, Deary, Blane, & Batty, 2006). A number of risk factors for obesity
within the intellectually disabled population have been identified, including female gender,
Down syndrome, and ability to eat, prepare meals, and shop for groceries independently. Obese
individuals with ID do not appear to have less nutrition knowledge than lean individuals with ID
(Caton et al., 2012; Golden & Hatcher, 1997).
Future research directions in the obesity-related etiology of cognitive dysfunction.
To summarize, there is conflicting evidence regarding whether associations between obesity and
cognitive dysfunctions are independent or can be sufficiently explained by mediating variables
(e.g., hypertension, diabetes status). In addition to focusing on medical diagnoses as mediating
variables, it may be of equal or greater importance for future research to study the contribution of
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lower-level obesity-related factors (e.g., low grade inflammation, increased circulation of
adipocyte hormones) to cognition decline. This idea is supported by a recent population-based
study of the elderly that found that circulating biomarkers of low-grade inflammation and
endothelial dysfunction were associated with impairments in processing speed and executive
functioning and that accounting for vascular risk factors only slightly attenuated their
relationship (Heringa et al., 2014). It may be further hypothesized that these lower-level obesityrelated factors that contribute to cognitive decline have an increased effect if the individual is
exposed to a greater magnitude (e.g., more hormones released from adipose tissue that contribute
to structural brain changes) and/or over a greater time period (e.g., chronic low-grade
inflammation in the chronically obese person). Therefore, it follows that knowledge of a
person’s weight history, which may serve as a proxy for a number of lower-level obesity
variables, may provide additional utility in predicting cognitive functioning than history of
medical diagnoses alone. Indeed, there is some evidence to support the notion that weight
history may impact cognition. However, this area of study is in its infancy, and its data has not
been adequately synthesized. Future research should work to clarify the impact of weight history
on cognition.
Importance of Processing Speed in the Elderly
Of the cognitive domains that weight history may impact, processing speed may have
some of the worst repercussions among the elderly. First, processing speed is a crucial driving
factor in many accounts of cognitive aging, which will be elaborated on in the following section.
This suggests that weight history-related cognitive deficits may speed the process of cognitive
aging. Second, elderly individuals with faster processing speed appear to have more satisfactory
outcomes in a variety of areas involving quality, satisfaction and duration of life, and these
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outcomes are typically independent of other cognitive domains. For example, faster processing
speed in the elderly has been found to be associated with shorter time to complete everyday tasks
and greater survival time independent of medical conditions and performance in other cognitive
domains (Iwasa et al., 2014; Owsley et al., 2002). Furthermore, processing speed and spatial
abilities, but not memory or other cognitive domains, were found to predict greater life
satisfaction prospectively in a large population-based sample of 78–98-year-old men and women
(Enkvist et al., 2013). Processing speed training may also protect against health-related quality
of life decline; a large randomized controlled trial reported that elderly individuals who
underwent processing speed training were significantly less likely to evidence extensive healthrelated quality of life decline at a two-year follow-up evaluation compared with those who
underwent memory training, reasoning training, or no training (Wolinsky et al., 2006).
Additionally, performance on the digit symbol substitution test (DSST), a commonly used
measure of processing speed, has been shown to be a more useful predictor of driving safety in
the elderly than performance on cognitive tasks measuring global functioning, visuospatial
perception, working memory, semantic fluency, and selective attention (Lafont et al., 2010).
Taken together, these findings suggest the importance of efforts to minimize processing speed
decline in the elderly. Research that will allow us to better understand the process of cognitive
aging and the contributors to processing speed decline among the elderly is also warranted.
Cognitive Aging
Humans experience declines in cognitive functioning as they age. Although normal agerelated cognitive decline has been difficult to clearly differentiate from pathological cognitive
decline due to difficulty ruling out underlying disease states and accounting for impact of
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medical history, there is a consensus that declines in most cognitive domains occur with aging
even in the absence of known health problems (e.g., Aine et al., 2011; Harada, et al., 2013).
Determining when age-related cognitive decline begins is complex. Decline onset varies
by a variety of factors including cognitive domain and birth cohort (Schaie & Willis, 2010).
Generally, it believed that fluid abilities, such as problem solving, begin declining in late
adolescence or early adulthood, whereas crystallized abilities, such as vocabulary, are maintained
or improve into late adulthood (e.g., Kaufman & Horn, 1996). Recently, attention has been
drawn to the impact of study design on our conclusions regarding when age-related decline
begins (Rönnlund, Nyberg, Bäckman, & Nilsson, 2005; Salthouse, 2009; Schaie, 2009). Most
research has been cross-sectional rather than longitudinal for practical reasons, and crosssectional research appears to be more likely to show continuous age-related decline throughout
the adult lifespan than longitudinal research, which is not likely to show significant decline until
approximately age 55 or later (Rönnlund et al., 2005; Salthouse, 2009; Schaie, 2009; Schaie &
Willis, 2010). Those who contend that age-related cognitive decline begins in early life argue
that longitudinal studies do not evidence decline due to retest effects, whereas those who contend
that age-related cognitive decline begins in late life argue against the validity of conclusions that
have been drawn on the basis of cross-sectional studies due to cohort effects (Salthouse, 2009;
Schaie, 2009).
Processing speed, inhibitory control, and working memory are among the factors most
frequently hypothesized to be important in explaining, or even driving, normal age-related
cognitive decline (e.g., Hasher, Stoltzfus, Zacks, & Rypma, 1991; Rozas, Juncos-Rabadán, &
González, 2008; Vance, 2009). Among these, processing speed may be particularly important,
as the effect of age on processing speed may mediate the effect of age on working memory and
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inhibition (Rozas et al., 2008). Furthermore, changes in the processing factor are a leading
indicator of changes in memory and spatial factors, whereas the inverse relationship does not
hold nor are changes in the processing factor a leading indicator of changes in the verbal factor
(Finkel et al., 2007). These findings are consistent with the processing speed theory of aging,
which holds that reduced processing speed in old age restricts other cognitive processes to the
extent that these cognitive processes rely on processing speed (Salthouse, 1996). In other
words, these findings suggest that processing speed, which is related to fluid ability more so than
crystallized ability, drives fluid ability decline but not crystallized ability decline (Finkel et al.,
2007).
In addition to these traditionally studied cognitive components, some researchers have
sought to understand age-related cognitive decline via the concept of cognitive control, which
Manard, Carabin, Jaspar, and Collette (2014) describe as being “required to adjust and flexibly
guide people’s behavior in changing environmental circumstances, especially in situations where
distracting information or a predominant response tendency must be ignored in order to
successfully act in a goal-oriented manner.” Therefore, cognitive control includes aspects of
executive and attentional control, goal maintenance, and response selection and inhibition. A
thorough review of cognitive control theories and models is beyond the scope of this document.
Briefly, information processing theory, among the earliest cognitive control theories proposed,
contended automaticity to be on a continuum based on processing speed and interference effects
rather than an all-or-nothing phenomenon (Cohen, Dunbar, & McClelland, 1990). Conflict
monitoring theory subsequently built on information processing theory by theorizing that
cognitive control processes are initiated when a monitoring system in the anterior cingulate
cortex detects conflicts in information processing (Botvinick, Braver, Barch, Carter, & Cohen,
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2001). Later work also suggested the dorsolateral prefrontal cortex to have a special role in
allowing one to actively maintain task-relevant memory representations, referred to as “context
processing,” during times of great interference (Kane & Engel, 2002).
It has been theorized that difficulties with context processing play a role in age-related
cognitive decline, an idea which became known as the “context processing theory of cognitive
aging” (Braver et al., 2001; Braver, Satpute, Rush, Racine, & Barch, 2005). Results of one
study support this theory over the role of processing speed or inhibition deficit alone in
explaining age-related cognitive decline, although more research is needed to clarify the relative
utility of context processing theory of cognitive aging (Rush, Barch, & Braver, 2006).
Within the context processing theory of cognitive aging, context processing has been
divided into reactive control and proactive control (Braver et al., 2005; Braver, 2012). Reactive
control, which is sometimes referred to as interference resolution, initiates temporary reminders
of context information after a probe stimulus (Bélanger, Belleville, & Gauthier, 2010; Braver et
al., 2005). In contrast, proactive control, which is sometimes referred to as goal maintenance,
actively updates and maintains context information and communicates with other attention
systems to prepare for an upcoming probe stimulus (Bélanger et al., 2010; Braver et al., 2005).
For example, a person can use proactive control to stop at the bank on her way home from work
by keeping her goal of stopping at the bank in mind as she approaches the intersection in which
she must make a left turn to go to the bank. In contrast, a person relying on reactive control
would not be keeping the goal of stopping at the bank in her mind as she approaches the
intersection, but the sight of the intersection may trigger a reminder of her goal of stopping at the
bank.
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Proactive control processes appear to decline with age more so than reactive control
processes (Bélanger et al., 2010; Braver et al., 2005). Preliminary evidence supports the
hypothesis that successful use of proactive control processes in the older population is partly
dependent upon amount of available cognitive resources, consisting of processing speed and
fluid intelligence (Manard et al., 2014). Indeed, older adults are more vulnerable to interference
effects on the Stroop test, which is believed to be partially attributable to slowed processing
speed, as well as inhibitory deficits (Bugg, DeLosh, Davalos, & Davis, 2007; Troyer, Leach, &
Strauss, 2007). Therefore, although the context processing theory of cognitive aging involves
many cognitive components, processing speed clearly remains a crucial concept in this account.
Hypothesized Origins of Processing Speed Decline in the Elderly
Chronic inflammation. Aging is associated with low grade chronic inflammation
(Michaud et al., 2013). Within the aging process, chronic inflammation is believed to be
primarily caused by changes in the immune system and increased secretion of adipokines
(Michaud et al., 2013). This state of low grade chronic inflammation may be detrimental for the
same reasons explained in regard to obesity-related chronic inflammation.
Neurobiological factors. The brain’s morphology, activation patterns, and metabolism
change throughout the lifespan. During the aging process, reduced total brain volume, reduced
total gray matter volume, reduced total white matter volume, and increased volume of ventricles
occur (Fjell & Walhovd, 2010). It has been theorized that reduced grey matter is primarily due
to factors such as shrinkage of neurons and synaptic spines, and factors such as resultant widened
synaptic gaps may impair neural communication and contribute to slower processing speed (Fjell
& Walhovd, 2010). In regard to white matter, it has been hypothesized that breakdown of
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myelin and/or shortened internodes due to remyelination result in slowed neural communication
and, therefore, reduced processing speed (e.g., Lu et al., 2013; Peters, 2009).
Although changes in total brain volume are characteristic of aging, brain matter volume
does not decrease uniformly across brain regions. The volume of frontal cortex (particularly in
the lateral prefrontal and orbitofrontal cortices), temporal cortex, thalamus, putamen, caudate
nucleus, nucleus accumbens, cerebellum, and hippocampus appear to be especially affected by
age (Eckert, 2011; Fjell & Walhovd, 2010; Raz et al., 2003; Van Der Werf et al., 2001). Smaller
volume and/or magnitude of atrophy over time of many of these areas negatively correlate with
processing speed, leading to the proposal of region-specific neurobiological explanations for agerelated processing speed decline (e.g., Nadkarni et al., 2014; Van Der Werf et al., 2001). For
example, one explanation focuses on specific areas of age-related grey matter reductions that
predict poor processing speed, including the bilateral inferior frontal and superior parietal
regions and the lingual and left superior frontal gyri (Chee et al., 2009). Other accounts focus on
the role of declines in white matter integrity, and, more specifically, volume of white matter
hyperintensities and myelin breakdown (Borghesani, Madhyastha, Aylward, & Reiter, 2014; Lu
et al., 2013; Papp et al., 2014). Specific areas of these declines in white matter integrity have
been found to be particularly important. For example, it has been found that age-related myelin
breakdown is more likely to occur in areas of the brain that form myelin later in life, including
the frontal lobe (especially in the prefrontal region; Lu et al., 2013). Myelin breakdown in these
late-myelinating areas have been found to mediate the relationship between age and processing
speed slowing, whereas early-myelinating brain areas have not (Lu et al., 2013). These findings
are consistent with accounts of age-related processing speed decline that focus on the role of the
prefrontal cortex, or, more broadly, the frontal lobe (e.g., Eckert, 2011). Despite degradation in
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the prefrontal area of the brain, research has shown increased activity in the prefrontal cortex in
the elderly during a variety of cognitive tasks, including attention/executive functioning and
motor planning, compared with younger adults (Berchicci, Lucci, Pesce, Spinelli, & Di Russo,
2012; Ohsugi, Ohgi, Shigemori, & Schneider, 2013). Increased activity in the prefrontal cortex,
however, is actually associated with worse ability in many domains, including processing speed
(e.g., Woodward, Duffy, & Karbasforoushan, 2013). It has been theorized the increased activity
in the prefrontal cortex of the elderly during these tasks may reflect the brain’s attempt to
compensate for adverse age-related brain changes or may be the result of the aging brain’s
difficulty in recruiting specialized brain regions (Cabeza & Dennis, 2013).
Age-related change in cellular functioning and brain glucose metabolism are thought to
have adverse effects on cognition. On a cellular level, oxidative stress within mitochondria,
which is believed to occur with age, may lead to the overproduction of reactive oxygen species,
which, in turn, may cause cell damage and death (Bergamini, Gambetti, Dondi, & Cervellati,
2004; Yin, Boveris, & Cadenas, 2014). In regard to brain glucose metabolism, declines with age
can be seen in many areas of the frontal cortex, as well as in the caudate nuclei and superior
lateral temporal cortex (Chételat et al., 2013). Decreased glucose utilization, which is closely
liked to regulation of neuronal death, is thought to reflect cognitive impairments (e.g., Gage,
Kelly, & Bjorklund, 1984; Mergenthaler, Lindauer, Dienel, & Meisel, 2013).
Changes in activity of a number of other brain chemicals are also seen in aging, and
many of these changes are thought to have adverse effects on cognition. For example, older
adults evidence reduced dopamine metabolism due to factors such as reduced dopamine
transporters in the striatum and reduced binding potential in the striatum and frontal cortex, and
impaired dopamine activity has been linked to declines in glucose metabolism in the frontal and
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temporal cortices, anterior cingulated gyrus, and caudate regardless of age (Suhara et al., 1991;
Volkow et al., 1996, 2000). Based on these findings, it has been suggested that age-related
changes in dopamine metabolism may play a contributory role in decreased glucose metabolism
in these brain areas, although it could also be hypothesized that decreased glucose metabolism
may contribute to reduced dopamine metabolism, as glucose is needed for the synthesis of
neurotransmitters (Mergenthaler et al., 2013; Volkow et al., 2000). The proportion of dopamine
relative to acetylcholine has been found to be particularly important in the processing of novel
stimuli by neurons in the medial temporal lobe and prefrontal cortex (Eckart & Bunzeck, 2013).
Another endogenous chemical for which the elderly develop a lack of sensitivity toward and may
subsequently experience adverse cognition is the neuroprotective hormone, leptin (Al Hazzouri,
Stone, Haan, & Yaffe, 2013; Folch et al., 2012). Central leptin resistance may be a contributor
to cognitive decline in obesity, as stated earlier in this document, but it has also been found to be
linked to aging even after the effects of body weight are accounted for (Gabriely, Ma, Yang,
Rossetti, & Barzilai, 2002). Changes in activity of other brain chemicals seen in aging and
thought to contribute to processes that impair cognition include thyroid stimulating hormone,
estrogen, and androgen (Akishita, 2004; Moon et al., 2004; Peeters, 2008).
Medical events and conditions. Many medical events and conditions that are more
common among the obese also have increased prevalence among the elderly; some examples
include T2DM, hypertension, hypercholesterolemia, heart failure, ischemic stroke, vascular
dementia, and many cancers (Centers for Disease Control and Prevention, 2014; Copeland et al.,
1999; Moon et al., 2013; National Heart Lung and Blood Institute, 2014). Ways in which these
events and conditions may contribute to cognitive decline have already been elaborated in this
document with the exception of cancer, which will be addressed in the medical treatments
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section below. Furthermore, it should be emphasized here that vascular risk factors (e.g.,
hypertension, hypercholesterolemia, T2DM, cerebrovascular diseases) have been implicated in
the progression of MCI to dementia, both of which are more prevelant in the elderly and the
latter for which midlife obesity has been documented as a risk factor (Copeland et al., 1999; Xu
et al., 2011). That being said, there are certainly medical events and conditions that are not
associated with obesity but which could have an adverse impact on the cognition of affected
older individuals, including those of hypotension and type 1 diabetes mellitus (Frier, 2011;
Hebert et al., 2004).
Medical treatments with potential adverse cognitive effects. Elderly individuals have
an increased risk for medication-induced confusion, which is thought to be due to
pharmacokinetics and pharmacodynamics that have been altered as a result of the normal aging
process or age-related diseases (Flaherty, 1998). Risk increases signficantly with the number of
medications taken (Flaherty, 1998). Anticholinergic medications in particular often have adverse
consequences for cognition in older individuals (Campbell et al., 2009). Use of these
medications is prevalent among the elderly, with the most common types including bladder
antimuscarinics, first-generation antihistamines, and tricyclic antidepressants (Gray et al., 2015).
Acutely, anticholinergic medication use is associated with confusion and slowed information
processing speed (Low, Anstey, & Sachdev, 2008; Nebes, Pollock, Halligan, Houck, & Saxton,
2011). Long-term anticholinergic medication use also seems to be problematic, as recent
longitudinal studies have linked persistent use with faster decline in episodic memory and higher
cumulative burden with increased risk for dementia (Gray & Hanlon, 2016; Papenberg et al.,
2017).
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In addition, certain chemotherapy and radiation therapy treatments for cancer have been
linked to decline in performance across measures of processing speed and executive functioning
in longitudinal studies, as well as self-reported increase in severity of memory and concentration
problems (Avila et al., 2015; Kohli et al., 2007). There is, however, little evidence to suggest
that many types of cancer are associated with cognitive impairment prior to systemic
chemotherapy or radiation therapy localized to the brain (Anstey, Sargent-Cox, Cherbuin, &
Sachdev, 2015; Avila et al., 2015; Mandelblatt et al., 2014).
Medical treatments with potential cognitive benefits. Among individuals with
hypertension, current and past use of antihypertensive medications have each been associated
with better cognitive performance than among those who have never taken antihypertensive
medications or who are not currently taking antihypertensive medication (Farmer et al., 1990).
These medications may protect cognition by avoiding vascular damage to the brain secondary to
hypertension (Hajjar et al., 2005). Additionally, it was discovered that certain antihypertensive
medications protect against cognitive decline to a greater extent than control of blood pressure
alone; these include antihypertensive medications that cross the blood brain barrier and impact
the renin-angiotensin-aldosterone system (RAAS) or intracellular calcium metabolism (Hajjar et
al., 2005). In particular, angiotensin-converting-enzyme (ACE) inhibitors are believed to be the
most efficacious class of hypertensive medication in preventing cognitive decline (Gard, 2010).
Comparatively less is known about the protective effects of anti-diabetic medication use
on cognition. Anti-diabetic medication is generally believed to improve cognition or protect
against cognitive decline; however, findings are mixed, and improved glycemic control does not
consistently predict quality of cognition (Alagiakrishnan, Sankaralingam, Ghosh, Mereu, &
Senior, 2013; Gradman, Laws, Thompson, & Reaven, 1993; Hewer, Mussell, Rist, Kulzer, &
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Bergis, 2003). Furthermore, anti-diabetic medication usage has not been reliably shown to
protect against development of MCI or AD, conditions for which diabetes is a risk factor
(Alagiakrishnan et al., 2013).
In regard to hypothyroidism, adverse cognitive effects are generally believed to be
reversible with proper medical treatment (Samuels, 2014). Moreover, individuals with long-term
use of thyroid medication do not show cogntive abilities that are significantly different than those
without a thyroid disorder (Kramer, von Mühlen, Kritz-Silverstein, & Barrett-Connor, 2009).
Psychosocial factors. Several psychosocial factors may also be important in explaining
cognitive functioning in the elderly, including gender, race, education, mood, sleep, exercise,
smoking, diet, and nutrition factors. There is some evidence to suggest that elderly women may
experience faster rate of age-related cognitive decline than elderly men; however, other studies
have found no differences between genders (Barnes et al., 2003; Mortensen & Hogh, 2001;
Zhang, 2006). Furthermore, there is preliminary evidence to suggest that elderly men may
perform worse on tests of processing speed than elderly women (MacDonald, Hultsch, Strauss,
& Dixon, 2003). In regard to race, African Americans may be more vulnerable to faster rate of
cognitive decline, although this also has not been fully established (Lee et al., 2012; Obidi et al.,
2008).
Low level of education has been shown to be associated with lower IQ and greater
cognitive impairment among the elderly; however, education does not appear to have a
significant relationship with processing speed in this population (Kirton & Dotson, 2016;
Ritchie, Bates, Der, Starr, & Deary, 2013; Strandberg, Pitkala, Eerola, Tilvis, & Tienari, 2005;
Zahodne et al., 2011). Although many have theorized that high education level may have a
protective role against rate of cognitive decline, research findings are mixed (e.g., Muniz-
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Terrera, Matthews, Dening, Huppert, & Brayne, 2009; Small, La Rue, Komo, Kaplan, &
Mandelkern, 1995; Zahodne et al., 2011). It may be the case that high education level is only
protective in certain populations or circumstances. This idea is supported by findings that
number of stressful life events predict faster rate of cognitive decline in those with a low level of
education, but not in those with a high level of education (Tschanz et al., 2013). Additionally, a
longitudinal study of community-dwelling elderly without dementia found that, among carriers
of two ApoE4 alleles but not among carriers of only one ApoE4 allele, the magnitude of
cognitive decline increased as years of education decreased even after adjustments for age,
gender, ethnicity, depression, diabetes, history of ischemic heart disease, and history of
cerebrovascular disease were made (Shadlen et al., 2005). More research is needed to
understand the potential protective role of education against cognitive decline.
Mood and sleep factors have also been hypothesized to impact cognitive functioning in
the elderly. Regarding mood, current depressed mood and long-term history of depressive
symptoms among the elderly have been associated with worse current cognitive functioning and
greater cognitive decline, respectively, and processing speed is among the cognitive domains
found to be affected by depression (Gualtieri, Johnson, & Benedict, 2006; Santos et al., 2013;
Singh-Manoux et al., 2010). Interestingly, self-reported frequency of feeling lonely has been
found to be associated with slower processing speed independent of depression, social networks,
and premorbid IQ (O’Luanaigh et al., 2012). Regarding sleep factors, shorter duration and worse
quality of sleep have been associated with both worse performance in several cognitive domains
(e.g., working memory, attention, abstract problem solving) and increased risk for cognitive
impairment among elderly without dementia (Keage et al., 2012; Miyata et al., 2013; Nebes,
Buysse, Halligan, Houck, & Monk, 2009; Potvin et al., 2012). However, preliminary evidence
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suggests that processing speed does not appear to be impacted by sleep quality (Nebes et al.,
2009). Interestingly, daytime napping among the elderly may be associated with less cognitive
decline in this population (Keage et al., 2012).
Lack of exercise may also play a key role in cognitive decline in many elderly
individuals. Both aerobic exercise and a combination of aerobic and strength training forms of
exercise have been shown to improve processing speed task performance (Nouchi et al. 2014;
Tam, 2013). More specifically, these effects have typically been found in regard to two or three
weekly sessions of exercise for both short-term (e.g., 4 weeks) and long-term (e.g., 3 years)
periods of time (e.g., Nouchi et al. 2014; Rikli & Edwards, 1991; van de Rest et al., 2014). The
duration of exercise sessions in studies examining their impact on cognition is typically around
30 minutes, totaling a minimum of two sessions or 60 minutes of exercise per week (e.g., Nouchi
et al., 2014; Voss et al., 2013). It is not yet well established if less frequent exercise or shorter
exercise duration may also benefit processing speed. Compared with anaerobic exercise, aerobic
exercise appears to be more beneficial for executive control processes that are frontally-mediated
(e.g., switching between tasks, ability to disregard task-irrelevant stimuli, ability to discontinue a
planned action; Kramer et al., 1999). Combination training, which includes both aerobic and
anaerobic exercises, appears to be more beneficial than either type of exercise alone regarding
overall cognition (Colcombe & Kramer, 2003).
In regard to the present study, it was then hypothesized that the group of elderly
individuals who engaged in either a minimum of 60 minutes of aerobic exercise weekly or a
minimum of two sessions of strength training sessions weekly would exhibit higher scores on the
DSST, a traditional measure of processing speed, than those who did not exercise. Further, those
who engaged in only aerobic exercise were expected to perform better on the DSST than those
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engaged in only strength training exercise, as the DSST has been shown to activate the frontal
lobe and involve elements of executive functioning (Davis & Pierson, 2012; Nakahachi et al.,
2008). Finally, it was hypothesized that elderly individuals who engaged in combination training
would perform better on the DSST compared to the aerobic only, strength training only, and no
exercise groups.
Other lifestyle factors, including smoking, alcohol use, and diet history, may also
contribute to cognitive impairment in the elderly. Current smoking has been associated with
deficits in a number of cognitive domains, including processing speed (Lo, Woodman, Pachana,
Byrne, & Sachdev, 2014). It could be hypothesized that smoking causes a decrease in lung
functioning that may lead to mild cerebral hypoxia or that inhaled toxins adversely impact the
brain. Smoking may also indirectly lead to cognitive dysfunction such that it is a risk factor for a
number of conditions that are thought to be causally related to cognitive decline, including CHD
(e.g., Wilson et al., 1998). Alcohol use may also be a salient lifestyle factor that contributes to
cognitive impairment in this population. Approximately 8.9% of the elderly meet criteria for
alcohol abuse, which is associated with dementia in this population, as well as impairments in
recent visuospatial memory, verbal memory, and executive functioning (Hudetz & Warltier,
2007; Thomas & Rockwood, 2001). Length of alcohol abuse history is also relevant for
cognition outcomes. For example, years of alcohol abuse has been inversely associated with
psychomotor speed and short-term memory (DeFranco, Tarbox, & McLaughlin, 1985).
Although heavy alcohol use is known to impair cognition, some evidence suggests that a history
of moderate alcohol use may have a protective influence on cognition (Lo et al., 2014). Given
the available variables in the NHANES, it was hypothesized that those who endorsed a likely
problem with lifetime history of excess alcohol consumption (i.e., answered yes to “Was there
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ever a time or times in your life when you drank 5 or more drinks of any kind of alcoholic
beverage almost every day?”) would exhibit worse processing speed task performance.
Likewise, it was hypothesized that those who endorsed a likely problem with past-year excess
alcohol consumption (i.e., endorsed consuming 5 or more drinks on half or more of the days
during the past year) would exhibit worse processing speed. Finally, it was hypothesized that
current smoking status would be associated with worse processing speed. It should be noted that
those with current or history of chronic use of other drugs, such as cocaine and heroin, have also
been found to have impaired cognition in various domains (Lundqvist, 2005). Unfortunately,
NHANES did not assess for these factors among the elderly.
Regarding diet, the most consistent findings in this area involve the association between a
Mediterranean-type diet and slower cognitive decline and reduced risk for AD (Cheung, Ho,
Chan, Sea, & Woo, 2014; Kuczmarski, Allegro, & Stave, 2014). Characteristics of this type of
diet include high consumption of vegetables and fruit and low consumption of processed foods,
sugar, and saturated fat. This pattern may have a beneficial impact on cognition for a number of
reasons. For example, it has also been hypothesized that regular consumption of certain fruits
and vegetables that contain polyphenolic compounds with antioxidant, anti-inflammatory, and
neuroprotective properties may protect against cognitive decline (Darvesh, Carroll, Bishayee,
Geldenhuys, & Van der Schyf, 2010). It has also been hypothesized that high levels of dietary
saturated fat may make clearing beta-amyloid proteins from the brain more difficult (Hanson et
al., 2013). Other ways in which diets high in fat may lead to cognitive impairment (e.g., central
inflammation, impaired insulin signaling) have already been discussed in this document.
A number of vitamins, nutrients, and related chemicals have also found to be important
for healthy cognitive functioning among the elderly, including homocysteine, folate, vitamin B12,
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iron, and vitamins C, D, and E. Although these factors are being discussed under the
psychosocial/diet section of this document, it should be noted here that abnormal levels of these
chemicals can occur not only as a result of diet, but also as a result of certain neurologic,
psychiatric, hematologic, or genetic reasons (e.g., Hector & Burton, 1988). Homocysteine,
folate, and vitamins B12 will be addressed first due to their interdependent relationship. Namely,
vitamin B12, vitamin B6, and folate are thought to be needed to convert homocysteine to an
amino acid called methionine, which is needed to produce a variety of other chemicals (Leishear,
Ferrucci, et al., 2012). Therefore, if vitamin B12, vitamin B6, and/or folate levels are depleted,
homocysteine levels may increase (Leishear, Ferrucci, et al., 2012). Likewise, increasing folate
and B12 via supplements has been shown to decrease homocysteine levels (Graham et al., 1997).
Levels of homocysteine, an amino acid, tend to increase with age and are typically
greater in men (Feng et al., 2013). High homocysteine level has been linked to reduced
information processing speed and visuoconstructional ability independent of folate levels,
although some have argued that high homocysteine levels are only associated with worse
cognition in those with low folate levels (Feng et al., 2013; Feng, Ng, Chuah, Niti, & Kua, 2006;
Vidal, Dufouil, Ducros, & Tzourio, 2008). Hyperhomocysteinemia, the condition of having high
homocysteine levels, has also been linked to lower global cognition (Di Bonito et al., 2007). The
pathways by which high homocysteine levels may negatively impact cognition are not wellestablished; however, it is thought that high levels of homocysteine damage the vascular
endothelium (i.e., interior lining of blood and lymphatic vessels) and increase risk for thrombosis
and atherosclerosis (Arnesen et al., 1995; Graham et al., 1997). Therefore,
hyperhomocysteinemia could be considered an indicator for endothelial dysfunction (Meigs et
al., 2001). These factors could, in turn, lead to cognitive impairment. It has also been proposed
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that direct neurotoxic effects might explain the link between high homocysteine levels and
cognitive impairment, or that insulin resistance might mediate this relationship (Di Bonito et al.,
2007). Indeed, T2DM, the hallmarks of which are insulin resistance and hyperglycemia, is
among the strongest predictors of peripheral arterial disease (PAD), a vascular disease marked by
atherosclerosis (American Diabetes Association, 2003). Interestingly, lowering homocysteine
levels (e.g., via folate or B12 supplements) has not been reliably shown to slow cognitive decline
(Vogel, Dali-Youcef, Kaltenbach, & Andrès, 2009). This may suggest a number of possibilities,
including hyperhomocysteinemia being an indicator, but not necessarily a cause, of endothelial
dysfunction. It may also suggest an inability to recover from previous damage, the strong
importance of other factors (e.g., diet, exercise) that likely remain unchanged, or limitations in
research methodology.
Low folate levels have been associated with worse episodic memory and language
ability, but its association with processing speed is less clear (Feng et al., 2006; Jelicic, Jonker, &
Deeg, 2001). Findings on the ability of folic acid supplementation to improve processing speed
have been mixed (Durga et al., 2007; Malouf & Evans, 2008; Vogel et al., 2009). In addition,
some have suggested that low vitamin B12 levels impact the relationship between folate levels
and cognition, but findings on the direction of this effect have been contradictory (Doets et al.,
2014; Moore et al., 2014).
Vitamin B12 deficiency (typically defined within the range of ≤ 145–260 pmol/L) is
associated with a variety of cognitive impairments (e.g., memory problems, slowed thinking,
confusion), and it has been hypothesized that cognitive impairments may also occur among
elderly with a low-normal range of this vitamin (Hector & Burton, 1988; Leishear, Ferrucci, et
al., 2012; Smith & Refsum, 2009). One recent study also found lower vitamin B12 plasma level
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to be associated with greater processing speed decline over a period of six years (Leishear,
2011). Furthermore, lower vitamin B12 plasma levels are related to poor sensory and motor
peripheral nerve function (Leishear, Boudreau, et al., 2012).
Iron deficiency has also been associated with lower scores on a screening instrument for
cognitive impairment among a sample of elderly hospital patients, although it is not known if
iron deficiency is specifically associated with processing speed in the elderly (Yavuz et al.,
2012). Among those with iron-deficiency, anemia, a condition that is sometimes caused by
deficiencies in iron, folate, or vitamin B12, has been linked to worse global cognition (MurrayKolb & Beard, 2007). Furthermore, severity of anemia has been found to adversely impact
processing speed to a greater extent than other cognitive domains (Murray-Kolb & Beard, 2007).
Low levels of vitamin D are associated with poor processing speed, with this relationship
being most salient when 25-hydroxyvitamin D level is below 35 nmol/L (Lee et al., 2009). It
may also be possible that vitamin E and vitamin C also impact processing speed. For example,
vitamin E intake was shown to predict better performance on a battery of cognitive tests that
included a processing speed measure (Morris, Evans, Bienias, Tangney, & Wilson, 2002).
Results of another study suggest that vitamin C deficiency, but not necessarily vitamin C level
itself, may be associated with greater age-related cognitive decline in the general population
(Harrison, 2012).
In regard to the present study, it was hypothesized that individuals with low vitamin D
level would perform worse on the processing speed task. Low vitamin D level was operationally
defined as 25-hydroxyvitamin D level < 35 nmol/L based on the aforementioned work of Lee
and colleagues (2009). Note that the current Merck Manual, Professional Edition states that
target 25-hydroxyvitamin D levels are approximately 50 to 60 nmol/L for maximal bone health
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but does not provide a specific definition of vitamin D deficiency (Johnson, 2016b). Concerning
homocysteine and folate, high homocysteine levels were expected to be related to worse
performance independent of folate levels. Folate levels, however, were not expected to be
significantly correlated with processing speed independent of homocysteine levels. It was
difficult to make further hypotheses with confidence given the complicated nature of
homocysteine, folate, vitamin B12, iron, and vitamins C, D, and E, but a number of exploratory
hypotheses were made in the hypothesis section of this document. For the purposes of these
exploratory analyses, folate deficiency was defined as serum folate < 1.4 ng/mL, as suggested by
the 1999–2000 CDC Laboratory Procedure Manual in regard to interpretation of results from the
Bio-Rad Laboratories’ “Quantaphase II Folate/Vitamin B12” Radioassay Kit. Iron deficiency
was operationally defined as a serum ferritin level of < 22µg/L, as this has been found to be the
optimal serum ferritin cutoff point for the diagnosis of iron deficiency within communitydwelling older adults (Choi et al., 2005). Vitamin B12 deficiency was defined as < 145 pmol/L
and low-normal vitamin B12 level as 145–260 pmol/L, as per the current Merck Manual,
Professional Edition (Johnson, 2016a). Vitamin E deficiency was defined as alpha-tocopherol <
11.6 µmol/L or, for adults with hyperlipidemia, a ratio of serum alpha-tocopherol to total lipids
of < 0.8 mg/g (Johnson, 2016c). Alpha-tocopherol was chosen rather than gamma-tocopherol,
another form of vitamin E with values also available in the NHANES database, because research
has shown low alpha-tocopherol to be associated with cognitive impairment and dementia in
community-dwelling older adults (Cherubini et al., 2005). Also note that, although both serum
and red cell folate assays were performed as part of the NHANES, all analyses in the present
study used the serum assay results due to a number of recent findings indicating its relative
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utility in determining folate deficiency (De Bruyn, Gulbis, & Cotton, 2014; Farrell, Kirsch, &
Herrmann, 2013; Galloway & Rushworth, 2003).
Other correlates. Usual slow gait speed and gait speed variability when fast-walking
have been linked to worse global cognition and MCI, respectively (Beauchet, Allali, Launay,
Herrmann, & Annweiler, 2013; Deshpande, Metter, Bandinelli, Guralnik, & Ferrucci, 2009).
Such gait changes typically precede onset of cognitive symptoms in those who go on to develop
MCI or dementia (Buracchio, Dodge, Howieson, Wasserman, & Kaye, 2010). These gait
patterns are not causally linked to cognitive dysfunction in these individuals, but they are
believed to be a result of the same underlying pathological process. Other factors that may slow
an individual’s gait speed include psychomotor slowing secondary to depression and relative
difficulty walking secondary to obesity, injury, or disability (Atkinson et al., 2007). In regard to
the present study, it was hypothesized that gait speed would remain positively correlated with
processing speed task performance after controlling for BMI.
Processing Speed Assessment and the Digit-Symbol Substitution Test
Processing speed can generally be defined as the rate at which information can be
processed (Lichtenberger & Kaufman, 2009). However, it is difficult to obtain a pure measure of
this construct due to a number of confounds in testing. Processing of visual information, for
example, depends on a number of other factors, including the integrity of one’s vision, ability to
perceive the visual information properly as a whole, and attention capacity. When the processing
speed measure requires a written response, motor control and speed may confound results.
Furthermore, certain processing speed tests place more attention on visual scanning and attention
to detail than others, and some researchers have distinguished processing speed tests based on
such considerations. For example, although both require visual processing in a divided-attention
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format, Kuo et al. (2006) refers to the Useful Field of View (UFOV) as a measure of visual
processing and the DSST as a measure of motor processing speed, seemingly due to the
relatively high visual scanning demands of the former and motor demands of the latter.
However, labels applied by researchers to the same processing speed test are often different; for
example, the DSST, which is historically among the most used measures of processing speed,
has been referred to as a measure of motor processing speed, information processing speed,
visuo-attentional psychomotor speed, psychomotor functioning, and general cognitive ability by
various researchers (González-Blanch et al., 2011; Kuo et al., 2006; Lafont et al., 2010; Lee et
al., 2012; Pieters, Maas, & Hulstijn, 2004). Some researchers also decline to label the DSST,
instead providing a description of domains it has been used to assess (e.g., Nakahachi et al.,
2008). This raises the question of what the DSST actually measures, the answer to which is
especially important given the vast amount of research using this measure.
The DSST is a test in which numbers are paired with symbols in a key at the top of a
page, and the participant has 120 seconds to copy symbols to corresponding numbers as quickly
and accurately as possible. Individuals must be able to complete the sample items and have no
significant visual or motor limitations in order to be administered the test. Scores are based on
the number of symbols that were copied correctly. Research indicates that Symbol Copy, an
optional measure on the Wechsler Adult Intelligence Scale, Third Edition (WAIS-III) and the
Wechsler Adult Intelligence Scale-Revised as a Neuropsychological Instrument (WAIS-R-NI)
that simply requires subjects to copy symbols from one box to another box below it, accounts for
35–50% of the DSST score variance (Joy et al., 2003; Joy, Fein, Kaplan, & Freedman, 2000;
Kreiner & Ryan, 2001). Symbol Copy has generally been considered to be a measure of “motor
skill” or “speed” (Joy et al., 2003; Kreiner & Ryan, 2001). Joy and colleagues (2003) further
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broke down this variable by assessing for graphomotor speed in a name-writing task. They
concluded that the Symbol Copy variable likely contains both graphomotor and perceptual speed
components, with the graphomotor component accounting for approximately half of the DSST
score variance that is explained by Symbol Copy. Visual scanning efficiency is also very
important in the DSST, as Joy and colleagues (2003) found 34% of the DSST score variance to
be explained by performance on a visual scanning measure. Memory/learning, although still
statistically significant, appear to be less important in explaining DSST scores, accounting for
only 4–5% of the variance (Joy et al., 2000, 2003; Kreiner & Ryan, 2001). One study even
failed to find a statistically significant association between DSST performance and paired
associative learning in older adults (Stephens & Kaufman, 2009). These findings imply that
subjects may not benefit from memorizing number-symbol pairs on the DSST, which Joy and
colleagues (2003) attempt to explain by hypothesizing that accessing memory to retrieve a
symbol may actually take longer than looking at the key to retrieve the symbol, especially as the
number of memorized symbols increases. Recently, it has been proposed that the DSST also
taps executive functioning on the basis that DSST scores correlate with the Letter-Number
Sequencing subtest of the Delis-Kaplan Executive Functions System (D-KEFS) Trail-Making
Test to a greater extent than the other subtests (Davis & Pierson, 2012). Finally, it has been
hypothesized that fine motor speed and manipulative dexterity may also contribute to DSST
scores (Joy et al., 2003). Their roles have not been established, but gait speed has been
positively associated with DSST scores (Killane et al., 2014). To summarize, DSST scores
appear to primarily reflect graphomotor speed, perceptual speed, visual scanning ability, and
executive functioning, although other areas such as learning and memory may play a smaller, yet
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still significant, role. It should be noted here that there are a number of DSSTs, including the
WAIS-III Digit Symbol—Coding subtest (CD) that is used in the NHANES.
The multifaceted nature of the DSST makes interpreting its scores with regard to one
specific cognitive domain difficult; however, this characteristic may also allow for its clinical
utility in screening for cognitive dysfunction arising from a variety of sources, and especially
those arising from generalized processes (González-Blanch et al., 2011; Joy, Kaplan, & Fein,
2004). For example, the DSST is particularly sensitive to cognitive impairment in multiple
sclerosis and schizophrenia, and is a predictor of stroke and heart disease independent of known
vascular risk factors (Elkins, Knopman, Yaffe, & Johnston, 2005). The latter suggests the
possible utility of DSST scores as an early indicator of poor health prognosis as a function of a
premorbid disease state. The DSST is also highly sensitive to aging and age-related changes in
brain morphology, and is useful in predicting incident disability, decline in basic and high levels
of functional capacity in daily activities, AD, and mortality (Iwasa et al., 2008, 2014; Mosley et
al., 2005; Rapp & Reischies, 2005; Salthouse, 1992).
Justification for the Present Study and Structure of NHANES Database
Obesity has been associated with cognitive impairment in nearly all cognitive domains.
The exact etiological processes that explain this relationship have not been fully elucidated. For
example, it is unclear whether the association between obesity and cognitive impairment is
independent or can be sufficiently explained by mediating variables (e.g., T2DM, hypertension).
In addition to focusing on medical diagnoses as mediating variables (as the majority of research
in this area does), it is important to consider the contribution of lower-level obesity-related
factors (e.g., low grade inflammation, increased circulation of adipocyte hormones, endothelial
dysfunction, insulin resistance, leptin resistance, hypoventilation) that may underlie a number of
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obesity-related disorders, as well as be present among obese individuals without obesity-related
disorders. Furthermore, it may be the case that lower-level obesity-related factors that contribute
to cognitive decline have an increased effect if the individual is exposed to a greater magnitude
(e.g., more hormones released from adipose tissue) and/or over a greater time period (e.g.,
chronic low-grade inflammation in the chronically obese person). Therefore, it follows that
knowledge of a person’s weight history, which may serve as a proxy for a number of lower-level
obesity variables, may provide additional utility in predicting cognitive functioning than history
of medical diagnoses alone. There has been some evidence to support the notion that weight
history may impact cognition; however, this area of study is in its infancy, and its data have not
been adequately synthesized.
The present study adds to the body of scientific literature in this area by examining the
relationship between weight history (beginning in early adulthood) and current processing speed
among the young-old (i.e., ages 65–74). The period of early adulthood to age 65–74 greatly
extends the length of weight history in any published study on the relationship between weight
history and processing speed. The young-old population and the domain of processing speed
were chosen in the present study for a number of reasons, including: (a) the number of elderly
with significant history of obesity is growing in the United States; (b) processing speed may be
foundational to other cognitive processes and drive cognitive aging (Finkel et al., 2007;
Salthouse, 1996; Vance, 2009); (c) processing speed in the elderly is predictive of a number of
outcomes, including time to complete everyday tasks, life satisfaction, and longevity, to an equal
or greater extent than other cognitive domains (Enkvist et al., 2013; Owsley et al., 2002).
Furthermore, it should be noted here that the young-old population was selected for the
present study due to consideration of available NHANES variables (e.g., weight “ten years
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ago”), consideration of age ranges studied in extant literature in this area (in order to inform this
study’s hypotheses), and consideration of the utility of limiting the study to a relatively small age
range due to the sensitivity of a number of the relationships of interest to age. Furthermore, it
was noted that the large sample size of NHANES allow for the narrowing of age range without
sacrificing the necessary statistical power for the present study’s analyses.
The 1999–2000 and 2001–2002 NHANES cycles were chosen for the present study due
to their inclusion of a processing speed measure, whereas subsequently completed cycles have
not. The variables of these cycles that are relevant to the present study are included in
Appendixes A–L and in the methods section of this document. The present study makes a
number of hypotheses regarding the relationships among NHANES variables and culminates
with creation of a model to explain poor processing speed among those with long-term obesity.
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Research Hypotheses

Basic Relationships
The following hypotheses or groups of hypotheses involve basic relationships that would
have either replicated those previously reported in the literature or have been very similar to
those already reported in the literature:

(1) Age and DSST performance:
There would be a strong negative correlation between age and processing speed task
performance (DSST score).

(2) Age and obesity indexes:
(a) Overall indexes: There would be a weak, non-significant negative correlation between
age and BMI but a significant positive correlation between age and % total body fat
measured by DEXA.
(b) Central indexes: There would be no significant correlation between age and WC but a
significant positive correlation between age and % trunk fat measured by DEXA.

(3) Substance use and DSST performance:
(a) Those with probable lifetime history of excess alcohol consumption (i.e., answered
yes to “Was there ever a time or times in your life when you drank 5 or more drinks of
any kind of alcoholic beverage almost every day?”) would exhibit worse processing
speed task performance.
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(b) Those with probable past-year excess alcohol consumption (i.e., endorsed consuming
5 or more drinks on half or more of the days during the past year) would exhibit worse
processing speed task performance.
(c) Those who currently smoke cigarettes would perform worse on the DSST than those
who do not currently smoke cigarettes.

(4) Exercise and DSST performance:
For the purposes of the following hypotheses, the following groups are defined:
Aerobic-only group: reported at least 60 minutes of moderate or vigorous aerobic
exercise per week but no instances of past-month strength training
Strength training-only group: reported at least 8 instances of past-month strength training
but no moderate or vigorous aerobic past-month exercise
Combination training group: reported at least 60 minutes of moderate or vigorous aerobic
exercise per week and at least 8 instances of past-month strength training
No exercise group: denied past-month vigorous exercise, moderate exercise, and strength
training

(a) The no exercise group would perform worse on the DSST than the aerobic-only,
strength training-only, and combination training groups.
(b) The aerobic-only group would perform better on the DSST than the strength trainingonly group.
(c) The combination training group would perform better on the DSST compared to the
aerobic-only, strength training-only, and no exercise groups.
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(5) Diabetes status and DSST performance:
For the purposes of these hypotheses, the following groups were operationally defined:
Diabetes group: Those with diagnosed history of diabetes or with fasting glucose or
HbA1c levels in the diabetic range.
Prediabetes group: Those without diagnosed history of diabetes who are not currently
taking antidiabetic medication and have fasting glucose or HbA1c levels in the prediabetic
range.
No diabetes group: Those without diagnosed history of diabetes who are not currently
taking antidiabetic medication and have fasting glucose and HbA1c levels in the normal
range.

(a) The diabetes group would perform worse on the DSST than the prediabetes and no
diabetes groups.
(b) The prediabetes group would perform worse on the DSST than the no diabetes group.

Main Hypotheses
The following hypotheses or groups of hypotheses involve relationships that have either
not been investigated to-date or have not been reported in the literature with consistency:

(6) Nutritional biochemistry and DSST performance:
(a) Homocysteine levels would be negatively correlated with processing speed
independent of serum folate levels.
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(b) Serum folate levels would not be significantly correlated with processing speed
independent of homocysteine levels.
(c) Those with low 25-hydroxyvitamin D levels (< 35 nmol/l) would perform worse on
the processing speed measure than those with healthy vitamin D levels.
Exploratory (less support from the literature):
(d) Those with iron deficiency would perform worse on the processing speed task than
those without iron deficiency.
(e) Vitamin E levels would be positively correlated with the processing speed measure
performance.
(f) Total number of nutrient deficiencies (i.e., vitamin B12, vitamin D, vitamin E, folate,
iron) would be negatively correlated with processing speed task performance.

(7) Obesity indexes and DSST performance:
(a) DSST scores would not be significantly correlated with the overall obesity indexes
(i.e., BMI, % DEXA total body fat).
(b) DSST scores would be significantly negatively correlated with the central obesity
indexes (i.e. WC, WTR, WHtR, and % DEXA trunk fat).
(c) Among those who are centrally obese (defined here as WC ≥ 102 cm for men and 88
cm for women):
(1) Individuals meeting BMI obesity criteria (i.e., BMI ≥ 30 kg/m2) would
perform worse on the DSST.
(2) Individuals meeting DEXA obesity criteria (fat mass ≥ 25% for men and ≥
35% for women) would perform worse on the DSST.
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Exploratory (less support from the literature):
(d) The best combination of obesity indexes to predict DSST score is unknown; however,
it was hypothesized that the combination would involve % DEXA trunk fat.

(8) Weight trajectory and DSST performance:
The groups in Hypotheses 8a-8c are defined in Table 1. Note that individuals who were
underweight (i.e., BMI < 18.5 kg/m²) at one or more of the three timepoints were
excluded from these analyses.

(a) Groups 1 and 2 would perform the worst on the DSST.
(b) Group 8 would perform the best on the DSST.
(c) Groups 4, 6, and 7 would perform better than Groups 1 and 2.
(d) Percent of weight gained between early adulthood (age 25) and late middle-age (10
years ago, which would be ages 55–64 in this study) would be associated with worse
performance on the DSST.
(e) Absolute value of percent of weight change over the previous 10-year period would
be associated with worse performance on the DSST.
(f) Individuals endorsing significant past-year unintentional weight loss would perform
worse on the DSST than those who achieved significant past-year weight loss that
was intentional and those who were past-year weight-stable.
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Table 1
Hypotheses 8a–8c Groups
Obese at age 25

Obese 10 years ago

Obese currently

Group 1

Y

Y

Y

Group 2

Y

Y

N

Group 3

Y

N

Y

Group 4

Y

N

N

Group 5

N

Y

Y

Group 6

N

Y

N

Group 7

N

N

Y

Group 8

N

N

N
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(9) Peripheral inflammation and DSST performance:
There would be a significant negative correlation between a marker of peripheral
inflammation (i.e., CRP level) and processing speed performance, which would remain
significant after controlling for health condition and smoking confounds.

(10) Medical history and DSST performance:
(a) Those who endorsed one or more of the following conditions would perform worse on
the DSST than those who did not endorse any: problems of blood flow to the heart
typically leading to or involving heart muscle damage (i.e., congestive heart failure,
coronary heart disease, heart attack), stroke, diabetes, weak/failing kidneys, chronic
respiratory disease (i.e., chronic bronchitis or emphysema), and thyroid disease (if
untreated).
(b) Duration of respiratory disease would be negatively correlated with processing speed
task performance.

(11) Dyslipidemia and DSST performance:
Those with dyslipidemia (i.e., unhealthy levels of total cholesterol, HDL cholesterol,
LDL cholesterol, and/or triglycerides) would demonstrate worse processing speed task
performance.

(12) Framingham risk scores and DSST performance:
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(a) Risk of first stroke, as indicated by score on the modified version of the FSRP, would
be inversely associated with processing speed. Note that the modified version of the
FSRP, as defined previously in this document, includes age, systolic blood pressure,
antihypertensive medication, diabetes, smoking status, CHD, and congestive heart failure.
(b) Risk of onset of CVD, as indicated by FRS for general CVD scores, would be
inversely associated with processing speed task performance.

(13) Gait speed and DSST performance:
There would be a significant positive correlation between speed of usual gait and
processing speed task performance, which would remain significant after controlling for
BMI.

Final Model
Finally, the present study used structural equation modeling (SEM) to develop a model of
the relationship between weight trajectory and DSST performance. Specifications of the model
depended on observed relationships between study variables, which were hypothesized to be
consistent with theoretical relationships addressed in the literature review and tested by many of
the aforementioned hypotheses. A theoretical mapping of relationships based on the literature
review is shown in Figure 1, although this mapping was modified extensively based on the
results of tests of relevant hypotheses and practical limitations. In regard to Figure 1, it should
be noted that potential causes of processing speed decline that underlie a number of variables on
this map (e.g., oxidative stress, endothelial dysfunction, central inflammation) can be causes of a
number of factors, while also contributing to the development or persistence of these factors.
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Due to their complicated interactions and the lack of biological markers for many of these
variables in the NHANES database, they were omitted from the theoretical mapping of
relationships in Figure 1, although they did influence reasoning behind many of the hypothesized
relationships in the theoretical mapping.
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Diet/nutrient hx

Current diet/nutrients

Peripheral inflammation

DSST score

Persistent obesity

Depression

Dyslipidemia
Physical
inactivity hx

Brain oxygen flow disruption/ insufficiency
indicators:

Current
physical
inactivity

Atherosclerosis
Problems of blood flow to the heart typically
leading to or involving heart muscle damage:
CHD, heart attack, CHF

Insulin resistance

Hyperglycemia

Ischemic stroke
Chronic hypoventilation during sleep or awake
periods: e.g., OSAS, OHS

Hypertension hx

Chronic respiratory disease: chronic asthma
chronic bronchitis, emphysema

Figure 1. Theoretical model of relationship between persistent obesity and DSST score. Error
terms are not shown.
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Method
Participants
The present study’s sample consists of the young-old men and women aged 65–74 (n =
1,381) who completed the National Health and Nutrition Examination Survey (NHANES) during
the years 1999–2002. NHANES participants were chosen to be representative of the United
States population; however, individuals aged 12–19 and over 70 years, as well as certain
racial/ethnic/socioeconomic groups (i.e., Non-Hispanic Black, Mexican American, and lowincome Caucasian individuals), were oversampled due to being “of particular public health
interest” (NHANES Plan and Operations, 1999–2010). NHANES participants were drawn from
urban, suburban, and rural locations across the United States, and are of diverse education
backgrounds. The aforementioned number of participants aged 65–74 who completed the
NHANES during the years 1999–2002 was found to be sufficient for the present study’s
secondary analyses based on an a priori power analysis using an expected medium effect size (f
= .25) and power = 0.8, which yielded a minimum total sample size for a one-way analysis of
variance (ANOVA) with eight groups to be 240 for a 95% confidence interval. See Table 2 for
participant characteristics.
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Table 2
Participant Characteristics
Demographic variable
Age (years)
BMI (kg/m²)
BMI category
Underweight
Normal weight
Overweight
Obese
Gender
Male
Female
Race/Ethnicity
Non-Hispanic White
Non-Hispanic Black
Mexican American
Other Hispanic
Other Race–Including Multiracial
Education
Less Than 9th Grade
9-11th Grade (Includes 12th grade with no diploma)
High School Grad/GED or Equivalent
Some College or AA degree
College Graduate or above
Marital status
Married/Living with Partner
Divorced/Separated
Widowed
Never married
Employment status
Not employed
Employed full-time
Employed part-time
Annual household income
< $10,000
$10,000-$19,999
$20,000-$34,999
$35,000-$54,999
$55,000-$75,000
> $75,000

All participants (n = 1,381)a
69.3 (2.9); 65–74
28.5 (5.8); 10.8-56.3
1.2
26.1
38.5
34.2
50.5
49.5
50.6
19.0
24.0
4.5
1.9
28.2
17.8
21.8
18.3
13.8
64.2
12.4
18.9
4.3
81.1
10.2
8.7
12.8
23.8
24.8
17.5
8.4
10.9

Note. Data are presented as percentages for all categorical variables, and as M (SD); range for Age and BMI.
a
n = 1,381 except for BMI and BMI category (n = 1,373), education (n = 1,374), marital status (n = 1,317),
employment status (n = 1,379), and annual household income (n = 1,133).
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Measures
It should be noted here that, due to the length and number of interviews in the NHANES,
only questions from the interviews that are theoretically relevant to the present study are
included in the appendices. These questions remain in the order in which they were asked. It
should also be noted here that the NHANES “questionnaires” in the appendices are actually
personal interviews conducted by NHANES staff or computerized questionnaires completed with
the assistance of NHANES staff. Questions were directed toward the sampled person, but a
proxy was used if the sampled person (abbreviated SP in the appendixes) needed assistance.
Socio-demographics. Socio-demographic information was collected in the Demographics
Questionnaire (Appendix A) and Occupation Questionnaire (Appendix B), which included
gender, age, race/ethnicity, education, marital status, number of people living in the household,
household income, and employment status.
Anthropometric measures. Current height and weight were measured with a stadiometer
and digital scale, respectively (NHANES Anthropometry Procedures Manual, 2000). Using the
Weight History Questionnaires, which is a personal interview conducted by NHANES staff,
participants were also asked to self-report their current weight and height, as well as recall their
weight at 1-year ago and 10-years ago, and weight and height at age 25 (Appendix C). Selfreported highest and lowest adult weight (excluding times of pregnancy) and corresponding ages
were also collected. Height and weight allow body mass index (BMI) to be calculated at each of
these timepoints. Current waist circumference (WC) and current thigh circumference were
determined using measuring tape at a standard position, which allows current waist-thigh ratio
(WTR) to be calculated. Additionally, current WC and height allow current waist-height ratio
(WHtR) to be calculated.
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Dual energy x-ray absorptiometry (DEXA) was conducted with a Hologic Densitometer
QDR4500A, allowing the following to be measured or estimated: total mass, fat mass, bone
mineral content (BMC), lean mass excluding BMC, lean mass including BMC, percent body fat,
and trunk fat (NHANES Body Composition Procedures Manual, 2000). DEXA has good
psychometric properties regarding measuring total fat and trunk fat. For example, total body fat
measured by DEXA shows strong correlations with total body fat measured by computerized
tomography (CT) and magnetic resonance imaging (MRI) -based T-1 mapping (Kullberg et al.,
2009). Furthermore, trunk fat measured by DEXA has been shown to strongly correlate with
trunk fat measured by CT scan among the elderly (r = 0.87 to 0.98 depending on gender and
race/ethnicity), indicating good convergent validity in this population (Snijder et al., 2002).
Wechsler Adult Intelligence Scale, Third Edition (WAIS-III) Digit Symbol—Coding
subtest. The WAIS-III Digit Symbol—Coding subtest (CD) is a digit symbol substitution test
(DSST). It is broadly intended to measure processing speed, and is one of two subtests of the
Processing Speed Index (PSI) of the WAIS-III. In the CD, numbers are paired with symbols in a
key at the top of the page, and the subject has 120 seconds to copy the symbols to corresponding
numbers below the key as quickly and accurately as possible. Individuals who cannot complete
the sample items or have significant visual or motor limitations are excluded from taking this
test. The CD score is the number of symbols that were copied correctly. There are 133 total
items, and therefore, scores range from 0–133, with higher scores indicating better performance.
Broadly, the CD is a measure of processing speed; however, more specifically, as reported in
detail previously in this document, DSST scores appear to primarily reflect graphomotor speed,
perceptual speed, and visual scanning ability, although other areas such as executive functioning
and learning/memory may play a smaller, yet still significant, role.
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The WAIS-III Digit Symbol—Coding subtest (CD) has acceptable test-retest reliability
among 65–74-year olds, which is the age range of the population in the present study (r = .86;
The Psychological Corporation, 1997). Acceptable reliability is also indicated by a standard
error of measurement of 1.12 among 65–74-year olds (The Psychological Corporation, 1997).
The CD also shows acceptable criterion validity, as evidenced by a correlation of .77 between
WAIS-III and Wechsler Adult Intelligence Scale-Revised (WAIS-R) versions of this subtest
among a sample of 16–74-year olds, as well as a correlation of .77 between WAIS-III and
WISC-III versions of this subtest among a sample of 16-year-olds (The Psychological
Corporation, 1997). Discriminant validity of the CD is reflected by a weak correlation (r = .25)
with the Raven’s Standard Progressive Matrices (SPM), an untimed test of reasoning.
Convergent validity is indicated by a strong negative correlation (r = -.46) between scores on the
WAIS-R version of the CD (which is very similar to the WAIS-III version of the CD) and the
Useful Field of View Test (UFOV), a test of visual processing speed in which higher scores
indicate worse performance (Lunsman et al., 2008).
Memory impairment. Participants are asked if they are limited in any way due to
difficulty remembering or periods of confusion. They may answer yes, no, don’t know, or refuse
to answer.
Medical conditions. Information regarding medical conditions was collected using a
number of interviews, including the Blood Pressure Questionnaire (Appendix D), the Diabetes
Questionnaire (Appendix E), the Medical Conditions Questionnaire (Appendix F), and the
Kidney Conditions Questionnaire (Appendix G). More specifically, participants were asked
whether they had ever been diagnosed with certain medical conditions, as well as age at first
diagnosis. Diagnoses relevant to this study include asthma, cancer, congestive heart failure,
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coronary heart disease, diabetes, hypercholesterolemia, hypertension, kidney failure, stroke,
emphysema, thyroid disease, and chronic bronchitis. If endorsed, participants were asked to
identify type(s) of cancer as well as whether they still had thyroid disease or chronic bronchitis,
whether they had an asthma attack in the past-year, and whether they’d been to the emergency
room or urgent care for asthma in the past year. If endorsed, they were also asked whether they
took insulin for diabetes (and for how long), whether they took pills for diabetes, and whether
they took prescription drugs for hypertension or hypercholesterolemia. Participants were asked
if they had been treated for anemia in the past three months, although they were not asked if they
had anemia. Finally, participants were asked whether any family members had Alzheimer
disease (AD) and, if so, to identify the family member’s relationship to them (e.g., mother,
father).
Physical activity. Information regarding physical activity was collected using the
Physical Activity Questionnaire (Appendix H) and the Physical Activity Individual Activities
File (Appendix I). Participants were asked to rate their average level of daily physical activity
out of four options. The interviewer then defined moderate and vigorous activities, gave
examples for the participant, and then asked if the participant had engaged in any moderate or
vigorous activities lasting at least ten minutes in the past month. If moderate or vigorous
activities were endorsed, the type of activity, past-month frequency, and duration was collected.
Frequency of any strength training exercises was then collected. Participants were asked to
report any strength training exercises even if they had included them in the moderate or vigorous
activity report.
There is no psychometric data available regarding this particular set of questions. For the
purposes of the present study, minutes of aerobic exercise per week was calculated using items
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PAD200 and PAD320 of the Physical Activity Questionnaire (Appendix H) and items
PADACTIV, PADTIMES, and PADDURAT of the Physical Activity Individual Activities File
(Appendix I). Likewise, number of sessions of strength training per week was calculated using
items PAD440 and PAD460 of the Physical Activity Questionnaire (Appendix H).
Generally, there is little agreement on how to best assess physical activity in the elderly
(Kowalski, Rhodes, Naylor, Tuokko, & MacDonald, 2012). The only systematic review and
meta-analysis of validity of indirect measures of physical activity in older adults to-date found
that self-reported physical activity in the elderly showed a moderate correlation with direct
measures of physical activity (Kowalski et al., 2012). However, it should be noted that the
validity of many direct measures of physical activity that are developed primarily on middleaged samples are questionable among the elderly population due to metabolic or physical activity
characteristics. For example, accelerometers are generally less accurate recording lower
intensity level activities, which elderly individuals are more likely to do (Garatachea, Luque, &
Gallego, 2010; Kowalski et al., 2012). Therefore, there currently appears to be no clear “gold
standard” for assessing physical activity in the elderly.
Diet. Information regarding diet was collected using the Diet Behavior and Nutrition
Questionnaire and the Dietary Interview. In regard to the former, participants were asked to
estimate the number of fruits/fruit juices and vegetables they typically consume per day (see
Appendix J). In regard to the latter, participants were asked to recall all food and beverage
consumed during the previous day (i.e., midnight to midnight). To improve accuracy of recall,
participants were asked time, occasion, and place of consumption of each food and beverage they
recalled and were shown a list of foods that individuals tend to forget to report. Participants
were then asked about specific details of each food and beverage consumed, including amount.
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Finally, all reported foods and beverages were repeated to the participant in chronological order
for confirmation or correction. Additional information regarding the Dietary Interview can be
found in the NHANES Dietary Interview Manual (NHANES Dietary Interview Manual, 1999–
2000). Previous day total fat and total saturated fat are estimated using the Dietary Interview
data. There are no psychometric data available on the Diet Behavior and Nutrition Questionnaire
or the Dietary Interview.
Blood pressure. NHANES blood pressure protocol was based on recommendations of
the American Heart Association. More specifically, blood pressure was taken by a physician or
health technologist using a mercury sphygmomanometer. Three to four trials were obtained. In
order to calculate a final blood pressure score, the first blood pressure reading was dropped and
the other readings were averaged. For participants who only completed one blood pressure trial,
the first blood pressure score was used for the final blood pressure score. Any diastolic readings
that were zero were dropped from computing the average unless there were only zero readings.
A zero reading likely indicates that the diastolic pressure was not measurable on that trial.
Cholesterol, triglycerides, C-reactive protein, glucose, and insulin. Total cholesterol,
high-density lipoprotein (HDL) cholesterol, triglycerides, C-reactive protein (CRP), fasting
glucose, and fasting insulin were measured using blood samples. Low-density lipoprotein (LDL)
cholesterol was calculated from total cholesterol, HDL cholesterol, and triglycerides.
Homeostasis model assessment of insulin resistance (HOMA-IR) was calculated from fasting
glucose and fasting insulin.
Nutritional biochemistries. Measurements of vitamin D, vitamin E, folate (serum and
red cell assays), vitamin B12, homocysteine, and iron were obtained via blood tests.
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Substance use history. Information regarding current smoking and smoking history was
collected using the Smoking Questionnaire (Appendix K). Information regarding current and
past alcohol use was collected using the Alcohol Use Questionnaire (Appendix L). There are no
psychometric data available on these questionnaires.
20-foot-walk test. The 20-foot-walk test is a frequently used measure of gait speed (e.g.,
Atkinson et al., 2007; Okoro et al., 2006). In this test, participants are asked to walk down a 20foot unobstructed hallway or track. Instructions to the participant vary according to the study.
Typically, participants are either told to walk at their usual pace or walk at a fast pace. The
present study used the 20-foot-walk test to assess usual pace of walking. Assistive devices (e.g.,
canes, walkers) were allowed if typically used. Time was measured using a hand-held
stopwatch.
Despite the frequency of use of this test, little has been published on its psychometric
properties. It has shown to produce reliable ratings of gait speed relative to the 8-foot-walk test
(ICC 0.912; Newton, Kilma, & Cromwell, 2006). Some concerns have been raised regarding
test-retest reliability in similar tests, namely the 10-meter-walk and 20-meter-walk tests. In these
tests, the first trial appears to be significantly slower than subsequent trials (Green, Forster, &
Young, 2002; Motyl, Driban, McAdams, Price, & McAlindon, 2013). Information on the testretest reliability of the 20-foot-walk test has not been published to-date.
Medical treatments. Participants were asked to list all prescription medications that they
are currently taking, as well as number of times each medication was taken in the past 30 days.
They were also asked to show the prescription bottles to NHANES staff. Additionally,
participants were asked whether they had received cancer chemotherapy in the past 4 weeks or
planned to receive cancer chemotherapy in the next 4 weeks. Although this question on
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chemotherapy was asked to determine eligibility for venipuncture, it can be used to more
inclusively describe medical treatments.
Procedures
The present study involved analysis of data from the National Health and Nutrition
Examination Survey (NHANES) collected throughout the country between 1999 and 2002. The
NHANES created by the National Center for Health Statistics (NCHS) in order to collect health
and nutrition data on individuals of all ages living in the United States to provide to the Centers
for Disease Control and Prevention (CDC) for the purposes of guiding public health action and
policy (NHANES Plan and Operations, 1999–2010). The NHANES protocol received approval
from the NCHS Research Ethical Review Board and was reviewed annually. The present study
used publically-available NHANES data. No additional permissions were required, and
exemption status from the Eastern Michigan University’s Institutional Review Board was
obtained in April 2015 (see Appendix M).
NHANES procedures are explained elsewhere (NHANES Plan and Operations, 1999–
2010). Briefly, identification of potential participants was accomplished via a multistage
probability sampling design aimed at enrolling a sample that is representative of the United
States civilian noninstitutionalized household population, although certain populations
(individuals aged 12–19, those aged over 70 years, Non-Hispanic black, Mexican American, and
low-income Caucasian individuals) were oversampled due to being “of particular public health
interest” (NHANES Plan and Operations, 1999–2010). Counties or groups of nearby small
counties were divided into neighborhoods, which were selected at random. Residences within
each selected neighborhood were then selected at random. The residence was then visited by an
NHANES researcher, who determined the eligibility of each resident using a screening
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questionnaire that solicited basic demographic data (e.g., age, gender, race). The researcher
entered this information into an electronic device that reported whether each participant was
eligible, which was based on match with the latest census data. Those identified as eligible were
provided information about the study and asked if they would be willing to participate. For each
of the two phases of NHANES participation, the home interview and the health examination,
documented written consent among adults and parents of participating children, as well as
documented assent of participants aged 7–17, was required. The informed consent process and
personal interview were typically conducted in English or Spanish, but interpreters for those
more comfortable with other languages were used, as needed. The English version of the
consent form is included in Appendix N. Remuneration, as detailed below, was only provided
after completion of the health examination, which is the second phase of NHANES participation.
Individuals who were eligible and consented/assented then completed the personal
interview. This interview took place in the participant’s home unless the participant strongly
preferred to complete the interview elsewhere. The personal interview consisted of a series of
“questionnaires” about a variety of topics, such as health history, weight history, and alcohol use.
Most questionnaires were verbally administered by NHANES staff, whereas the others were
completed on a computer with the assistance of NHANES staff. If an individual needed
assistance in answering questions, a proxy (e.g., family member) was consulted. During the
personal interview, individuals were also administered the WAIS-III Digit Symbol—Coding
subtest. Prior to the start of the Coding subtest, participants were asked to put on any glasses that
they usually use to read. Those who could not take the Coding subtest without distraction in the
home and those who could not complete the sample items on the subtest (e.g., due to physical or
cognitive limitations) were not administered the test.
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At the end of the personal interview, participants were asked to schedule an appointment
for their health examination at a nearby Mobile Examination Center (MEC) during a randomized
portion of the day (i.e., morning, afternoon, or evening). Participants were asked to attend
during these assigned appointment times, but were allowed to attend during alternate times, if
needed. These MEC appointments were made approximately two weeks from the time of the
personal interview. A postal letter was sent to participants one week before their scheduled
MEC appointment, which included health exam location information, approximate duration of
appointment, and remuneration amount. Duration of MEC appointment ranged from 40 minutes
to 4 hours depending on the tests administered (which was based on participant age, gender, and
health conditions). The amount of the cash remuneration varied from $30 to $100 according to a
number of characteristics, including survey year, participant age, and type of appointment
attended (i.e., assigned vs. alternate). Namely, adult participants were offered more money than
child participants. Adult participants were also offered additional money as an incentive to
attend their assigned health examination appointment. To improve attendance, a reminder phone
call was also made two days prior to this appointment.
Those who attended the MEC appointment underwent a variety of tests, including those
of vision, hearing, blood pressure, walking pace, body composition (i.e., DEXA) and blood (e.g.,
glucose, iron, CRP). At the end of the health examination, participants were provided their cash
remuneration, as well as reimbursement for any incurred travel expense. Approximately 3-4
months after the MEC appointment, participants were mailed a report of results of several of the
health tests (e.g., vision, hearing, blood). Individuals with results outside of healthy ranges were
recommended to consult a doctor.
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For each of the 2-year NHANES cycles in the present study (i.e., 1999–2000 and 2001–
2002), approximately 30 counties were sampled and 12,000 individuals were invited to
participate. During the 1999–2000 cycle, 9,965 individuals completed the personal interview
and, of those, 9,282 completed the health examination (NHANES Plan and Operations, 1999–
2010). During the 2000–2001 cycle, 11,309 individuals completed the personal interview and,
of those, 10,477 completed the health examination (NHANES Plan and Operations, 1999–2010).
Exact response rates of these two cycles have not been reported.
Design
The present study analyzed data collected as part of NHANES during the years 1999–
2002. NHANES uses a multistage probability sampling design aimed at enrolling a sample that
is representative of the United States civilian noninstitutionalized household population
(NHANES Plan and Operations, 1999–2010). As explained above, counties or groups of small
counties were divided into neighborhoods, which were selected at random. Residences within
each selected neighborhood were then selected at random. Occupants of those residences were
then screened to determine study eligibility.
This was a cross-sectional study, as tests were conducted but no interventions were made.
Participants were assessed on two occasions: the personal interview and the health exam. The
personal interview occurred first, at which time the health exam was scheduled for a date
approximately two weeks later. Because these data were collected so close together and do not
include repeated measures, the present study used them as the same timepoint. This study also
used retrospective pretests (e.g., self-report history of weight and alcohol use).
Analysis
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For hypotheses 1–13, data were analyzed using IBM SPSS version 21. All data were
screened using frequency distributions and descriptive statistics, and checked for outliers.
Relevant data were then assessed for the multivariate statistical testing assumptions of normality,
linearity, and homoscedasticity. More specifically, visual inspection of a histogram and normal
Q-Q plot for each variable of interest was used to assess univariate normality. Significance of
skewness and kurtosis was evaluated at an alpha level of .01. Bivariate scatterplots for all
subsets of variables were also examined; roughly elliptical patterns supported the assumption of
multivariate normality and linearity. Homoscedasticity was assessed through a visual inspection
of bivariate scatterplots and Levene’s Test for Equality of Variances.
Inferential statistical procedures also assume simple random sampling. This assumption
was technically not met, as all noninstitutionalized civilians living in the United States did not
have equal chance of being selected due to oversampling of certain groups of interest. However,
the assumption of independence in independent samples t-tests and Analysis of Variance
(ANOVA) was met because participant responses did not influence one another.
The minimum sample size needed within each group in order to run a two-tailed t-test or
chi-square test (1 df) using an alpha level of .05 was set at 26, as per results of an a priori power
analysis using an expected large effect size (d = .8) and power = 0.8. Unless otherwise specified,
all statistical analyses excluded underweight participants and used a two-tailed test of
significance at alpha level .05.
Analysis for Hypothesis 1. It was hypothesized that there would be a strong negative
correlation between age and DSST score. To test this hypothesis, a Pearson product-moment
correlation coefficient was calculated for age and DSST score, and its significance was tested
using a two-tailed test of significance at alpha level .05.
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Analysis for Hypotheses 2a and 2b. Hypotheses 2a and 2b are concerned the
relationship between age and overall and central obesity indexes, respectively. More
specifically, it was hypothesized that there would be a weak, non-significant negative correlation
between age and BMI but a significant positive correlation between age and % total body fat
measured by DEXA. In addition, it was hypothesized that there would be no significant
correlation between age and WC but a significant positive correlation between age and % trunk
fat measured by DEXA. To test these hypotheses, four Pearson product-moment correlation
coefficients were calculated, and significance of these correlations were tested using two-tailed
tests of significance at alpha level .05.
Analysis for hypotheses 3a and 3b. It was hypothesized that participants with probable
lifetime history of excess alcohol consumption (i.e., answered yes to “Was there ever a time or
times in your life when you drank 5 or more drinks of any kind of alcoholic beverage almost
every day?”) would exhibit worse processing speed. To test this hypothesis while controlling for
gender as a potential confound, a two-way between-subjects ANOVA using a test of significance
at alpha level .05 was conducted with gender and probable lifetime history of excess alcohol
consumption as the independent variables and DSST score as the dependent variable.
Likewise, it was hypothesized that participants with probable past-year excess alcohol
consumption (i.e., endorsed consuming five or more drinks on half or more of the days during
the past year) would exhibit worse processing speed. An independent samples t-test using a twotailed test of significance at alpha level .05 was planned to compare those with and without
probable past-year history of excess alcohol consumption on DSST score; however, this analysis
could not be conducted as planned due to the probable past-year excess alcohol consumption
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group having fewer participants than the minimum group size of 26 determined by the a priori
power analysis.
Analysis for Hypothesis 3c. It was hypothesized that individuals who currently smoke
would perform worse on the DSST than those who do not currently smoke. To test this
hypothesis, those who endorsed currently smoking tobacco via cigarettes, cigars, and/or pipe
were defined as current smokers, whereas those who denied currently smoking tobacco via
cigarettes, cigars, or pipe were defined as current non-smokers. An independent samples t-test
using a two-tailed test of significance at alpha level .05 was conducted to compare those who do
and do not currently smoke on DSST score.
Analysis for Hypothesis 4. Hypotheses 4a–4c stated the following: The no exercise
group would perform worse on the DSST than the aerobic-only, strength training-only, and
combination training groups. The aerobic-only group would perform better on the DSST than
the strength training-only group. The combination training group would perform better on the
DSST compared to the aerobic-only, strength training-only, and no exercise groups. To test
these hypotheses, a one-way ANOVA at alpha level .05 was run with exercise group as the
independent variable and DSST score as the dependent variable, followed by Tukey’s HSD posthoc test.
Analysis for Hypothesis 5. It was hypothesized that the diabetes group would perform
worse on the DSST than the prediabetes and no diabetes groups. It was also hypothesized that
the prediabetes group would perform worse on the DSST than the no diabetes group. To test
these hypotheses, a one-way ANOVA at alpha level .05 was run with diabetes group as the
independent variable and DSST score as the dependent variable, followed by Tukey’s HSD posthoc test.
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Analysis for Hypothesis 6a. It was hypothesized that homocysteine levels would be
negatively correlated with processing speed independent of serum folate levels. To test this
hypothesis, a Pearson product-moment correlation coefficient was calculated for homocysteine
level and DSST score, and significance of this correlation was tested using a two-tailed test of
significance at alpha level .05. A partial correlation calculated for homocysteine level and DSST
score while controlling for folate level was then conducted using a two-tailed test of significance
at alpha level .05.
Analysis for Hypothesis 6b. It was hypothesized that folate levels would not be
significantly correlated with processing speed independent of homocysteine levels. To test this
hypothesis, a Pearson product-moment correlation coefficient was calculated for folate level and
DSST score, and significance of this correlation was tested using a two-tailed test of significance
at alpha level .05. Given the significant bivariate correlation, a partial correlation controlling for
homocysteine level was then conducted using a two-tailed test of significance at alpha level .05.
Analysis for Hypothesis 6c. It was hypothesized that those with low vitamin D levels (<
35 nmol/l) would perform worse on the processing speed measure than those with healthy
vitamin D levels. To test this hypothesis, an independent samples t-test using a two-tailed test of
significance at alpha level .05 was conducted to compare those with and without low vitamin D
levels on DSST score.
Analysis for Hypothesis 6d (exploratory). It was hypothesized that participants
suffering from an iron deficiency (serum ferritin level of < 22µg/L) would perform worse on the
processing speed task than participants without an iron deficiency. An independent samples ttest using a two-tailed test of significance at alpha level .05 was conducted to compare
participants with and without iron deficiency on DSST score.
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Analysis for Hypothesis 6e (exploratory). It was hypothesized that vitamin E level
(i.e., alpha-tocopherol) would be positively correlated with processing speed performance. As an
additional exploratory analysis, gamma-tocopherol, another type of Vitamin E, was also
investigated. For each of the forms of vitamin E included in the NHANES dataset (i.e., alphatocopherol and gamma-tocopherol), a Pearson product-moment correlation coefficient was
calculated for vitamin E level and DSST score, and significance of this correlation was tested
using a two-tailed test of significance at alpha level .05. The Bonferroni post-hoc test was then
applied to prevent alpha inflation.
Analysis for Hypothesis 6f (exploratory). It was hypothesized that the total number of
nutrient deficiencies (i.e., vitamin B12, vitamin D, vitamin E, folate, iron) would be negatively
correlated with processing speed task performance. To test this hypothesis, a Pearson productmoment correlation coefficient was calculated for number of nutrient deficiencies and DSST
score, and significance of this correlation was tested using a two-tailed test of significance at
alpha level .05. Prior to running this analysis, cutoffs for defining nutrient deficiency statuses
were reviewed, and relationships between single nutrient deficiencies and processing speed task
performance were assessed to determine which nutrients should be included in the analysis.
Analysis for Hypotheses 7a and 7b. It was hypothesized that DSST scores would not
be significantly correlated with the overall obesity indexes (i.e., BMI, % DEXA total body fat)
but that they would be significantly negatively correlated with the central obesity indexes (i.e.
WC, WTR, WHtR, and % DEXA trunk fat). A bivariate correlation matrix was computed, and
significance of these correlations was tested using a two-tailed test of significance at alpha level
.05.
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Analysis for Hypothesis 7c. It was hypothesized that, among those who are centrally
obese (WC ≥ 102 cm for men and 88 cm for women), (a) individuals meeting BMI obesity
criteria (BMI ≥ 30 kg/m2) would perform worse on the DSST and (b) individuals meeting DEXA
obesity criteria (fat mass ≥ 25% for men and ≥ 35% for women) would perform worse on the
DSST. To test the first part of the hypothesis, an independent samples t-test using a two-tailed
test of significance at alpha level .05 was conducted to compare those with central obesity and
BMI obesity to those with central obesity but no BMI obesity. Likewise, to test the second part
of the hypothesis, an independent samples t-test using a two-tailed test of significance at alpha
level .05 was conducted to compare those with central obesity and DEXA obesity to those with
central obesity but no DEXA obesity.
Analysis for Hypothesis 7d (exploratory). A stepwise multiple regression using
backward elimination was run to determine which obesity indices make meaningful
contributions to the overall prediction of DSST scores.
Analyses for BMI category by gender interaction on DSST score (exploratory). A
series of 2x3 ANOVAs were conducted to investigate main and interaction effects of BMI
weight category (i.e., normal weight, overweight, obese) and gender on current DSST score for
each of three timepoints (i.e., current, 10 years ago, and age 25), followed by Fischer’s LSD
post-hoc tests.
Analysis for Hypotheses 8a–8c. Hypotheses 8a–8c concerned the relationship between
weight trajectory and DSST score. Eight groups were created based on whether participants
were obese or not obese at age 25, 10 years ago (ages 55–64), and currently (ages 65–74). It was
hypothesized that those who were obese at age 25 and 10 years ago would perform the worst on
the DSST, whereas those with no history of obesity would perform best on the DSST. It was
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also hypothesized that those who were obese at only one timepoint would perform better than
those who were obese at age 25 and 10 years ago. To test this hypothesis, a one-way ANOVA
with eight groups at alpha level .05 was planned with weight trajectory group as the independent
variable and DSST score as the dependent variable, followed by Tukey’s HSD post-hoc test.
However, the decision was made to remove three groups from this analysis after it was
discovered that each contained a very low number of participants. After removal of these three
groups from the analysis, five groups remained. To test this hypothesis using the new groups, a
one-way ANOVA with five groups at alpha level .05 with weight trajectory group as the
independent variable and DSST score as the dependent variable was conducted, followed by
Tukey’s HSD post-hoc test.
Analysis for Hypothesis 8d. It was hypothesized that percent of weight gained between
early adulthood (age 25) and late middle-age (10 years ago, which is ages 55-64 in the present
study) would be associated with worse performance on the DSST. To test this hypothesis, a
Pearson product-moment correlation coefficient was calculated for percent of weight gained and
DSST score, and significance of this correlation was tested using a two-tailed test of significance
at alpha level .05. As planned, individuals who were underweight in early adulthood were
excluded from this analysis. Additionally, since the question addressed the percent of weight
gained between early adulthood and late middle-age, individuals who did not gain weight
between these two timepoints were excluded from this analysis.
Analysis for Hypothesis 8e. It was hypothesized that the absolute value of the percent
of weight change over the previous 10-year period would be associated with worse performance
on the DSST. To test this hypothesis, a Pearson product-moment correlation coefficient was
calculated for absolute value of percent of weight change and DSST score, and significance of
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this correlation was tested using a two-tailed test of significance at alpha level .05. As planned,
individuals who were underweight 10 years ago (during their “late middle-age” period) were
excluded from this analysis, as well as the Hypothesis 8e exploratory analyses.
Analysis for Hypothesis 8f. It was hypothesized that individuals endorsing significant
past-year unintentional weight loss would perform worse on the DSST than those who achieved
significant past-year weight loss that was intentional and those who were past-year weightstable. No specific hypotheses were made regarding how participants with significant past-year
weight gain would perform on the DSST relative to the other three groups.
For the purposes of this hypothesis, “significant past-year weight loss” was defined as
having a current body weight that is less than or equal to 95% of the body weight reported one
year ago, representing a 5% or greater decrease in body weight. Likewise, “significant past-year
weight gain” was defined as having a current body weight that is greater than or equal to 105%
of the body weight reported one year ago, representing a 5% or greater increase in body weight.
Finally, “past-year weight-stable” was defined as having a weight that was greater than 95% of
the body weight reported one year ago but less than 105% of the body weight reported one year
ago, representing less than a 5% change in body weight.
To test this hypothesis, a one-way ANOVA at alpha level .05 was run with past-year
weight group as the independent variable (four levels: unintentional significant past-year weight
loss, intentional significant past-year weight loss, significant past-year weight gain, and past-year
weight stable) and DSST score as the dependent variable. The Tukey-Kramer modification of
Tukey’s HSD test, which was chosen due to the presence of unequal group sizes, was then used
to make post-hoc comparisons of means.
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Analysis for Hypothesis 9. It was hypothesized that there would be a significant
negative correlation between a marker of peripheral inflammation (i.e., CRP level) and DSST
score, which would remain significant after controlling for health condition and smoking
confounds. To test this hypothesis, a Pearson product-moment correlation coefficient was
calculated for CRP level and DSST score, and significance of this correlation was tested using a
two-tailed test of significance at alpha level .05. Given that the bivariate correlation was not
significant, there was no need to conduct a partial correlation controlling for health conditions
and smoking, as planned.
Analysis for Hypothesis 10a. It was hypothesized that participants who endorsed one or
more of the following conditions would perform worse on the DSST than those who did not
endorse any: problems of blood flow to the heart typically leading to or involving heart muscle
damage (i.e., congestive heart failure, coronary heart disease, heart attack), stroke, diabetes,
weak/failing kidneys, chronic respiratory disease (i.e., chronic bronchitis or emphysema), and
thyroid disease (if untreated). As previously explained, upon implementation of the present
study, it was discovered not to be possible to determine whether thyroid disease had been treated;
therefore, hypothyroidism was not included in this analysis as planned. To test the hypothesis,
an independent samples t-test followed by a two-tailed test of significance at alpha level .05 was
conducted to compare DSST scores of those with none of these health conditions and those with
≥ 1 of these health conditions.
Analysis for Hypothesis 10b. It was hypothesized that duration of respiratory disease
would be negatively correlated with DSST score. To test this hypothesis, a Pearson productmoment correlation coefficient was calculated for duration of respiratory disease and DSST
score, followed by a two-tailed test of significance at alpha level .05.
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Analysis for Hypothesis 11. It was hypothesized that participants with dyslipidemia
(i.e., unhealthy levels of total cholesterol, HDL cholesterol, LDL cholesterol, and/or
triglycerides) would demonstrate worse processing speed task performance. To test this
hypothesis, an independent samples t-test followed by a two-tailed test of significance at alpha
level .05 was conducted to compare DSST scores of participants with and without dyslipidemia.
Analysis for Hypothesis 12a. It was hypothesized that risk of first stroke, as indicated
by score on the modified version of the FSRP, would be inversely associated with processing
speed. To test this hypothesis, a Pearson product-moment correlation coefficient was calculated
for modified FSRP score and DSST score, and significance of this correlation was tested using a
two-tailed test of significance at alpha level .05. Individuals with a history of stroke were
excluded from this analysis, as planned.
Analysis for Hypothesis 12b. It was hypothesized that risk of onset of CVD, as
indicated by modified FRS for general CVD scores, would be inversely associated with
processing speed task performance. To test this hypothesis, a Pearson product-moment
correlation coefficient was calculated for modified FRS for general CVD score and DSST score,
and significance of this correlation was tested using a two-tailed test of significance at alpha
level .05. Individuals with a history of CVD (defined as one or more of the following: CHF,
angina pectoris, heart attack, stroke) were excluded from this analysis, as planned.
Analysis for Hypothesis 13. It was hypothesized that there would be a significant
positive correlation between speed of usual gait and DSST score, which would remain significant
after controlling for BMI. To test this hypothesis, a Pearson product-moment correlation
coefficient was calculated for gait speed and DSST score, and significance of this correlation
was tested using a two-tailed test of significance at alpha level .05. Given that the bivariate
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correlation was significant, a partial correlation controlling for BMI was then conducted using a
two-tailed test of significance at alpha level .05.
Final model. Mplus 6.1 was used for the final structural equation model (Muthén &
Muthén, 2008). Missing data was treated with weighted least squares with mean and variance
adjustment (WLSMV) due to the use of categorical data. A theoretical model of the relationship
between persistent obesity and DSST score, as outlined in Figure 1, was extensively revised prior
to testing due to practical limitations, results of the previously described analyses, and theoretical
considerations. Confirmatory modeling was used, with an absolute fit index cut-off of root mean
square error of approximation (RMSEA) ≤ 0.06 and an incremental index cut-off of comparative
fit index (CFI) ≥ 0.95 (Bentler, 1990; Hu & Bentler, 1999). Additionally, chi-square statistics
were examined for significance, with nonsignificant results suggestive of acceptable fit. Further,
standardized factor loadings of > .35 were required for indicators to be retained in the
measurement model (Brown, 2006).
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Results
Prior to each parametric analysis, data were assessed with respect to all assumptions
relevant to the planned statistical tests. Namely, group data for relevant variables were checked
for normality using visual inspection of a histogram and Q-Q plot, significance of skewness and
kurtosis was evaluated at an alpha level of .01, bivariate scatterplots for all subsets of variables
were examined for roughly elliptical patterns to support the assumptions of multivariate
normality and linearity, and homoscedasticity was assessed though a visual inspection of
bivariate scatterplots and Levene’s Test for Equality of Variances. Nonparametric tests were
used to analyze data that were not normally distributed and could not achieve normality with the
appropriate transformation.
Of the total 1,381 participants in the study sample, 1,143 had a recorded DSST score, and
238 did not have a recorded DSST score. Common reasons for lack of DSST score included
decision not to attempt the DSST or its sample exercise due to distractions in the home
environment (n = 90), refusal to complete the DSST sample exercise (n = 33), and inability to
complete the DSST sample exercise due to cognitive (n = 26) or physical (n = 25) limitations.
Independent samples t-tests failed to reveal a statistically significant difference in mean age, t
(1379) = -.705, p = .481, or mean BMI, t (1371) = -.372, p = .710, between the group with
recorded DSST scores and the group without recorded DSST scores. See Table 2 for participant
characteristics. Of note, gender was identified as a potential covariate for analyses involving
DSST score. Namely, men were found to have significantly lower DSST scores (M = 40.3, SD =
18.2) compared to women (M = 44.2, SD = 18.6), t (1141) = -3.643, p < .001. Therefore, gender
was considered as a potential covariate in relevant analyses.
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Hypothesis 1 Results
It was hypothesized that there would be a strong negative correlation between age and
processing speed task performance, as indicated by DSST score. A Pearson product-moment
correlation coefficient calculated for age and DSST score revealed a very weak, but statistically
significant, negative relationship between age and DSST score, r (1141) = -.084, p = .005.
Hypothesis 2a Results
It was hypothesized that there would be a negative correlation between age and BMI that
would not reach statistical significance. A Pearson product-moment correlation coefficient
calculated for age and BMI yielded a very weak, but statistically significant, negative correlation,
r (1371) = -.071, p = .008.
In contrast, it was hypothesized that there would be a significant positive correlation
between age and % total body fat measured by DEXA. Given that the NHANES database
contained multiply imputed data for DEXA measurements, a Pearson product-moment
correlation coefficient was calculated for each of the five versions of completed data, and these
estimates were then pooled by calculating their mean. Results were not statistically significant, r
(1239) = .003, p = .916.
Hypothesis 2b Results
It was hypothesized that there would be no significant correlation between age and WC.
Consistent with this hypothesis, the correlation between age and WC was not statistically
significant, r (1210) = -.006, p = .835.
In contrast, it was hypothesized that there would be a significant positive correlation
between age and % trunk fat measured by DEXA. A Pearson product-moment correlation
coefficient was calculated for each of the five versions of completed data. Results of these
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estimates were then pooled, failing to reveal a significant relationship between age and % total
trunk fat measured by DEXA, r (1239) = -.009, p = .752.
Hypothesis 3a Results
It was hypothesized that those with probable lifetime history of excess alcohol
consumption (i.e., answered “yes” to “Was there ever a time or times in your life when you
drank 5 or more drinks of any kind of alcoholic beverage almost every day?”) would exhibit
worse processing speed task performance than those without probable lifetime history of excess
alcohol consumption (i.e., answered “no” to this question). In order to control for gender as a
potential confound in this analysis, a two-way between-subjects ANOVA was run with gender
and probable lifetime history of excess alcohol consumption as the independent variables and
DSST score as the dependent variable. Results revealed a main effect for probable lifetime
history of excess alcohol consumption on DSST score, F (1, 1039) = 5.742, p = .017, but failed
to reveal a significant main effect for gender on DSST score or a significant interaction effect
between the two independent variables. More specifically, participants with probable lifetime
history of excess alcohol consumption scored significantly lower on the DSST (M = 36.5, SD =
16.3) than those without probable lifetime history of excess alcohol consumption (M = 43.7, SD
= 18.7), indicating worse processing speed task performance.
Hypothesis 3b Results
Hypothesis 3b concerned the survey question “In the past 12 months, on how many days
did you have 5 or more drinks of any alcoholic beverage?” It was predicted that those with
probable past-year excess alcohol consumption (i.e., endorsed consuming five or more drinks on
half or more of the days during the past year) would exhibit slower processing speed than those
without probable past-year excess alcohol consumption (i.e., reported consuming five or more
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drinks on fewer than half of the days during the past year). Due to the number of participants in
the probable past-year excess alcohol consumption group (n = 14) being less than the minimum
group size of 26 determined by the a priori power analysis, an independent samples t-test could
not be conducted as planned.
Hypothesis 3c Results
It was hypothesized that individuals who currently smoke would perform worse on the
DSST than those who do not currently smoke. As expected, individuals who reported that they
currently smoke cigarettes, cigars, and/or pipes scored significantly lower on the DSST (M =
37.0, SD = 17.0) than those who reported that they do not currently smoke (M = 43.4, SD =
18.1), indicating worse processing speed task performance, t (624) = -3.989, p < .001.
In exploratory analyses, the relationship between current smoking frequency and DSST
score was investigated. A one-way between subjects ANOVA was performed to compare the
effect of smoking frequency on DSST score in the “not at all,” “some days,” and “everyday”
conditions. There was a statistically significant effect of smoking frequency on DSST score for
the three groups, F (2, 623) = 8.661, p < .001. A post hoc Tukey’s HSD test revealed that the
“not at all” group (M = 43.4, SD = 18.1) scored significantly higher on the DSST than the
“everyday” group (M = 36.3, SD = 17.1), whereas the “some days” group (M = 40.3; SD = 16.4)
did not differ significantly from either group. Results indicate that nonsmokers performed
significantly better on the processing speed task than everyday smokers, whereas individuals
who smoked only “some days” of the week performed in a manner that was not statistically
different from the nonsmokers or the everyday smokers.
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Hypothesis 4 Results
Using the operational definitions for no exercise, aerobic-only, strength training-only,
and combination training specified in the hypotheses section of this document, it was
hypothesized that (a) the no exercise group would perform worse on the DSST than the aerobiconly, strength training-only, and combination training groups; (b) the aerobic-only group would
perform better on the DSST than the strength training-only group; and (c) the combination
training group would perform better on the DSST compared to the aerobic-only, strength
training-only, and no exercise groups. A one-way ANOVA conducted with exercise group as the
independent variable and DSST score as the dependent variable revealed a statistically
significant effect of exercise group on DSST score, F (3, 959) = 31.697, p <.001. Post hoc
Tukey’s HSD tests were then performed, revealing that the combination training group (M =
53.4, SD = 15.1) scored significantly higher on the DSST than the aerobic-only (M = 47.3, SD =
17.5; p = .017), strength training-only (M = 41.9, SD = 17.9; p = .009), and no exercise groups
(M = 37.8, SD = 18.1; p < .001). It also revealed that the aerobic-only group scored significantly
higher on the DSST than the no-exercise group, p < .001. No other group differences were
statistically significant.
Hypothesis 5 Results
Using the operational definitions for diabetes, prediabetes, and no diabetes specified in
the Hypotheses section of this document, it was predicted that the diabetes group would perform
worse on the DSST than the prediabetes and no diabetes groups. It was also expected that the
prediabetes group would perform worse on the DSST than the no diabetes group. To test these
hypotheses, a one-way ANOVA at alpha level .05 was run with diabetes status as the
independent variable (three levels) and DSST score as the dependent variable, revealing a
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significant effect of diabetes status on DSST score [F (2, 758) = 14.04, p < .001]. Post hoc
comparisons using the Tukey HSD test indicated that the mean DSST score of the diabetes group
(M = 36.5, SD = 17.0) was significantly lower than both the prediabetes group (M = 43.9, SD =
18.3; p < .001) and the no diabetes group (M = 43.7, SD = 19.8; p < .001). The difference
between the prediabetes group and the no diabetes group was not statistically significant, p =
.992.
In exploratory analyses, the potential impact of past-month blood glucose regulator
medication on DSST was investigated among participants with diabetes, using the same
operational definition for this condition as above. An independent samples t test failed to find a
statistically significant difference in mean DSST scores between participants with diabetes who
reported past-month use of blood glucose regulator medication and participants with diabetes
who denied past-month use of blood glucose regulator medication, t (273) = .519, p =.604.
Next, the relationship between fasting blood glucose and DSST score was investigated.
Individuals were divided into the following groups based on their fasting blood glucose levels:
diabetic range (> 125 mg/dl), prediabetic range (100–125 mg/dl), normal range (70–99 mg/dl),
and hypoglycemic range (< 70 mg/dl). Only one individual was found to have tested within the
hypoglycemic range; therefore, this category was excluded from subsequent analyses. A oneway ANOVA with fasting blood glucose group as the independent variable (three levels) and
DSST score as the dependent variable failed to find a significant effect of fasting blood glucose
on DSST score [F (2, 465) = 2.39, p = .093].
The relationship between HbA1c and DSST score was then investigated. Individuals were
divided into the following groups based on their HbA1c values: diabetic range (≥ 6.5%),
prediabetic range (5.7% to 6.4%), and normal range (< 5.7%). A one-way ANOVA with HbA1c
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group as the independent variable (three levels) and DSST score as the dependent variable
revealed a significant effect of HbA1c group on DSST score [F (2, 1042) = 18.22, p < .001]. Post
hoc comparisons using the Tukey HSD test indicated that the mean DSST score of the diabetic
range group (M = 36.0, SD = 17.0) was significantly lower than both the prediabetic range group
(M = 41.3, SD = 18.3; p = .007) and the normal range group (M = 45.3, SD = 18.6; p < .001). In
addition, the prediabetic range group scored significantly lower than the normal range group, p =
.007.
Finally, the relationship between HOMA-IR and DSST score was investigated. HOMAIR was calculated by multiplying fasting insulin (U/l) by fasting blood glucose (mg/dl) and
dividing by 405, as described by Matthews and colleagues (1985). Individuals taking insulin
were excluded from this analysis. Peripheral insulin resistance was operationally defined as a
HOMA-IR value of greater than the 75th percentile; this criterion was chosen in accordance with
the practice of a number of other studies (e.g., Lee et al., 2006; Nasution, Setiati, Trisnohadi, &
Oemardi, 2006; Wilson et al., 2007). An independent samples t-test conducted to compare
DSST scores of participants with peripheral insulin resistance (M =38.7, SD = 18.3) and without
peripheral insulin resistance (M =43.6, SD = 17.6) revealed a statistically significant difference
between groups, t (389) = -2.311, p = .021. The same analysis among only participants without
diabetes was attempted, but it could not be completed due to the number of participants in the
peripheral insulin resistance group (n = 6) being lower than the minimum sample size of 26
determined by the a priori power analysis.
Hypothesis 6a Results
It was hypothesized that homocysteine levels would be negatively correlated with
processing speed task performance independent of folate levels. First, a Pearson product-
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moment correlation between homocysteine level and DSST score was calculated, which revealed
a statistically significant weak negative relationship between these two variables, r (1039) = .108, p < .001. Next, a partial correlation was run to determine the relationship between these
two variables while controlling for folate level. There was a statistically significant very weak
negative partial correlation between homocysteine level and DSST score while controlling for
folate level, r (1038) = -.084, p = .007. A comparison of the zero-order correlation and partial
correlation suggests that folate had relatively little influence in controlling for the relationship
between homocysteine level and processing speed task performance. Results indicate that higher
homocysteine levels are very weakly associated with worse processing speed task performance
independent of folate levels.
In an exploratory analysis, participants with and without hyperhomocysteinemia were
compared on DSST score. Hyperhomocysteinemia was defined as ≥ 12 μmol/L based on the
work of Castañon, Lauricella, Kordich, and Quintana (2007). An independent samples t-test
revealed that participants with hyperhomocysteinemia scored significantly lower on the DSST
(M = 37.2, SD = 18.0) than participants without hyperhomocysteinemia (M = 44.0, SD = 18.5),
indicating worse processing speed task performance, t (1041) = -4.764, p < .001. Cohen’s effect
size (d = .37) suggested weak-to-moderate practical significance.
Hypothesis 6b Results
It was hypothesized that folate levels would not be significantly correlated with
processing speed independent of homocysteine levels. A Pearson product-moment correlation
between folate level and DSST score revealed a statistically significant weak positive association
between these two variables, r (1039) = .204, p < .001. In addition, there was a statistically
significant weak positive partial correlation between folate level and DSST score while
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controlling for homocysteine level, r (1038) = .193, p < .001. A comparison of the zero-order
correlation and partial correlation suggests that homocysteine level had very little influence in
the relationship between folate level and processing speed task performance. Results indicate
that higher folate levels are weakly associated with better processing speed task performance
regardless of homocysteine levels.
No participants in the present study met folate deficiency criteria (i.e., serum folate < 1.4
ng/mL). Given the lack of consensus on the lower limit of serum folate reference values in the
literature and the results from the present study’s previous correlation analyses that showed
folate to be positively associated with processing speed independent of homocysteine levels, it
was deemed acceptable to include a folate variable in this analysis that would capture folate
depletion rather than folate deficiency. A serum folate value < 8 ng/mL was chosen for a cutoff
for “folate depletion” based on the results of De Bruyn and colleagues (2014). An independent
samples t-test conducted to compare those with and without folate depletion on DSST score
showed that participants with folate depletion scored significantly lower on the DSST (M = 35.0,
SD = 18.5) than participants without folate depletion (M = 43.6, SD = 18.3), indicating worse
processing speed task performance, t (1026) = -4.406, p < .001. Cohen’s effect size (d = .47)
suggested moderate practical significance.
Next, a two-way ANOVA conducted to investigate interaction effects between
hyperhomocysteinemia and folate depletion on DSST score failed to show a statistically
significant interaction, F (1, 1022) = .797, p = .372. See Figure 2. Note that results of main
effects for this analysis are identical to the previously reported t-test results.
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Figure 2. DSST scores by folate depletion and hyperhomocysteinemia status. Significant main
effects for hyperhomocysteinemia, p < .001, and folate depletion, p < .001, on DSST score. Nonsignificant interaction effect between hyperhomocysteinemia and folate depletion on DSST
score, p = .372.
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Hypothesis 6c Results
It was hypothesized that participants with low 25-hydroxyvitamin D levels (< 35 nmol/L)
would perform worse on the processing speed task than those with healthy vitamin D levels.
Results of an independent samples t-test conducted to compare those with low vitamin D levels
and those without low vitamin D levels on DSST score showed that participants with low
vitamin D levels scored significantly lower on the DSST (M = 39.2, SD = 17.9) than participants
without low vitamin D levels (M = 46.0, SD = 16.8), indicating worse processing speed task
performance, t (516) = -2.855, p = .004.
Exploratory analyses were used to investigate possible interaction effects between
individual obesity variables, gender, and 25-hydroxyvitamin D level on DSST score. First, a
2x2x2 factorial ANOVA was conducted to investigate interaction effects of current obesity status
(two levels: obese, non-obese), gender (two levels: male, female), and 25-hydroxyvitamin D
status (two levels: low vitamin D, adequate vitamin D) on DSST score. The interaction effect
between vitamin D status and gender trended toward significance, F (1, 518) = 2.957, p = .086,
such that men’s DSST scores tended to be more negatively impacted by low vitamin D status
than women’s DSST scores. No other interaction effects were significant.
Second, a 2x2x2 factorial ANOVA was conducted to investigate potential interaction
effects between late middle-age obesity history, gender, and current 25-hydroxyvitamin D level
on DSST score. The interaction effect between late middle-age obesity history and vitamin D
status was statistically significant, F (1, 504) = 5.116, p = .024, such that low vitamin D status
appeared to have little impact DSST score in those with history of late middle-age obesity but
did appear to have significant impact on DSST score in those without history of late middle-age
obesity. More specifically, among those without late middle-age obesity, those with current low
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vitamin D level had lower DSST scores (M = 37.5, SD = 18.2) than those without current low
vitamin D level (M = 48.2, SD = 16.1). See Figure 3 for more information. No other interaction
effects were significant.
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Women’s DSST scores by obesity and vitamin D status

DSST Score

Low Vitamin D

Yes

No

Obese 10 Years Ago

Yes

No

Currently Obese

Men’s DSST scores by obesity and vitamin D status

DSST Score

Low Vitamin D

Yes

No

Obese 10 Years Ago

Yes

No

Currently Obese

Figure 3. Interaction effects between gender, current vitamin D status, and obesity status on
DSST score for current obesity status and obesity status ten years ago. Significant interaction
effect between obesity status ten years ago (i.e., late middle-age obesity history) and vitamin D
status on DSST score, p = .024. Interaction effect between vitamin D status and gender on DSST
score trended toward significance, p = .086, when data was analyzed by current obesity status.
All other interaction effects were non-significant.
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Hypothesis 6d Results (exploratory)
It was hypothesized that participants with iron deficiency (serum ferritin level < 22µg/L)
would perform worse on the processing speed task than participants without iron deficiency. An
independent samples t-test was conducted to compare participants with iron deficiency to
participants without iron deficiency on DSST score. The iron deficient group scored lower on
the DSST (M = 39.3, SD = 18.0) compared to the non- iron deficient group (M = 43.0, SD =
18.5), but this difference was not statistically significant, t (1026) = -1.391, p = .165.
Hypothesis 6e Results (exploratory)
It was hypothesized that vitamin E level (i.e., alpha-tocopherol) would be positively
correlated with processing speed task performance. A Pearson product-moment correlation
coefficient calculated for alpha-tocopherol (µmol/L) and DSST score using a two-tailed test of
significance at alpha level .05 revealed a statistically significant weak-to-moderate positive
relationship between these two variables, r (490) = .258, p < .001, indicating that higher alphatocopherol levels are associated with better processing speed task performance.
A set of exploratory analyses were conducted to investigate the relationship between
gamma-tocopherol and DSST score. In contrast to the findings involving alpha-tocopherol, a
Pearson product-moment correlation coefficient calculated for gamma-tocopherol and DSST
score revealed a statistically significant weak inverse relationship between these two variables, r
(417) = -.140, p = .004, indicating that higher gamma-tocopherol levels are associated with
worse processing speed task performance. Next, a correlation was calculated for alphatocopherol and gamma-tocopherol, which revealed a moderate inverse relationship, r (497) = .395, p < .001. Finally, a partial correlation between gamma-tocopherol level and DSST score
while controlling for alpha-tocopherol level was run, which failed to indicate a significant
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relationship, r (409) = -.012, p = .804. Results suggest that higher gamma-tocopherol levels are
not associated with worse processing speed task performance after alpha-tocopherol levels are
controlled.
Another exploratory analysis was attempted in order to assess the relationship between
vitamin E deficiency status and DSST score. It was discovered that only 2 of the 492
participants with both an alpha-tocopherol value and DSST score met vitamin E deficiency
criteria (i.e., alpha-tocopherol < 11.6 µmol/L or, for adults with hyperlipidemia, a ratio of serum
alpha-tocopherol to total lipids of < 0.8 mg/g). Therefore, the relationship between vitamin E
deficiency status and DSST score could not be assessed.
Hypothesis 6f Results (exploratory)
It was hypothesized that the total number of nutrient deficiencies (i.e., vitamin D, iron,
vitamin B12, vitamin E, folate) would show a negative correlation with processing speed task
performance. Prior to running this analysis, cutoffs for defining nutrient deficiency statuses were
reviewed, and relationships between single nutrient deficiencies and processing speed task
performance were assessed. Low vitamin D level (25-hydroxyvitamin D < 35 nmol/L), folate
depletion (serum folate < 8 ng/mL), iron deficiency (serum ferritin level < 22µg/L), and low
vitamin E level (alpha-tocopherol < 11.6 µmol/L or, for adults with hyperlipidemia, a ratio of
serum alpha-tocopherol to total lipids of < 0.8 mg/g) have already been addressed in hypotheses
6b-e. In regard to vitamin B12, a one-way ANOVA run at alpha level .05 with vitamin B12 group
as the independent variable (three levels: deficient [< 145 pmol/L], low-normal range [145–260
pmol/L], normal range [> 260 pmol/L]) and DSST score as the dependent variable failed to
reveal a significant effect of vitamin B12 group on DSST score [F (2, 1025) = .132, p = .876].
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Based on the above analyses, the following nutrient deficiencies/depletions were chosen
to be included in the main analysis for this hypothesis: 25-hydroxyvitamin D level (< 35
nmol/L), serum ferritin level (< 22µg/L), and serum folate depletion (< 8 ng/mL). A Pearson
product-moment correlation coefficient calculated for total number of these nutrient
deficiencies/depletions and DSST score using a two-tailed test of significance at alpha level .05
revealed a statistically significant weak negative relationship between these two variables,
r (1141) = -.111, p < .001, indicating that greater number of nutrient deficiencies/depletions is
associated with worse processing speed task performance.
In an exploratory analysis, a one-way ANOVA was run with methylmalonic acid quartile
as the independent variable and DSST score as the dependent variable, revealing a significant
effect of methylmalonic acid quartile on DSST score [F (3, 1036) = 5.104, p = .002]. Post hoc
comparisons using the Tukey-HSD test indicated that the highest methylmalonic acid quartile
scored significantly lower on the DSST (M = 38.7, SD = 18.9) than the second highest quartile
(M = 44.0, SD = 17.9), third highest quartile (M = 43.9, SD = 18.4), and bottom quartile (M =
43.8, SD = 18.6). No other group differences were statistically significant.
Results of Exploratory Analyses on Self-Reported Dietary Habits
The relationship between self-reported dietary habits and processing speed task
performance was explored. Results of vegetables and fruits/fruit juices are presented first, as
these were the only self-reported eating habit variables for which exploratory analyses were
planned. Note that these analyses were only possible for participants examined during the 1999–
2000 data collection cycle due to subsequent changes in the NHANES Diet Behavior and
Nutrition questionnaire.
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A Pearson product-moment correlation coefficient calculated for self-reported number of
helpings of vegetables consumed per day and DSST score revealed a statistically significant
weak-to-moderate positive relationship between these two variables, r (556) = .231, p < .001,
indicating that greater self-reported number of helpings of vegetables consumed per day is
associated with better processing speed task performance. A Pearson product-moment
correlation coefficient calculated for self-reported number of helpings of fruits/fruit juices
consumed per day and DSST score revealed a statistically significant weak positive relationship
between these two variables, r (555) = .137, p < .001, indicating that greater self-reported
number of helpings of fruits/fruit juices consumed per day is associated with better processing
speed task performance. Self-reported numbers of helpings of vegetables and fruits/fruit juices
consumed per day were found to have a moderate positive relationship with one another,
r (708) = .344, p < .001.
A stepwise multiple regression was then run to determine whether daily number of
fruits/fruit juices made a meaningful contribution to the overall prediction of DSST score above
and beyond that of daily number of helpings of vegetables. Note that the statistical assumptions
of stepwise multiple regression, including the lack of multicollinearity, were met prior to running
this analysis. A significant regression equation was found, F (2,554) = 16.725, p < .001 with an
R2 of .053 with the predictor daily number of helpings of vegetables, but daily number of
helpings of fruits/fruit juices did not meaningfully contribute to the model.
Relationship between DSST score and self-reported number of helpings of each of the
following types of foods were investigated in additional exploratory analyses: breads/grain
foods, milk/dairy foods, and protein foods. None of the Pearson product-moment correlation
coefficients calculated for these variables and DSST score reached statistical significance.
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Hypotheses 7a and 7b Results
It was hypothesized that DSST scores would not be significantly correlated with the
overall obesity indexes (i.e., BMI, % DEXA total body fat) but would show significant negative
correlations with the central obesity indexes (i.e., WC, WTR, WHtR, and % DEXA trunk fat).
First, bivariate correlations were calculated to analyze the relationship between DSST
score and each of the obesity indexes that were not derived from DEXA (i.e., BMI, WC, WTR,
and WHtR). Results are displayed in Table 3. As hypothesized, these analyses revealed
statistically significant inverse relationships between DSST score and each of the central obesity
indexes (i.e., WC, WTR, WHtR) but no statistically significant relationship between DSST score
and the overall obesity index (i.e., BMI).
Next, the relationship between DSST score and each DEXA variable (i.e., % DEXA total
body fat and % DEXA trunk fat) was analyzed using multiply imputed data. For each DEXA
variable, bivariate correlations between DSST score and each of its five versions of completed
data were calculated, and results of these estimates were pooled. In contrast to what was
hypothesized, a very weak but statistically significant positive correlation between DSST score
and % total body fat measured by DEXA was found. Further, results failed to show a
statistically significant correlation between DSST score and % trunk fat measured by DEXA.
See Table 3 for more information.
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Table 3
Summary of Correlations between DSST Score and Obesity Indexes
Overall obesity indexes
BMI
DEXA % total body fat
Central obesity indexes
WC
WHtR
WTR
DEXA % trunk fat

DSST score

p

-.046
.076a

.121
.013

-.072
-.135
-.154
.050a

.019
<.001
<.001
.103

Note. BMI = body mass index; WC = waist circumference; WHtR = waist-height ratio; WTR = waist-thigh ratio;
DEXA = dual energy x-ray absorptiometry.
a
pooled estimates using multiply imputed data
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Hypothesis 7c Results
It was hypothesized that, among participants who met WC central obesity criteria, those
who also met BMI obesity criteria would perform worse on the DSST than those who did not.
An independent samples t-test conducted to compare centrally obese individuals with
BMI obesity (M = 40.9, SD = 18.0) and without BMI obesity (M = 44.3, SD = 18.3) on DSST
score revealed a statistically significant difference between groups, t (667) = -2.448, p = .015.
Similarly, it was hypothesized that, among participants who met WC central obesity
criteria, those who also met DEXA obesity criteria would perform worse on the DSST than those
who did not. An independent samples t-test to compare centrally obese individuals with and
without DEXA obesity on DSST score was run for each of the five versions of the completed
DEXA data. Results of these estimates were then pooled. In contrast to what was hypothesized,
results failed to show a statistically significant difference between centrally obese individuals
with and without DEXA obesity on DSST score, t (660) = .642, p = .521.
Hypothesis 7d Results (exploratory)
The question of which obesity indexes make meaningful contributions to the overall
prediction of DSST scores was explored. Note that, for Hypothesis 7d exploratory analyses,
single imputation of missing DEXA data was used rather than multiple imputation to allow for
multiple regression analysis. Also note that correlations between the dependent variable and the
predictor variables as shown in Table 3 are weaker than ideal for multiple regression analysis;
however, the decision was made to continue given the exploratory nature of this analysis.
While testing the present data against statistical assumptions of stepwise multiple
regression, the problem of multicollinearity was identified on the basis of a bivariate correlation
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matrix of the obesity indices using a cut-off value of .7, as shown in Table 4. It was further
confirmed by examining the tolerance and variance inflation factor for each predictor variable.
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Table 4
Summary of Correlations between Obesity Indexes
BMI

BMI
WC
WHtR
WTR
DEXA % total
body fat
DEXA % trunk fat

WC

WHtR

WTR

DEXA %
total body
fat

.859
.902
.126
.595

1.000
.896
.468
.362

1.000
.422
.589

1.000
-.086

1.000

.674

.514

.701

.100

.949

DEXA %
trunk fat

1.000

1.000

Note. BMI = body mass index; WC = waist circumference; WHtR = waist-height ratio; WTR = waist-thigh ratio;
DEXA = dual energy x-ray absorptiometry. All correlations significant at p < .01.
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Based on this data, the following obesity indices were excluded from the multiple
regression analysis: BMI, WC, and DEXA % trunk fat. A stepwise multiple regression using
backward elimination was then run to determine which of the remaining obesity indices (i.e.,
WHtR, WTR, DEXA % total body fat) make meaningful contributions to the overall prediction
of DSST scores. A significant regression equation was found (F(2, 1025) = 29.188, p < .001)
with an R2 of .054 with the predictors WHtR and DEXA % total body fat, which indicates that
5.4% of variance in DSST score is explained by movement in WHtR and DEXA % total body
fat. WTR did not meaningfully contribute to the model. Results are further detailed in Table 5.
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Table 5
Summary of Multiple Regression Analyses for Obesity Index Variables Predicting DSST Score
b

SE b

β

T

p

Part
value

Model 1
Constant
WHtR
WTR
DEXA % total body fat

63.738
-55.845
-2.625
.489

6.098
10.330
3.307
.095

-.251
-.030
.218

10.452
-5.406
-.794
5.170

< .001
< .001
.427
< .001

-.164
-.024
.157

Model 2
Constant
WHtR
DEXA % total body fat

60.203
-60.654
.523

4.166
8.366
.084

-.273
.234

14.452
-7.250
6.217

< .001
< .001
< .001

-.220
.189

Note. WHtR = waist-height ratio; WTR = waist-thigh ratio; DEXA = dual energy x-ray absorptiometry.
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Results of Exploratory Analyses on BMI Category by Gender Interaction on DSST Score
In exploratory analyses, a series of 2x3 ANOVAs were conducted to investigate main and
interaction effects of BMI weight category (i.e., normal weight, overweight, obese) and gender
on current DSST score for each of the following three timepoints: current, 10 years ago, and age
25. These are described below.
First, regarding the current timepoint, results revealed a significant main effect for
gender, F (1, 1120) = 20.880, p < .001 and a trend toward a significant main effect for current
weight category, F (2, 1120) = 2.919, p = .054. More specifically, men scored significantly
lower on the DSST (M = 40.4, SD = 18.2) than women (M = 44.4, SD = 18.6). Additionally, the
currently obese group tended to score lower on the DSST (M = 40.7, SD = 18.0) than the
currently overweight (M = 43.4, SD = 18.1) and currently normal weight (M = 43.0, SD = 19.7)
groups, though these differences are not assumed to be significant, as p values were not
calculated for these group differences. The interaction effect between gender and current weight
category was statistically significant, F (2, 1120) = 9.753, p < .001. More specifically, there was
a statistically significant simple effect of gender within the normal weight group, F (1, 1114) =
33.039, p < .001, but not within the overweight or obese groups. Fischer’s LSD post hoc tests
revealed that currently normal weight females scored significantly higher on the DSST (M =
49.3, SD = 18.2) than currently normal weight males (M = 37.1, SD = 18.8). Further, as Figure
4a reveals, the mean DSST score of the female group decreased when the weight category
increased from normal weight to overweight, whereas the mean DSST score of the male group
increased during that interval.
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Figure 4a. DSST scores by current BMI category and gender. Significant interaction effect
between gender and current weight category on DSST score, p < .001. Additionally, there is a
significant main effect for gender, p < .001, and a trend toward significance for current weight
category, p = .054.
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Second, regarding the late middle age timepoint (i.e., 10 years ago), results revealed
significant main effects for gender, F (1, 1098) = 13.740, p < .001 and late middle age weight
category, F (2, 1098) = 11.415, p < .001. More specifically, men scored significantly lower on
the DSST (M = 40.8, SD = 18.1) than women (M = 44.8, SD = 18.3). Additionally, Fischer’s
LSD post-hoc tests revealed that the late middle age obese group scored significantly lower on
the DSST (M = 38.2, SD = 17.7) than the late middle age overweight (M = 43.2, SD = 17.7) and
the late middle age normal weight (M = 45.5, SD = 18.3) groups. The interaction effect between
gender and late middle age weight category was statistically significant, F (2, 1098) = 6.207, p =
.002. There was a statistically significant simple effect of gender within the normal weight
group, F (1, 1092) = 24.328, p < .001, but not within the overweight or obese groups. Fischer’s
LSD post hoc tests revealed that females who were normal weight in late middle age scored
significantly higher on the DSST (M = 49.8, SD = 18.3) than males who were normal weight in
late middle age (M = 40.3, SD = 18.4). Moreover, as Figure 4b reveals, the mean DSST score of
the female group decreased when the weight category increased from normal weight to
overweight, whereas the mean DSST score of the male group increased during that interval.

131

Figure 4b. DSST scores by late middle-age BMI category and gender. Significant interaction
effect between gender and late middle-age BMI category (i.e., BMI category 10 years ago) on
current DSST score, p = .002. Additionally, there are significant main effects for gender, p <
.001, and late middle-age weight category, p < .001, on current DSST score.
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Finally, regarding the age 25 timepoint, results revealed significant main effects for
gender, F (1, 999) = 4.255, p = .039 and age 25 weight category, F (2, 999) = 5.782, p = .003.
More specifically, men scored significantly lower on the DSST (M = 41.2, SD = 17.9) than
women (M = 45.4, SD = 17.6). Additionally, Fischer’s LSD post-hoc tests revealed that the age
25 normal weight group scored significantly higher on the DSST (M = 44.2, SD = 17.6) than the
age 25 overweight (M = 40.8, SD = 18.2) and the age 25 obese (M = 35.6, SD = 17.8) groups.
No other group differences were statistically significant. See Figure 4c.
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Figure 4c. DSST scores by young adult BMI category and gender. Non-significant interaction
effect between gender and young adult BMI category (i.e., BMI category at age 25) on current
DSST score. Significant main effects for gender, p = .039, and young adulthood weight
category, p = .003, on current DSST score.
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Hypothesis 8a–8c Results
Eight groups were created based on whether participants were obese at age 25, 10 years
ago (ages 55–64), and currently (ages 65–74), as depicted in Table 6. It was hypothesized that
participants who were obese at age 25 and 10 years ago would perform the worst on the DSST,
whereas those with no history of obesity would perform best on the DSST. It was also
hypothesized that those who were obese at only one timepoint would perform better than those
who were obese at age 25 and 10 years ago.
To test these hypotheses, a one-way ANOVA with eight groups at alpha level .05 with
weight trajectory group as the independent variable and DSST score as the dependent variable
was planned. Prior to this analysis, however, it was discovered that three of the eight groups
contained very few participants, as shown in Table 6. The decision was made to remove these
groups from this analysis rather than combine them with similar groups because it was unclear as
to which other group, if any, was most similar to each of the three groups in question. For
example, the mean DSST score of Group 4 was extremely low and may suggest that the
individuals in this group are relatively unique, perhaps due to illness, and could not be
appropriately combined into another group for this analysis. After removal of these groups, five
groups remained. Means and standard deviations for each of the new and original groups are
included in Table 6.
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Table 6
Means and Standard Deviations of DSST Score by Weight Trajectory Group
Hypothesis 8 Group
Original
New

Obese at
age 25

Obese 10
years ago

Obese
currently

n

M

DSST score
SD

1

A

Y

Y

Y

29

37.2

18.0

2

__

Y

Y

N

7

34.1

18.6

3

__

Y

N

Y

2

39.5

31.8

4

__

Y

N

N

5

26.6

12.7

5

B

N

Y

Y

152

41.9

16.6

6

C

N

Y

N

54

32.8

16.7

7

D

N

N

Y

163

43.7

17.3

8

E

N

N

N

558

45.4

17.9

Note. Groups removed from Hypothesis 8 analyses due to low sample size are shaded in grey.
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Given the results of preliminary analyses that showed a statistically significant
relationship between gender and DSST score, conducting an ANCOVA rather than an ANOVA
was considered. However, the relationship between the covariate (i.e., gender) and predictor
variable (i.e., weight trajectory group) would have violated the ANCOVA assumption of
independence of the covariate and treatment effect (Miller & Chapman, 2001). Therefore, the
decision was then made to conduct the one-way ANOVA as planned, with the addition of an
exploratory analysis to assess for interaction effects between gender and weight trajectory group
on DSST score.
A one-way ANOVA with five groups with weight trajectory group as the independent
variable and DSST score as the dependent variable was conducted. Results showed a significant
effect of weight trajectory group on DSST score, F (4, 951) = 7.851, p < .001. Post hoc
comparisons using the Tukey-HSD test revealed that Group C scored significantly lower on the
DSST than Groups B, D, and E. No other group differences were statistically significant, though
a slight trend toward significance for Group A scoring lower than Group E was noted, p = .102.
In an exploratory analysis, a two-way ANOVA conducted to investigate interaction effects
between gender and weight trajectory group on DSST score failed to reveal a statistically
significant interaction, F (4, 946) = .577, p = .679.
Group differences in mean processing speed between participants with history of
persistent obesity (i.e., obesity in both early adulthood and late middle-age) and participants with
history of persistent non-obesity (i.e., obesity in neither early adulthood nor late middle-age)
were also investigated in exploratory analyses. The persistent obesity group consisted of a
combination of the original Groups 1 and 2, whereas the persistent non-obesity group consisted
of a combination of the original Groups 7 and 8. Results of an independent samples t-test
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conducted to compare mean DSST scores of those with persistent obesity (M = 36.6, SD = 17.9)
to those with persistent non-obesity (M = 45.0, SD = 17.8) revealed a statistically significant
difference between groups, t (755) = -2.770, p = .006. Other exploratory analyses showed that
persistently obese males (M = 33.1, SD = 17.5) had significantly lower DSST scores than
persistently non-obese males (M = 42.9, SD = 18.1), t (409) = -2.423, p = .006. No statistically
significant difference in DSST score between persistently obese females (M = 41.4, SD = 18.0)
and persistently non-obese females (M = 47.4, SD = 17.1) was found, t (344) = -1.326, p = .186;
however, caution was taken when interpreting results of this analysis, as the number of
participants in the persistently obese female group (n = 15) was lower than the minimum group
size of 26 needed to run a two-tailed t-test at alpha level .05 determined by an a priori power
analysis.
Hypothesis 8d Results
It was hypothesized that the percent of weight gained between early adulthood (age 25)
and late middle-age (age 55–64) would be associated with worse performance on the DSST. To
test this hypothesis, a Pearson product-moment correlation coefficient was calculated for DSST
score and percent weight gain between early adulthood and late middle-age. Results of this
analysis uncovered a statistically significant weak negative correlation between DSST score and
percent weight gain between early adulthood and late middle-age, r (805) = -.14, p < .001.
In exploratory analyses, the relationship between performance on the DSST and extent of
weight gain (i.e., absolute weight gain in pounds) between early adulthood and late middle-age
was assessed. Results of a Pearson product-moment correlation coefficient revealed a
statistically significant weak negative relationship between DSST score and extent of weight
gain between early adulthood and late middle-age, r (805) = -.14, p < .001. Next, the
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relationship between performance on the DSST and extent of weight loss (i.e., absolute weight
loss in pounds) between early adulthood and late middle-age was assessed. The correlation
between DSST score and extent of weight loss between early adulthood and late middle-age was
not significant, r (83) = .03, p = .80.
Hypothesis 8e Results
It was hypothesized that the absolute value of the percent of weight change over the
previous 10-year period (i.e., from late middle-age to young-old) would be associated with worse
performance on the DSST. To test this hypothesis, a Pearson product-moment correlation
coefficient was calculated for DSST score and the absolute value of percent of weight change
over the previous 10-year period, revealing a statistically significant weak negative relationship,
r (1096) = -.11, p < .001.
In exploratory analyses, a Pearson product-moment correlation coefficient was calculated
for DSST score and the extent of weight change over the previous 10 year period (i.e., absolute
value of weight change in pounds), revealing a statistically significant weak negative correlation
between these two variables, r (1096) = -.13, p < .001. Exploratory analyses also showed
statistically significant weak inverse relationships between performance on the DSST and the
extent of weight loss (i.e., absolute value of weight loss in pounds) over the previous 10 year
period, r (409) = -.20, p < .001, as well as between performance on the DSST and the extent of
weight gain (i.e., absolute value of weight gain in pounds) over the previous 10 year period, r
(685) = -.13, p < .001.
Hypothesis 8f Results
It was hypothesized that individuals with unintentional significant past-year weight loss
would perform worse on the DSST than those who achieved intentional significant past-year
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weight loss and those who were past-year weight-stable. No specific hypotheses were made
regarding how participants with significant past-year weight gain would perform on the DSST
relative to the other three groups. A one-way ANOVA was run with past-year weight group as
the independent variable (four levels) and DSST score as the dependent variable, revealing a
significant effect of past-year weight group on DSST score [F (3, 1022) = 12.53, p < .001]. Post
hoc comparisons using the Tukey-HSD test indicated that the unintentional significant past-year
weight loss group scored significantly lower on the DSST (n = 65, M = 31.0, SD = 17.1) than the
intentional significant past-year weight loss group (n = 83, M = 41.0, SD = 17.9), the significant
past-year weight gain group (n = 187, M = 42.1, SD = 18.8), and the past-year weight-stable
group (n = 691, M = 44.8, SD = 17.6). No other group differences were statistically significant.
Hypothesis 9 Results
It was hypothesized that there would be a significant negative correlation between CRP
level and DSST score and that this correlation would remain significant after controlling for
health and smoking confounds. In contrast to the predicted outcome, a Pearson product-moment
correlation coefficient calculated for CRP level and DSST score failed to reveal a statistically
significant relationship between these two variables, r (1027) = -.045, p = .153.
Hypothesis 10a Results
It was hypothesized that individuals who endorsed one or more of the following
conditions would perform worse on the DSST than those who did not: problems of blood flow to
the heart typically leading to or involving heart muscle damage (i.e., congestive heart failure
[CHF], coronary heart disease [CHD], or heart attack), stroke, diabetes, weak/failing kidneys,
chronic respiratory disease (i.e., chronic bronchitis or emphysema), and thyroid disease (if
untreated). As previously explained, upon implementation of the present study, it was
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discovered not to be possible to determine whether thyroid disease had been treated; therefore,
thyroid disease was not included in this analysis. Results of an independent samples t-test
conducted to compare mean DSST scores of those with none of these health conditions (M =
44.8, SD = 18.9) to those with ≥ 1 of these health conditions (M = 38.4, SD = 17.3) showed a
statistically significant difference between groups, t (1113) = -5.642, p < .001.
In exploratory analyses, a series of t-tests were conducted in order to investigate the
relationship between individual self-reported medical conditions and DSST score. Results of
these analyses are listed in Table 7. In addition, a one-way ANOVA was run with cardiac
diagnostic group as the independent variable (four levels: no history of CHF, CHD, or heart
attack; history positive for CHF; history positive for only CHD; history positive for only heart
attack) and DSST score as the dependent variable, revealing a significant effect of cardiac
diagnostic group on DSST score [F (3, 1090) = 5.91, p = .001]. Post hoc comparisons using
Tukey’s HSD test indicated that the group without history of any of these cardiac diagnoses
scored significantly higher on the DSST (M = 42.9, SD = 18.7) than the group with history of
CHF (M = 35.6, SD = 17.1; p = .013) and the group with history positive for only heart attack
(M = 33.2, SD = 15.5; p = .014). No other group differences were statistically significant.
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Table 7
Results of t-tests Comparing Groups on DSST Score by Self-reported History of Medical
Condition
M

SD

df

T

p

Stroke
Yes
No

34.5
42.7

16.7
18.5

1137

-3.555

< .001

Diabetes
Yes
No

36.0
43.6

16.5
18.8

1113

-5.308

< .001

Hypertension
Yes
No

39.6
44.5

17.8
18.8

1136

-4.452

< .001

Weak or failing kidneys
Yes
No

35.6
42.6

16.0
18.6

1136

-2.746

.006

Cardiac
Yes
No

39.3
42.9

17.0
18.7

1129

-2.349

.019*

Chronic respiratory disease
Yes
No

39.5
42.5

17.0
18.6

1138

-1.638

.102

Any liver condition
Yes
No

44.3
42.2

17.0
18.6

1136

.670

.503

Note. *Did not remain statistically significant after Bonferroni correction for alpha inflation. Cardiac = self-reported
history of congestive heart failure, coronary heart disease, and/or heart attack. Chronic respiratory disease = chronic
emphysema and/or chronic bronchitis.
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Hypothesis 10b Results
It was hypothesized that duration of respiratory disease would be negatively correlated
with processing speed task performance. In contrast to the predicted outcome, a Pearson
product-moment correlation coefficient calculated for duration of respiratory disease and DSST
score revealed a nonsignificant positive relationship between these two variables, r (85) = .178, p
= .104.
Hypothesis 11 Results
It was hypothesized that individuals with dyslipidemia (i.e., high levels of total
cholesterol, low levels of HDL cholesterol, high levels of LDL cholesterol, and/or high levels of
triglycerides) would demonstrate worse processing speed. To test this hypothesis, an
independent samples t-test was conducted to compare DSST scores of those with dyslipidemia
(M = 42.2, SD = 18.4) and without dyslipidemia (M = 44.4, SD = 18.4), which failed to reveal a
statistically significant difference between groups, t (543) = -1.306, p = .192.
In exploratory analyses, the relationship between each of the above types of dyslipidemia
(i.e., unhealthy levels of total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides)
and DSST score was investigated. The relationship between DSST and high levels of non-HDL
cholesterol was also examined. A series of independent samples t-tests using a two-tailed test of
significance at alpha level .05 was conducted to compare participants with and without each
dyslipidemia type on DSST score. Results showed significantly lower DSST scores in those
with low HDL cholesterol (M = 39.9, SD = 18.5) compared to those without low HDL
cholesterol (M = 44.4, SD = 18.2), t (1018) = -3.699, p < .001. Significantly lower DSST scores
were also found among those with high non-HDL cholesterol (M = 40.6, SD = 18.8) compared to
those without high non-HDL cholesterol (M = 43.5, SD = 18.4), t (1018) = -2.045, p =.041.
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Additionally, results showed a trend toward significance for lower DSST scores in those with
high LDL cholesterol (M = 39.7, SD = 19.1) compared to those without high LDL cholesterol
(M = 43.9, SD = 18.1), t (1018) = -1.859, p = .064. In contrast to what would have been
expected, results showed significantly higher DSST scores in those with high triglycerides (M =
46.8, SD = 16.8) compared to those without high triglycerides (M = 42.1, SD = 18.6), t (459) =
2.332, p = .020. Further, results failed to show a significant difference between DSST scores in
those with high total cholesterol compared to those without high total cholesterol, t (1018) = .585, p = .559. After the Bonferroni correction was applied to prevent alpha inflation, mean
group DSST scores only remained significantly different between participants with and without
low HDL cholesterol.
Additional analyses were later used to explore whether the above relationships differed
by sex. Results showed sex-specific relationships between DSST score and two types of
dyslipidemia: high non-HDL cholesterol and high triglycerides. Namely, men with high nonHDL cholesterol scored significantly lower on the DSST (M = 36.8, SD = 17.2) than men
without high non-HDL cholesterol (M = 41.9, SD = 18.4), t (517) = -2.442, p = .015, but the
same relationship was not found among women, t (499) = -1.013, p = .312. Moreover, women
with high triglycerides scored significantly higher on the DSST (M = 51.0, SD = 17.2) than
women without high triglycerides (M = 43.3, SD = 18.3), t (227) = 2.725, p = .007, but the same
relationship was not found among men, t (230) = .486, p = .628.
Hypothesis 12a Results
It was hypothesized that risk of first stroke, as indicated by score on a modified version
of the FSRP, would be inversely associated with processing speed task performance. A Pearson
product-moment correlation coefficient calculated for modified FSRP score and DSST score
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revealed a statistically significant weak negative correlation between these two variables, r (216)
= -.136, p = .045.
Hypothesis 12b Results
It was hypothesized that risk of onset of CVD, as indicated by score on a modified
version of the FRS for general CVD, would be inversely associated with processing speed task
performance. A Pearson product-moment correlation coefficient calculated for modified FRS for
general CVD score and DSST score revealed a statistically significant weak negative correlation
between these two variables, r (171) = -.205, p = .007.
Hypothesis 13 Results
It was hypothesized that there would be a significant positive correlation between speed
of usual gait and processing speed and that this correlation would remain significant after
controlling for BMI. Speed of usual gate (ft/s) was calculated using results from the 20-footwalk test. A Pearson product-moment correlation coefficient calculated for gait speed and DSST
score revealed a statistically significant moderate positive correlation between these two
variables, r (999) = .369, p < .001. Next, a partial correlation was run to determine the
relationship between gait speed and DSST score while controlling for BMI. A statistically
significant moderate positive correlation between gait speed and DSST score remained after
controlling for BMI, r (998) = .366, p < .001. A comparison of the zero-order correlation and
partial correlation suggests that BMI had very little influence in controlling for the relationship
between gait speed and DSST score. Results indicate that faster usual gait speed is moderately
associated with faster processing speed regardless of BMI.
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Final Model
The originally proposed theoretical model of the relationship between persistent obesity
and DSST score, as depicted in Figure 1, required extensive revision prior to testing due to
practical limitations, results of the previously described analyses, and theoretical considerations.
Most notably, it was deemed inappropriate to hypothesize that persistent obesity (which refers to
the span of time from young adulthood to late middle-age in the present study) would have a
bidirectional relationship with current habits and characteristics (e.g., diet, physical activity,
cholesterol levels), as there was a 10-year gap between late middle-age and the time of data
collection (i.e., young adulthood); therefore, these observed variables were removed from the
original model. Additionally, a number of proposed latent constructs (i.e., depression, physical
inactivity history, diet/nutrient history) were removed from the model due to lack of available
indicators to represent them. In other words, this information was not collected as part of the
NHANES cycles under analysis. Likewise, one proposed indicator of “brain oxygen flow
disruption/ insufficiency” (i.e., chronic hypoventilation during sleep or awake periods) was
removed due to this data not having been collected. Furthermore, some observed variables (i.e.,
chronic respiratory disease, peripheral inflammation) were removed from the model due to the
lack of significant relationship with DSST score found in earlier analyses. The remaining
variables were then examined for theoretical considerations. It was noted that each of the
remaining variables were vascular risk factors that conceivably could have a) been partially
“caused” by a history of persistent obesity and b) contributed to a decline in processing speed.
Another consideration relating to the decision to proceed with a model that focused on vascular
health history was the understanding that vascular risk factors are more theoretically relevant to a
decline in processing speed than risk factors associated with only Alzheimer disease (AD), as
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deficits of processing speed and executive functioning are typical of a vascular pattern of
cognitive impairment whereas deficits in memory and language are typical of cognitive
impairment seen in AD, particularly in this age group when AD is less likely to be advanced
stages in which additional domains tend to become impaired (American Psychiatric Association,
2013; Gasecki, Kwarciany, Nyka, & Narkiewicz, 2013; Lezak, Howieson, Bigler, & Tranel,
2012). As a result of the above considerations, a measurement model of vascular health history
was hypothesized using the remaining variables as indicators, as depicted in Figure 5.
Additionally, a structural model in which vascular health history partially mediates the
relationship between persistent obesity and DSST score was hypothesized, as shown in Figure 6.
Note that cardiac history in Figure 5 refers to a binary variable that reflects the presence or
absence of self-reported CHD, CHF, and/or heart attack, which is consistent with its use in
previous analyses in the present study.
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Hypertension history
Stroke history
Diabetes history

Vascular health
history

Cardiac history

Figure 5. Hypothesized measurement model of vascular health history. Error terms
not shown.
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Vascular health
history

Persistent obesity

DSST score

Figure 6. Revised hypothesized structural model of DSST score. Error terms not shown.
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The hypothesized measurement model for vascular health history was tested using
confirmatory factor analysis (CFA) prior to assessment of the hypothesized structural model.
The hypothesized measurement model included one latent variable (i.e., vascular health history)
and four observed indicators (i.e., self reported history of hypertension, stroke, diabetes, and
cardiac event/ condition). Results of the CFA for vascular health history revealed an acceptable
fit between the measurement model and the present study’s data [χ2 (2, 1380) = 1.404, p = .496;
CFI = 1.000; RMSEA = .000 (90% CI = .000–.048)]. Further, the standardized factor loadings
for each of the four indicators exceeded the cut-off criterion of > .35 and, therefore, were
retained in the measurement model. See Table 8 for complete information on factor loadings.
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Table 8
Confirmatory Factor Analysis for Vascular Health History
Estimate

SE

p

Stroke

0.57

0.08

0.000

Hypertension

0.66

0.07

0.000

Diabetes

0.45

0.06

0.000

Cardiac

0.44

0.06

0.000

Note. Standardized regression weights and two-tailed p values are reported.
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Next, the revised hypothesized structural model of DSST score, as previously depicted in
Figure 6, was tested, revealing inadequate fit with the present study’s data [χ2 (8, 874) = 15.409,
p = .052; CFI = 0.949; RMSEA = 0.033 (90% CI = .000–.057)]. See Figure 7 and Table 9 for
results regarding individual factor loadings of the revised hypothesized structural model.
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Vascular health
history

.29**

Persistent obesity

.35**

.00

DSST score

Figure 7. Revised hypothesized structural model of DSST score with standardized regression
weights. Error terms not shown. **p < .001.
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Table 9
Factor Loading Summary of Revised Hypothesized Structural Model of DSST Score
Estimate

SE

Estimate/SE

p

Vascular health history

10.27 (0.35)

2.50

4.11

0.000

Persistent obesity

0.05 (0.00)

3.91

0.01

0.990

0.82 (0.29)

0.17

4.81

0.000

DSST score on:

Vascular health history on:
Persistent obesity

Note. Standardized estimates are in parentheses. Two-tailed p values are reported.
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Modification indices and factor loadings were then examined to determine if an
adjustment to the structural model could be made to improve model fit in the event that the
adjustment made theoretical sense. In doing so, the direct path between persistent obesity and
DSST score was removed. The resulting structural model, as depicted in Figure 8, was then
tested, revealing adequate fit with the present study’s data [χ2 (9, 874) = 14.661, p = .101; CFI =
0.961; RMSEA = 0.027 (90% CI = .000–.051)]. See Figure 9 and Table 10 for results regarding
individual factor loadings of the final model.
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Persistent obesity

Vascular
health history

Figure 8. Final structural model of DSST score. Error terms not shown.

DSST score
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.29**
Persistent obesity

Vascular
health history

.37**
DSST score

Figure 9. Final structural model of DSST score with standardized regression weights. Error
terms not shown. **p < .001.
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Table 10
Factor Loading Summary of Final Structural Model of DSST Score
Estimate

SE

Estimate/SE

p

10.93 (0.37)

2.34

4.68

0.000

0.81 (0.29)

0.16

5.03

0.000

DSST score on:
Vascular health history
Vascular health history on:
Persistent obesity

Note. Standardized estimates are in parentheses. Two-tailed p values are reported.
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Discussion

Hypothesis 1 Discussion
It was hypothesized that there would be a strong negative correlation between age and
processing speed task performance, as indicated by Digit Symbol Substitution Test (DSST)
score. This hypothesis was based on the consensus that declines in most cognitive domains
occur with aging even in the absence of known health problems as well as research that supports
the notion that processing speed is among the most important factors in explaining normal agerelated cognitive decline (e.g., Aine et al., 2011; Harada et al., 2013; Hasher et al., 1991; Rozas
et al., 2008; Vance, 2009).
This hypothesis was partly supported by the data. Age was found to have a significant
inverse relationship with DSST score, which suggests that processing speed task performance
declines as age increases within the young-old age category. This finding is consistent with
previous research on other tests of processing speed within this age category, including the
Wechsler Adult Intelligence Scale, Fourth Edition (WAIS-IV) Processing Speed Index (PSI)
subtests Coding and Symbol Search (Wisdom, Mignogna, & Collins, 2012).
The strength of the relationship between age and DSST score in the present study was
weak, whereas it was predicted to be strong. This finding may be related to the cross-sectional
nature of the present study, as longitudinal effects have been shown to be larger than crosssectional effects for the Wechsler Adult Intelligence Scale-Revised (WAIS-R) DSST and a
variety of other cognitive measures among a sample of older adults aged 66–92 at baseline who
were followed for up to five 18-month intervals (Sliwinski & Buschke, 1999). In other words,
cross-sectional age differences in processing speed may be less obvious than longitudinallymeasured age-related changes in this population (Sliwinski & Buschke, 1999).
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Additionally, evidence of increased intragroup variability on tests of processing speed as
age increases, as captured by Wisdom, Mignogna, and Collins (2012) with the use of the
coefficient of variation (CV), should be considered when interpreting these results. The CV,
which is calculated by dividing the standard deviation by the mean and multiplying by 100, has
utility as a measure of score dispersion above and beyond that of standard deviation, the latter of
which has been shown to vary relatively little on the WAIS-IV PSI subtests for participants
within this age category (Wisdom et al., 2012). In other words, in regard to a variable whose
mean decreases with age but whose standard deviation remains stable with age (similar to the
DSST variable in the present study), the variable will show increased score dispersion with age,
which would then yield a weaker correlation between that variable and age.
On the other hand, it is possible that the relationship between age and processing speed
would be stronger in a population older than the present study’s sample of 65–74-year olds.
Salthouse (2012) presented data suggestive of stability in rate of decline in processing speed in
adults up to age 75, but future reseach is needed to understand whether this rate of decline
remains stable, or perhaps accelerates, beyond age 75. Finally, the finding that age was only
weakly correlated with DSST score in the present study highlights the importance of other
contributors to processing speed task performance in this age group.
Hypothesis 2 Discussion
It was hypothesized that age would show a significant positive association with % body
fat as measured by dual energy x-ray absorptiometry (DEXA) but would show a slight, negative,
statistically insignificant correlation with body mass index (BMI). Likewise, it was hypothesized
that visceral adiposity estimated by % trunk fat DEXA would increase significantly with age but
waist circumference (WC) would not be significantly correlated with age. These hypotheses
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were based on a number of interrelated findings that highlight the changing body composition
with age as well as the discrepancy between this group’s body composition markers and obesity
indexes. The hypotheses involving anthropometrically derived obesity indexes (i.e., BMI, WC)
were largely supported by the data, whereas those involving DEXA-derived obesity indexes (i.e.,
% body fat DEXA, % trunk fat DEXA) were not.
The hypothesis that % total fat DEXA would increase with age had been informed by a
study that showed increase in bioelectrical impedance analysis (BIA)-derived percentage of total
body fat with age across the adult lifespan (Kyle, et al., 2001). The present study, however, did
not find a statistically significant relationship between age and % total fat DEXA among its
young-old participants. The absence of this finding may be related to the specific age decade
under investigation (ages 65–74) and the timing of the onset of significant age-related decline in
fat-free mass. Namely, Obisesan and colleagues (2005) found that declines in fat-free mass
typically began during one’s 50s but did not become significant until ages 65–69 in Black men,
70–74 in Black women and White men, and 75–79 in White women. It may be the case that
many participants in the present study had not yet experienced significant decline in fat-free
mass, a change in body composition that would have contributed to increased % total fat DEXA
values. Another possible explanation for the apparent discrepancy between the results of Kyle
and colleagues (2001) and the present study pertains to the health of their respective participants,
as the former attempted to exclude individuals with acute or chronic diseases (a number of which
are known risk factors for dementia). Because dementia risk increases with age and individuals
who go on to develop dementia are more likely to have lost a significant amount of weight
between midlife and late-life compared to individuals who remain free of dementia, it may be the
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case that the present study contained more individuals at relatively higher ages with recently
reduced body weights (Stewart et al., 2005).
The hypothesis that % trunk fat DEXA would increase with age in the young-old
population had been informed by results of a cross-sectional study reported by Oldroyd and
colleagues (1998), which showed increased % trunk fat DEXA in males over the age of 50 (M =
59.2 years) and postmenopausal women (M = 61.6 years) relative to males below the age of 50
(M = 37.5 years) and premenopausal women (M = 37.2 years), respectively. Results of the
present study suggest that the increase in abdominal fat that appears to occur between
approximately midlife and late midlife may not continue to occur during the young-old portion
of the lifespan (i.e., 65–74 years of age). This idea is supported by findings from a recent crosssectional study of women using BIA, which found statistically significant increases in visceral
fat area during the third, fourth, and fifth decades of life but statistically insignificant increases in
visceral fat area in the sixth decade of life and beyond (Gába & Přidalová, 2014).
Hypothesis 3 Discussion
The hypothesis that participants with probable lifetime history of excess alcohol
consumption would exhibit worse processing speed task performance than participants without
this history was supported by the data. This finding is not surprising given that individuals with
a history of chronic alcohol use are at risk for alcohol-induced neurocognitive disorders. In
addition, there is evidence of impaired cognition during periods of abstinence subsequent to
chronic alcohol use, mostly with regard to tasks dependent on the hippocampus and/or prefrontal
cortex (e.g., working memory and executive functioning; Staples & Mandyam, 2016). Further,
history of chronic alcohol use is associated with other lifestyle variables that may be
independently linked to worsened processing speed task performance, such as those of smoking.
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The present study adds information to the current body of literature on associations between
history of chronic excess alcohol use and processing speed task performance in a nationally
representative sample of young-old adults.
The hypothesis that participants who currently smoke would perform worse on the DSST
than those who do not currently smoke was supported by the data. Moreover, exploratory
analyses showed that everyday smokers performed worse on the DSST than nonsmokers,
whereas occasional smokers did not differ significantly from either group. Results indicate that
smoking everyday is associated with worsened processing speed in adults aged 65–74 compared
to not smoking. This finding was expected, as smoking has been hypothesized to lead to
impaired cognition through the initiation of atherogenesis and subsequent development of
atherosclerosis, which can lead to cardiovascular and/or cerebrovascular diseases that negatively
impact cognition (Messner & Bernhard, 2014). It is also possible that daily smoking may
decrease lung functioning, which in turn may discourage individuals from participation in
regular aerobic exercise, which itself is linked with improved cognitive outcomes and decreased
risk of cardiovascular and cerebrovascular diseases. Previous research has found that, among
women aged 40–79, current smokers and previous smokers scored lower on the WAIS-III PSI
than never-smokers (Lo et al., 2014). The present study’s findings add information to the current
body of literature on associations between frequency of current smoking behavior and processing
speed task performance in a nationally representative sample of young-old adults.
Hypothesis 4 Discussion
Participants were divided into the following groups for this set of hypotheses: participants
who did not engage in regular exercise (no exercise group); participants who engaged in both
regular aerobic exercise and regular strength training exercise (combination training group);
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participants who engaged in regular aerobic exercise only (aerobic-only group); and participants
who engaged in regular strength training exercise only (strength training-only group). Among
these groups, it was hypothesized that the no exercise group would perform worst on the DSST,
whereas the combination training group would perform the best and the aerobic-only group
would outperform the strength training-only group.
These hypotheses were based on results of experimental studies showing the benefit of
immediate and regular aerobic exercise on processing speed and other aspects of cognition (e.g.,
Nouchi et al. 2014; Tam, 2013). Additionally, they were informed by an experimental study that
found evidence for a program of aerobic exercise to selectively improve performance of
executive control processes supported by the frontal and prefrontal regions of the brain (e.g.,
switching between tasks, ability to disregard task-irrelevant stimuli, ability to discontinue a
planned action), which is relevant to the present study given that the DSST involves elements of
executive functioning and has been shown to activate the frontal lobe (Davis & Pierson, 2012;
Nakahachi et al., 2008). Further, these hypotheses were informed by results of a meta-analysis
on the effects of exercise on the cognitive functioning of older adults that yielded the finding that
those in combination training programs demonstrated improvements in cognitive outcomes to a
greater degree than those in aerobic training groups (Colcombe & Kramer, 2003).
This group of hypotheses was partially supported by the results of the present study. As
predicted, the present study found that, in regard to the DSST, the combination training group
outperformed each of the other three exercise groups, and the aerobic-only group outperformed
the no-exercise group. However, in contrast to what was hypothesized, the strength training-only
group did not perform in a significantly different manner on the DSST than the aerobic-only
group or the no exercise group. Results suggest that, in this nationally representative sample of
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adults aged 65–74, regular strength training may have an additive effect on regular aerobic
exercise with regard to its association with improved processing speed task performance but that
regular strength training alone does not have a significant association with processing speed task
performance relative to that of no exercise. Interestingly, results from two recent 24-week,
randomized, double-blind, placebo-controlled trials that tested the effect of strength training (vs.
no exercise training) with or without protein supplementation in older adults found that strength
training with protein supplementation improved information processing speed relative to no
exercise with protein supplementation, but the same benefits of strength training were not found
among participants who did not receive protein supplementation (van de Rest et al., 2014). This
suggests the possibility of diet having a moderating role with regard to the impact of strength
training exercises on information processing speed outcomes. Indeed, many tasks created to
measure processing speed have a strong motor component, and it would seem that increased
muscle strength (which requires adequate dietary protein to achieve) could have a beneficial
impact on motor speed; however, efforts taken by van de Rest and colleagues (2014) to control
for motor speed on performance outcomes suggest that the benefits of strength training on
information processing speed in those who received protein supplementation is not simply due to
increased motor speed secondary to strengthened muscles. Future research is needed to clarify
the role of diet and nutrition in regard to cognitive outcomes of exercise programs for older
adults.
Hypothesis 5 Discussion
Using the operational definitions for diabetes, prediabetes, and no diabetes specified in
the Hypotheses section, participants with diabetes were expected to perform worse on the DSST
than participants with prediabetes and participants without diabetes. In addition, participants
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with prediabetes were expected to perform worse on the DSST than those without diabetes.
These hypotheses were informed by studies that have shown processing speed impairment in
those with type-2 diabetes mellitus (T2DM), as well as findings of similar impairment in those
with metabolic syndrome, suggesting that cognitive decline may develop in the early stages of
T2DM (e.g., van den Berg et al., 2008). The present study’s hypotheses were partially supported
by the results. Namely, the mean DSST score of the diabetes group was significantly lower than
both the prediabetes group and the no diabetes group; however, the mean DSST score of the
prediabetes group did not differ significantly from the no diabetes group.
Exploratory analyses were used to investigate the relationship between individual
markers of diabetes status and processing speed task performance. Concerning fasting blood
glucose group (i.e., diabetic range, prediabetic range, normal range), group membership did not
have a statistically significant effect on DSST score. Regarding HbA1c group (i.e., diabetic
range, prediabetic range, normal range), those in the diabetic range performed worst on the
DSST, those in the normal range performed best, and those in the prediabetic range performed
better than those in the diabetic range but worse than those in the normal range; each of these
group differences was statistically significant.
These results showed that individuals with diabetes demonstrated worse processing speed
task performance relative to individuals free of diabetes when HbA1c level was used to define
diabetes status but not when fasting blood glucose level was used to define diabetes status. It
may be the case that chronic hyperglycemia, as represented by HbA1c diabetic range, is involved
in the etiology of impaired processing speed in young-old adults or otherwise associated with
this impairment, whereas current hyperglycemia status itself is less relevant. Alternatively, it is
possible that measurements of HbA1c, a non-fasting test, were more accurate than measurements
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of fasting blood glucose given that the latter would have been vulnerable to human error in recall
(e.g., inaccurate report of hours of fasting status).
Further, the finding that participants in the HbA1c prediabetic range performed better than
those in the HbA1c diabetic range but worse than those in the HbA1c normal range supports the
theory that diabetes-associated cognitive decline may begin developing in the early stages of the
disease (van den Berg et al., 2008). The present study’s finding that young-old adults with
prediabetic HbA1c levels demonstrate impaired processing speed relative to same aged peers with
normal HbA1c are consistent with previous research that has found this relationship among
middle-aged adults and adds to the current literature (Sanz et al., 2013; Young, Mainous, &
Carnemolla, 2006).
Exploratory analyses were also used to investigate the relationship between peripheral
insulin resistance and processing speed task performance. Participants with peripheral insulin
resistance, operationally defined as a homeostasis model assessment of insulin resistance
(HOMA-IR) score above the 75th percentile, performed significantly worse on the DSST than
participants without peripheral insulin resistance. This could be taken to support the theory that
cognitive decline develops in the early stages of T2DM, as peripheral insulin resistance proceeds
the onset of hyperglycemia in the development of T2DM; however, in the present study, the
majority of individuals with peripheral insulin resistance also had diabetes mellitus. This is not
surprising because average onset of T2DM during the years 1999 to 2002 ranged from 52 to 53
years of age, whereas the participants in the present study were aged 65–74 (Centers for Disease
Control and Prevention, 2017). The low number of participants who had peripheral insulin
resistance but were free of diabetes prevented investigation of the potential impact of peripheral
insulin resistance on processing speed task performance among non-diabetic young-old adults.
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Hypothesis 6 Discussion
Homocysteine. Folate and vitamin B12 are needed to convert homocysteine to
methionine; therefore, homocysteine levels may increase when levels of folate or vitamin B12 are
depleted (Leishear, Ferrucci, et al., 2012). Vitamin B12 level and DSST score were not
significantly associated in the present study. It was, therefore, unnecessary to control for vitamin
B12 level in either the homocysteine or folate analyses. The discussion that follows focuses on
the relationship between homocysteine and processing speed as it relates to the potential impact
of folate.
Some research has found high homocysteine levels to be associated with reduced
information processing speed independent of folate levels, but results of other studies suggest
that high homocysteine levels are only associated with worse cognition in those with low folate
levels (Feng et al., 2013; Feng et al., 2006; Vidal et al., 2008). Results from the present study
indicate that, among a nationally representative sample of adults aged 65–74, homocysteine level
has a weak inverse relationship with processing speed and a very weak inverse relationship with
processing speed after controlling for folate level.
Although the above results were statistically significant, their practical value is low. In
contrast, hyperhomocysteinemia, defined as homocysteine level ≥ 12 μmol/L, showed a
moderate relationship to DSST score and may be of greater practical significance than
homocysteine level. This relationship was independent of folate status, as no statistically
significant interaction between hyperhomocysteinemia and folate depletion was found.
Results support the hypothesis that higher homocysteine level, and
hyperhomocysteinemia in particular, is associated with worse processing speed independent of
folate and vitamin B12 levels in young-old adults. In other words, reduced processing speed in
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young-old adults with hyperhomocysteinemia is not simply a consequence of low folate or
vitamin B12 levels.
Results from the present study are consistent with findings from a recent study showing
that, among adults aged 65–80 with normal serum levels of folate and vitamin B12, DSST scores
of those with hyperhomocysteinemia were significantly lower than those without
hyperhomocysteinemia; the same relationship was not found among adults aged 50–64 in that
study, indicating that this relationship may be sensitive to age (Hsu et al., 2016). Moreover,
hyperhomocysteinemia was not significantly associated with performance in any other
neuropsychological domain, which adds to the body of literature that supports the idea that
reduced processing speed is the type of cognitive impairment most associated with
hyperhomocysteinemia (Hsu et al., 2016; Feng et al., 2006; Feng et al., 2013).
Whether hyperhomocysteinemia causes cognitive dysfunction or is a marker of this
dysfunction is uncertain. Hyperhomocysteinemia has been theorized to be a common risk factor
for many dementia subtypes (including Alzheimer disease [AD] and vascular dementia [VaD])
via disrupted cerebrovascular homeostasis (Kamut, Vacek, Kalani, & Tyagi, 2015). Specific
mechanisms of action suggested by research include, but are not limited to, facilitation of
oxidative distress, direct neurotoxic effects, increased risk for atherosclerosis and thrombosis via
damage to the vascular endothelium, and disruption of the blood-brain barrier leading to microvascular degeneration and accumulation of toxic substances (Arnesen et al., 1995; Di Bonito et
al., 2007; Graham et al., 1997; Kamut et al., 2015).
Folate. There is a lack of consensus on the lower limit of serum folate reference values
in the literature. The 1999–2000 CDC Laboratory Procedure Manual defined folate deficiency
as serum folate < 1.4 ng/mL with regard to interpretation of results from the particular radioassay
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kit that was used (CDC Laboratory Procedure Manual). In contrast, the current Merck Manual
states that folate deficiency is likely if serum folate is < 3 ng/mL (Johnson, 2016d). Further,
according to the World Health Organization (WHO), serum folate level that is < 3 ng/mL
indicates folate deficiency, whereas the 3 ng/mL to 5.9 ng/mL range indicates “possible folate
deficiency” (WHO, 2015). These criteria are generally consistent with results of an early
experimental study of the development of folate deficiency through a low folate diet that was
conducted by a physician on himself, which concluded that a persistent serum folate level of less
than 3 ng/mL led to folate deficiency, as evidenced by megaloblastic changes in his blood cells
(Herbert, 1962). More recently, the use of a higher cut-off value has also been argued, as some
metabolic changes associated with folate deficiency can be observed prior to changes in blood
cells (Green et al., 2008; De Bruyn, Gulbis, & Cotton, 2014).
The present study had selected an operational definition of folate deficiency to be serum
folate < 1.4 ng/mL in order to be consistent with the 1999–2000 CDC Laboratory Procedure
Manual. However, none of the participants in the present study met that criterion. Given that
folate and DSST score were found to have a statistically significant positive relationship
independent of homocysteine level in a previous analysis in the present study, the utility of an
alternate folate cut-off value was explored. Namely, a cutoff value of < 8 ng/mL was selected
for the present study’s operational definition of folate depletion on the basis of recent research,
with 9.5% of the present study’s sample meeting this criterion (De Bruyn, Gulbis, & Cotton,
2014). Those with folate depletion performed significantly worse on the processing speed task
than those without folate depletion independent of hyperhomocysteinemia status. Therefore,
based on results of the present study, folate depletion is of greater practical significance than
folate level in regard to its relationship to processing speed among young-old adults.
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Results of the present study are not consistent with results of an earlier study of adults
aged 55–85 living in the Netherlands that failed to find a statistically significant difference in
processing speed task performance between participants with and without low folate level
(Jelicic et al., 2001). Relative to the present study, Jelicic and colleagues (2001) used a similar
folate cutoff (i.e., 7 ng/mL) and processing speed task (i.e., a letter substitution task). This
discrepancy highlights the need for additional research to clarify this relationship, as it is not yet
known whether low folate level has a causal or contributory relationship to slowed processing
speed in young-old adults and/or whether low folate level is a marker of another condition that
explains this association.
Folate is believed to be important to cognitive and emotional functioning. Symptoms of
folate deficiency can include depression and confusion (Johnson, 2016d; Reynolds, 2002).
Furthermore, some have speculated that low folate level contributes to an increased risk for
dementia (e.g., Reynolds, 2002). There is some evidence to support this idea. For example, one
large prospective study of older adults over a 2.4-year period found that baseline folate level, but
not baseline B12 or homocysteine levels, predicted incident dementia (Kim et al., 2008). During
the follow-up period of that study, those with incident dementia showed an accelerated decline in
folate and a steeper increase in homocysteine compared to those who did not develop dementia.
Moreover, one recent study using amyloid positron emission tomography (PET) scans found that
those whose imaging was positive for amyloid plaques had lower folate levels than those who
tested negative (Yoshinaga, Nishimata, Kajiya, & Yokoyama, 2017). Of course, these studies
are not experimental in nature and cannot show evidence for a causal role of folate in the
development of dementia.
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Folate is also important to physical functioning, and a chronic low level of this vitamin
can cause medical problems that lead to cognitive and/or emotional dysfunction (Reynolds,
2002). For example, chronic alcohol use can impair intestinal absorption of folate, leading to
folate deficiency and subsequent development of alcoholic liver disease and its associated
cognitive impairments (Medici & Halsted, 2013). Additionally, folate assists in proper
deoxyribonucleic acid (DNA) methylation, without which cancer and other diseases are more
likely to develop (Crider, Yang, Berry, & Bailey, 2012; Duthie, 2011). Though most types of
cancers themselves are not believed to impair cognition, cancer treatments of systemic
chemotherapy and radiation localized to the brain may negatively impact processing speed and
executive functioning (Anstey et al., 2015; Avila et al., 2015; Mandelblatt et al., 2014).
Vitamin D. The hypothesis that participants with low 25-hydroxyvitamin D levels
would perform worse on the processing speed task than those with healthy vitamin D levels was
supported by the data. This finding is consistent with previous research among adults of various
ages (Karakis et al., 2016; Lee et al., 2009). The present study contributes to the literature by
reporting this relationship specifically within a nationally representative sample of young-old
adults. Findings that suggest that, among young-old adults, men’s processing speed tends to be
more negatively impacted by low vitamin D status than women’s processing speed are also
noteworthy.
It is unclear if, and to what extent, low 25-hydroxyvitamin D level contributes to slowed
processing speed or whether it is primarily a biomarker for one or more other conditions. This
question is complicated by the dual functioning of vitamin D through both endocrine (e.g.,
regulation of calcium and phosphate absorption) and intracellular (e.g., regulation of target gene
expression) signaling mechanisms (Vanherwegen, Gysemans, & Mathieu, 2017). Moreover, the
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vitamin D receptor (VDR) and the enzyme needed for conversion of vitamin D to its active form
are both present in the human brain, as well as multiple other tissues throughout the human body
(Eyles, Smith, Kinobe, Hewison, & McGrath, 2005; Feldman & Malloy, 2014). Given this,
vitamin D functioning is likely to have a variety of bodily effects. Consistent with this idea is
empirical evidence that implicates vitamin D in skeletal, immune functioning, cardiovascular
health, and cancer outcomes (Wilson, Tripkovic, Hart, & Lanham-New, 2017).
There are, therefore, several possible explanations for the present study’s finding that
young-old adults with low vitamin D levels evidenced slower processing speed than young-old
adults with healthy vitamin D levels. Select possibilities relevant to the present study are briefly
discussed here. First, it may be the case that a certain level of 25-hydroxyvitamin D is needed in
order to support good vascular health, as low 25-hydroxyvitamin D has been associated with
endothelial dysfunction and arterial stiffness (Mheid et al., 2011). There is also evidence to
suggest that 25-hydroxyvitamin D may contribute to impaired glucose metabolism (Binkley,
Ramamurthy, & Krueger, 2010). These findings are consistent with the associations between
low 25-hydroxyvitamin D level and the two cognitive domains most likely to be impacted by
cerebrovascular damage: processing speed and executive functioning (Karakis et al., 2016).
Second, there may be a more direct impact of 25-hydroxyvitamin D on the brain. Empirical
studies have suggested a role for 25-hydroxyvitamin D in protecting neuronal integrity via
detoxification pathways and synthesis of proteins necessary for neuronal survival (Buell &
Dawson-Hughes, 2008). Third, research suggests that 25-hydroxyvitamin D may be protective
against depression, a disorder that often includes slowed cognitive and psychomotor speed
(Marazziti et al., 2010). Mechanisms by which 25-hydroxyvitamin D may be protective against
depression are not well-established, but one hypothesis is that 25-hydroxyvitamin D reduces the
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increased neuronal levels of calcium ions that drive depression (Berridge, 2017). Fourth, lower
25-hydroxyvitamin D has been associated with the presence of obesity, a condition that has also
been associated with slowed processing speed (Mai, Chen, Camargo, & Langhammer, 2012).
Per the current literature, it is not clear whether obesity promotes low serum 25-hydroxyvitamin
D levels, low serum 25-hydroxyvitamin D promotes obesity, they are related through other
common variables (e.g., diet), or some combination thereof (Mai, et al., 2012). In any case,
results of the present study indicate that history of persistent obesity in young adulthood and late
middle-age does not account for the relationship between low 25-hydroxyvitamin D level and
slow processing speed in young-old adults once vascular health history is controlled.
The present study’s finding that current low vitamin D level significantly and negatively
impacts DSST score in the absence of late middle-age obesity history (but not in the presence of
late middle-age obesity history) in young-old adults is interesting, though its meaning is unclear.
Perhaps reasons for low vitamin D tend to differ between young-old adults with and without
history of late middle-age obesity. It could be hypothesized that reasons for low vitamin D in
young-old adults without history of late middle-age obesity tend to contribute to slowed
processing speed whereas reasons for low vitamin D in young-old adults with history of late
middle-age obesity tend not to contribute as much to slowed processing speed.
Iron deficiency. Research on the relationship between iron deficiency and processing
speed has primarily focused on infants and children (e.g., Hamid, Amal, Rohani, & Norimah,
2010). Little has been reported on this relationship among adults, and what has been reported is
mostly limited to women of childbearing age (e.g., Murray-Kolb & Beard, 2007; Scott &
Murray-Kolb, 2016). Findings from that body of research suggest that severity of anemia may
adversely impact processing speed to a greater extent than other cognitive domains, whereas

174
severity of iron deficiency may be associated with a broader pattern of cognitive dysfunction
(Murray-Kolb & Beard, 2007). Regarding older adults, one study reported an association
between iron deficiency and lower scores on a cognitive impairment screening measure (Yavuz
et al., 2012). The present study adds to the literature by reporting that young-old adults with iron
deficiency do not have significantly slower processing speed than young-old adults without iron
deficiency, though it should be emphasized that this finding does not imply that these two groups
have equivalent processing speed abilities. More research is needed to better understand the
relationship between iron deficiency and processing speed in young-old adults.
Vitamin E. There are multiple forms of vitamin E, including tocopherols, tocotrienols,
and stereoisomers (Johnson, 2016c). Of these, alpha-tocopheral is the most biologically active,
whereas gamma-tocopherol is the most abundant in the typical American diet (Brigelius-Flohe &
Traber, 1999; Camara et al., 2014; Johnson, 2016c). Vitamin E is believed to be important in
preventing diseases caused by oxidative stress through its antioxidant properties, though
additional mechanisms for health promotion are also likely (Brigelius-Flohe & Traber, 1999;
Niki, 2015).
Results from the present study indicate that higher alpha-tocopherol levels are associated
with better processing speed task performance in young-old adults. This finding is consistent
with a study of community-dwelling older adults that reported that those with alpha-tocopherol
levels in the highest tertile were significantly less likely to be suffering from cognitive
impairment or dementia than those in the lowest tertile (Cherubini et al., 2005). These results,
though they do not imply a causal role of vitamin E on health outcomes, are consistent with the
idea that vitamin E may aid in the prevention and/or treatment of diseases driven by oxidative
stress. Clinical trials testing this theory have been inconsistent and somewhat disappointing thus
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far, though there is growing evidence that d-l-alpha-tocopherol supplementation can slow
functional decline in AD (Dysken et al., 2014; Niki, 2015).
Only 2 of the 492 participants with both an alpha-tocopherol value and DSST score in the
present study met vitamin E deficiency criteria; therefore, the relationship between vitamin E
deficiency and processing speed could not be assessed as planned. Results suggest that vitamin
E deficiency is rare in young-old adults in the United States and that a study of greater sample
size would be needed to properly assess this relationship. Of note, the low percentage of
participants meeting criteria for vitamin E deficiency in the present study is similar to results
from a study of European adults aged 55–87 that used a similar vitamin E deficiency criterion
(Polito et al., 2005). These findings are consistent with the assertion that vitamin E deficiency is
uncommon in developed countries (Johnson, 2016c).
Surprisingly, exploratory analyses revealed higher levels of gamma-tocopherol to be
associated with worse cognitive functioning in young-old adults, though this relationship nearly
vanished once the effect of alpha-tocopherol level was controlled. There is a paucity of
published information on the relationship between gamma-tocopherol and cognition in the
literature to date. When literature in areas outside of cognition is consulted for context, a few
important differences between alpha-tocopherol and gamma-tocopherol emerge. First, recent
research has shown that tocopherols regulate signaling pathways in the inflammatory process;
namely, during allergic inflammation, alpha-tocopherol is anti-inflammatory, whereas gammatocopherol is pro-inflammatory (Abdala-Valencia, Berdnikovs, & Cook-Mills, 2013; Berdnikovs
et al., 2009). Second, there is some difference in associations between health outcomes and
serum levels of these two tocopherols. A recent meta-analysis, for example, concluded that
serum alpha-tocopherol level, but not serum gamma-tocopherol level, was inversely associated
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with the risk of prostate cancer (Cui, Liu, & Xu, 2014). Results of the present study, as well as
the studies described above, suggest that the role of gamma-tocopherol should be more closely
studied. If better physical and cognitive outcomes are seen for alpha-tocopherol than gammatocopherol, it may be advisable to consider efforts to increase alpha-tocopherol in the typical
American diet.
Vitamin B12. Vitamin B12 status, which was defined based on serum vitamin B12 level,
was not found to have a significant relationship with DSST score in the present study. Results
are in contrast to a population-based study of older adults in the Netherlands that found that those
with low serum vitamin B12 levels performed significantly worse on a letter substitution task
designed to measure processing speed (Jelicic et al., 2001). Reasons for this discrepancy are
unclear, and there does not appear to be any other published studies that have assessed this
particular relationship.
One limitation in research on the relationship between vitamin B12 and cognition has
been the considerable difficulty in accurately assessing the former. Vitamin B12 is often assessed
using serum B12 levels, as was done in the present study. Some, however, have expressed
concern that this method may not accurately reflect intracellular vitamin B12 levels (e.g., Hin et
al., 2006). Instead, other potential indicators of low vitamin B12 status (i.e., high methylmalonic
acid and high total homocysteine) have been suggested for use either alone or in combination
with serum B12 level (Clarke et al., 2003; Hin et al., 2006; Smith & Refsum, 2009). Of those two
potential indicators, high methylmalonic acid has been described as a more specific marker of
vitamin B12 deficiency (Tangney, Tang, Evans, & Morris, 2009).
Interestingly, exploratory analyses in the present study indicated that individuals in the
highest quartile for methylmalonic acid had significantly slower processing speed than
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individuals in each of the other quartiles. These results are consistent with a community-based
study of older adults in England that found that participants in the top two quartiles of
methylmalonic acid level had a 3.7-fold risk for cognitive impairment, as operationally defined
as a Mini-Mental State Examination (MMSE) score of < 22/30, compared to those in the bottom
two quartiles (Hin et al., 2006). It is difficult to conclude that low vitamin B12 is associated with
slower processing speed in young-old adults on the basis of the present study, as there is still
some uncertainty regarding whether methylmalonic acid accurately reflects intracellular vitamin
B12 (Miller, 2006). In any case, high methylmalonic acid is associated with slowed processing
speed in young-old adults.
Hypothesis 7 Discussion
Individual obesity indexes. The present study sought to determine the relationship
between processing speed and various obesity indexes in young-old adults. There was no
statistically significant relationship between BMI and DSST score. This was expected because
individuals with midlife obesity have an increased risk for developing dementia, and individuals
who go on to develop dementia are more likely to have lost a significant amount of weight
between midlife and late-life (Xu et al., 2011; Stewart et al., 2005). Furthermore, those who are
obese during midlife may develop dementia earlier; a recent study found overweight and obese
BMI at age 50 to be associated with earlier onset of AD compared to normal BMI, with each unit
increase in BMI at age 50 predicting earlier onset by 6.7 months (Chuang et al., 2016).
The present study found statistically significant inverse relationships between DSST and
each of the following central obesity indexes: WC, waist-height ratio (WHtR), and waist-thigh
ratio (WTR). This was expected due to the greater utility of central obesity indexes in predicting
a number of health conditions that have associated cognitive decline relative to BMI, which is in
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part believed to be due to differences between metabolic activity in visceral and other fat tissue.
Of these relationships, results of the present study suggest that those involving WHtR and WTR
have greater practical value than WC in regard to their relationship with processing speed in
young-old adults. It is possible that these findings reflect these indexes’ abilities to predict the
presence of relevant medical conditions (i.e., those associated with cognitive decline) within the
young-old adult population. For example, WHtR and WC were found to predict diabetes
mellitus, hyperglycemia, atherogenic dyslipidemia, and metabolic syndrome better than BMI in a
large cohort of Mediterranean adults aged 55–80 at high cardiovascular risk (Guasch-Ferre et al.,
2012).
The present study found a very weak, statistically significant positive correlation between
DSST score and % total body fat DEXA. These results were not as predicted and suggest that
greater adiposity is related to better processing speed in young-old adults. It should, however, be
noted that the magnitude of this finding suggests low practical value. Nevertheless, it may be the
case that young-old adults with greater adiposity performed better on the cognitive task since
they may have been less likely to be in the early stages of development of AD or other type of
dementia process (Xu et al., 2001). Results of the present study are generally consistent with a
recent community-based study of adults aged 74–94 that found that individuals in the lowest
tertile of DEXA body fat evidenced poorer executive functioning compared to those in the
middle tertile for men and the middle and highest tertiles for women (Smith et al., 2014).
The present study failed to find a statistically significant correlation between DSST score
and % trunk fat measured by DEXA. This finding is in contrast to the statistically significant
inverse relationships between DSST and the other central obesity indexes included in this study
(i.e., WC, WHtR, and WTR). It may be the case that central adiposity itself (i.e., % trunk fat
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measured by DEXA) is not predictive of medical conditions associated with cognitive decline
among young-old adults as was previously hypothesized. Rather, it may be the case that an
increase in waist circumference (resulting in increased WC, WHtR, and WTR) occurs as a result
of complications from medical conditions associated with cognitive decline. For example,
gastroparesis, a disorder in which gastric emptying is delayed in the absence of physical
obstruction, is a common complication of uncontrolled diabetes and often includes the symptom
of bloating (Dickman et al., 2013; Koch & Calles-Escandón, 2015). Results of the present study
highlight the importance of factors other than trunk adiposity in the relationship between
anthropometrically derived central obesity indexes and processing speed in young-old adults.
Combinations of obesity indexes. The hypothesis that, among participants who met WC
central obesity criteria, those who also met BMI obesity criteria would perform worse on the
DSST was supported by the data. Results suggest that BMI obesity adds some value in
predicting poor processing speed task performance beyond WC alone among a nationally
representative sample of young-old U.S. adults. The reason this may be the case, however, is
unclear. This hypothesis was based on findings from a community study of elderly individuals
in Korea that found obese BMI (defined as ≥ 25 kg/m2 per modified WHO guidelines) predicted
a positive result on a brief screener for dementia using an empirically supported cut-point only
when abdominal obesity was also present (Jeong et al., 2004; Jeong et al., 2005).
The related hypothesis that, among participants who met WC central obesity criteria,
those who also met DEXA obesity criteria would perform worse on the DSST was not supported
by the data. Results suggest that BMI adds greater value than a more accurate estimate of
current adiposity in this population. It is unclear as to why this may be the case, but, as
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hypothesized above, BMI may somehow better take into account other factors important in this
population. Future research is needed to better understand this relationship.
Finally, an attempt was made to find which combination of obesity indexes made the
most meaningful contribution to the prediction of DSST score among young-old adults. Given
the weak to very weak relationships between individual obesity indexes and DSST score
uncovered in prior analyses in the present study, it was not expected that findings of good
practical significance would be made in this planned analysis. After excluding a number of
indexes from a stepwise multiple regression based on issues of multicollinearity (i.e., BMI, WC,
DEXA % trunk fat), WHtR, DEXA % total body fat, and WTR remained. Results indicated that
WHtR and DEXA % total body fat accounted for 5.4% of variance in DSST score, and that
WTR did not meaningfully contribute to the model. Although results suggest WHtR and DEXA
% total body fat did make significant contributions to the overall prediction of DSST scores, the
low R2 value indicates that this model was not a good fit. This suggests that current obesity
indexes may not be particularly valuable in the prediction of processing speed in young-old
adults. Indeed, based on these findings as well as on the literature previously discussed, it would
appear that midlife obesity indexes are of greater predictive value on cognition in young-old
adults than are current obesity indexes.
BMI category. The present study found that young-old adults who were obese in young
adulthood have slower processing speed than young-old adults who had normal range BMI in
young adulthood. Additionally, young-old adults who were obese in late middle age were found
to have slower processing speed than young-old adults who were overweight in late middle age
as well as young-old adults who had normal range BMI in late middle age. These results are
generally consistent with the theory that history of persistent obesity, which is operationally
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defined in this study as obesity throughout young adulthood and late middle age, is associated
with slower processing speed in young-old adults.
BMI category and gender interaction. The present study found that young-old males
had slower processing speed than young-old females. When potential interactions with BMI
were assessed, it was found that this relationship was mostly limited to individuals with normal
range BMI. More specifically, findings from the present study suggest that normal range BMI is
associated with slower processing speed in males aged 65–74 (i.e., young-old males) compared
to their female counterparts. The same relationship was found between BMI and current
processing speed when BMIs at various time points were used. These time points included
current BMI (i.e., young-old BMI), BMI 10 years ago (i.e., late middle age BMI), and BMI at
age 25 (i.e., young adult BMI). In contrast, no significant differences in processing speed
between males and females in the other BMI categories studied (i.e., obese, overweight) were
found at any of the time points, with the exception of a trend toward men who were obese in
young adulthood having slower processing speed than women who were obese at that time.
It is unclear as to why this relationship would be almost entirely limited to those with
normal range BMI. One possible explanation is that men in the normal range BMI category may
tend to have a greater number of, or more severe, medical problems that can adversely impact
processing speed over time than do women in the normal range BMI category. Another possible
explanation is that women may tend to have faster processing speed than men under “normal
conditions” (i.e., normal range BMI) but are, perhaps, more sensitive to the cognitive effects of
some of the comorbidities of overweight and obesity that can contribute to slowed processing
speed over time.
Hypothesis 8 Discussion
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Pattern of obesity. Participants were divided into eight groups based on all possible
combinations of obesity status (yes/no) at age 25, 10 years ago, and the present, as depicted in
Table 5. It was hypothesized that participants who were obese at age 25 (i.e., young adulthood)
and 10 years ago (i.e., late middle age) would perform the worst on the DSST. In addition, it
was hypothesized that participants with no history of obesity would perform best on the DSST.
Further, it was hypothesized that those who were obese at only one timepoint would perform
better than those who were obese at age 25 and 10 years ago.
The analyses could not be run as originally planned due to three of the eight groups
containing very few participants. Each of these three groups shared the characteristic of obesity
at age 25. In retrospect, it seems likely that the small numbers of participants in these groups is
due to a lower prevalence of obesity in the past relative to the current day. Namely, in the
present study, data from participants aged 65–74 was collected during the years 1999–2002,
which means that self-reported young adult weight (i.e., age 25) referred to the participants’
weights during the years 1950–1962. The prevalence of obesity in U.S. adults aged 20–29
during the years 1960–1962, however, was estimated to be only 7.6% (Flegal, Carroll,
Kuczmarski, & Johnson, 1998). Obesity rates rose dramatically in the United States and many
other developed countries between approximately 1976 and 1994 (Flegal et al., 1998).
Consistent with this increase, the present study evidenced an adequate number of participants
with self-reported late middle age (i.e., age 55–64) weight, which referred to the participants’
weights during the years 1989–1992, in the obese range.
After removal of the three groups containing very few participants from the planned
analysis, five groups remained; they are shown in Table 6. Results revealed that Group C
(defined as those who were obese at late mid-life but not during young adulthood or the present)
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scored significantly lower on the DSST than Groups B, D, and E. No other group differences
were statistically significant, though a slight trend toward significance for Group A (defined as
those who were obese at each of the three time points) scoring lower than Group E (defined as
those who were not obese at any of the three time points) was noted.
The finding that Group C (defined as those who were obese at late mid-life but not during
young adulthood or the present) scored significantly lower on the DSST than Groups B, D, and E
suggests that, of the young-old adults who were not obese at age 25, the pattern of the presence
of obesity in late middle age and the absence of obesity at the present is associated with
significantly slower processing speed than any other possible pattern of obesity status at those
two time points (i.e., presence of obesity at late middle age and at the present; absence of obesity
at late middle age and the present; absence of obesity at late middle age and presence of obesity
at the present).
More specifically, when comparing Groups B and C, both groups gained significant
weight by late middle age and were possibly facing similar obesity-related health risks at that
time. It may be the case that Group B (those who remained obese at the present) outperformed
Group C because Group C represents those individuals who lost between late middle age and the
present secondary to physical illness (obesity-related or otherwise) or preclinical dementia.
Further, it is possible that Group E outperformed Group C because those in Group E did not gain
as much weight by late middle age or reach the obesity category, at which point risk for many
diseases is known to increase. Finally, it is possible that Group D outperformed Group C
because becoming obese in young-old adulthood is less of a health risk than becoming obese in
middle age. Generally, results suggest that slowed processing speed in young-old adults may be
more related to the timing of their obesity status rather than number of time points for which they
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can be categorized as obese, though some caution is taken with regard to this conclusion due to
inability to compare each of the eight groups as planned.
In any case, exploratory analyses were then conducted to better understand the
relationship between persistent obesity (i.e., obesity during young adulthood and late middleage) and processing speed in young-old adults. Young-old adults with a history of persistent
obesity were found to have slower processing speed than young-old adults with a history of
persistent non-obesity (i.e., obesity neither during young adulthood nor during late middle-age).
These findings are consistent with the hypothesis that long-term obesity in adulthood is
associated with slower processing speed in older adults.
Extent of weight gain between early adulthood and late middle-age. The hypothesis
that the extent of weight gain between early adulthood (i.e., age 25) and late middle-age (i.e., age
55–64) would be associated with slower processing speed was supported by the data. Results are
consistent with Sabia and colleagues (2009), who reported the extent of weight gain between
early adulthood and late middle-age among a large sample of London-based office staff to be
associated with executive dysfunction. Further, findings from an exploratory analysis in the
present study suggest that there is no significant relationship between processing speed in youngold adults and the extent of weight loss between early adulthood and late middle-age. Taken
together, results suggest that weight gain, but not weight loss, between early adulthood and late
middle-age is associated with slower processing speed in young-old adulthood. It may be the
case that weight gain during this time is detrimental to processing speed via onset of weightrelated diseases or disorders that also impact processing speed over time. Alternatively, it may
be the case that onset of new diseases or disorders during this time led to both weight gain and
slower processing speed, or that slow processing speed in early adulthood led to weight gain over
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time. Overall, however, results are generally consistent with the contraindication of gaining a
great amount of weight between early adulthood and late middle-age and suggest that amount of
weight lost between these two timepoints, assuming that one is not underweight at either time
point, is not detrimental to processing speed in young-old adulthood.
Extent of weight change between late middle-age and young-old adulthood. The
hypothesis that the extent of weight change over the previous 10-year period (i.e., from late
middle-age to young-old) would be associated with worse performance on the DSST was
supported by the data. Likewise, exploratory analyses uncovered inverse relationships between
processing speed and the extent of weight loss over the previous 10-year period as well as
between processing speed and the extent of weight gain over the same time period. These
findings are consistent with a previous study that have found that the extent of weight change
during a 10-year period between late middle-age (mean age 59) and early young adulthood
(mean age 69) was associated with poorer overall cognitive performance (Brubacher et al..,
2004). The present study adds to the literature by reporting this relationship to also be true of
processing speed among a nationally-representative sample of young-old adults. The findings of
the present study and that of Brubacher and colleagues (2004) may be related to the pattern of
significant weight loss between midlife and late-life prior to onset of dementia (Stewart et al.,
2005). However, because the present study did not include a baseline processing speed measure,
it is not possible to rule out the possibility that slower baseline processing speed led to, or
contributed to, significant weight change during the 10-year period in question.
Past-year weight change. The present study found that young-old adults with
unintentional significant past-year weight loss performed worse on the DSST than participants
who experienced significant intentional past-year weight loss, significant past-year weight gain,
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or past-year weight stability. This finding is consistent with the tendency for unintentional
weight loss to be associated with an underlying illness, which may or may not also be impacting
cognition. Results may have implications for the utility of conducting brief cognitive screenings
of young-old adults who present to their physicians with past-year unintentional weight loss.
Hypothesis 9 Discussion
Peripheral inflammation is a metabolic consequence of excess adipose tissue, and obese
individuals tend to evidence higher levels of peripheral inflammation markers independent of
other known sources of inflammation (Visser et al., 1999). Obesity creates a state of chronic
low-grade peripheral inflammation, and research suggests that this state may lead to cognitive
impairment through mechanisms such as invocation of central neuroinflammatory response,
development of inflammation resistance, accumulation of proinflammatory cytokines in the
bloodstream, and interaction of these cytokines with free fatty acids to impair insulin signaling
(Dali-Youcef et al., 2013; Ye & Keller, 2010).
The present study’s hypothesis that C-reactive protein (CRP), a marker of peripheral
inflammation, would have a statistically significant inverse association with processing speed
among young-old adults was not supported by the data; their association was in the expected
direction but did not reach statistical significance. The few other extant studies that have
reported on the relationship between CRP and processing speed in older adult populations have
yielded mixed findings (Tegeler et al., 2016; Trollor et al., 2012).
There are a number of possible explanations for the lack of a clear relationship between
CRP and processing speed in older adult populations. First, CRP is only one of several markers
of peripheral inflammation, which also include interleukins-1β, -6, -8, -10, -12, plasminogen
activator inhibitor, serum amyloid A, tumour necrosis factor-α, and vascular adhesion molecule-

187
1 (Trollor et al., 2012). It may be the case that some of these other markers of peripheral
inflammation are more closely associated with processing speed in young-old adults. Of these,
interleukins -6 and -12 may be of particular importance (Palta et al., 2015; Rafnsson et al., 2007;
Trollor et al., 2012). Second, it is possible that CRP does not have a significant relationship to
processing speed but does have a significant relationship to one or more other cognitive domains
among young-old adults. There is, in fact, some evidence to suggest an association between
CRP and executive functioning in this age group (Schram et al., 2007; Sweat et al., 2008;
Tegeler et al., 2016). Third, it is possible that a history of elevated CRP level in midlife is more
relevant to processing speed performance in older adult populations than current CRP level. No
published study has reported on this to-date; however, high CRP in midlife has been found to be
associated with decline in inductive reasoning ability ten years later (Gimeno, Marmot, & SinghManoux, 2008).
Hypothesis 10 Discussion
The hypothesis that individuals who endorsed history of one or more of the following
conditions would perform worse on the DSST was supported by the data: cardiac (i.e.,
congestive heart failure [CHF], coronary heart disease [CHD], or heart attack), stroke, diabetes,
weak/failing kidneys, and chronic respiratory disease (i.e., chronic bronchitis or emphysema).
Potential mechanisms for cognitive decline with regard to these diseases and conditions have
already been discussed.
Exploratory analyses were used to investigate group differences in processing speed with
respect to the presence or absence of each of the aforementioned conditions, as well as
hypertension and any liver condition. Among the conditions tested, all but chronic respiratory
disease, any liver condition, and CHD in the absence of other cardiac conditions were
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significantly linked to slower processing speed. Furthermore, length of chronic respiratory
disease was not significantly correlated with processing speed task performance. Results suggest
that history of any liver condition, history of chronic respiratory disease, length of chronic
respiratory disease, and history of CHD in the absence of other cardiac conditions may not be
relevant factors with regard to current processing speed in young-old adults.
Hypothesis 11 Discussion
The hypothesis that participants with one or more types of dyslipidemia, as determined
by blood tests, would demonstrate worse processing speed was not supported by the data. This
finding suggests that overall lipid health status, as operationally defined as the presence or
absence of one or more types of dyslipidemia, may not be important with regard to current
processing speed in young-old adults. Results of exploratory analyses, however, indicate that
three individual types of dyslipidemia are salient to this relationship: low high-density
lipoprotein [HDL] cholesterol, high non-HDL cholesterol, and high triglycerides, the latter two
of which are sex-specific. Each of these three is discussed below.
Low HDL cholesterol. Among both men and women in the present study, young-old
adults with low HDL cholesterol had worse DSST performance than those without low HDL
cholesterol. Because young-old adults are in the age range that is particularly susceptible to a
preclinical stage of dementia, the present study’s finding is consistent with results of large
prospective studies that show HDL cholesterol to have an inverse relationship with risk of allcause dementia (Koch & Jensen, 2016; Reitz et al., 2010). The present study’s finding is also
consistent with research that shows low HDL cholesterol to be independently associated with
memory dysfunction and decline in middle-aged adults and linked to structural brain changes in
regions associated with AD (Singh-Manoux et al., 2008; Ward et al., 2010). How low HDL
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cholesterol, in particular, may contribute to the development of cognitive impairment and
dementia is not well established, but indirect pathways are believed to include atherosclerosis,
which may lead to decreased cerebral blood flow, as well as increased risk for other vascular
events and diseases that in turn can cause cognitive impairment and dementia (Ancelin et al.,
2013; Vinkers et al., 2005). There also appears to be a relationship between low HDL and buildup of amyloid plaque deposits in the brain, though the nature of this relationship is unclear (Reed
et al., 2014). In addition to low levels of HDL cholesterol, emerging evidence suggests that
other aspects of HDL cholesterol may be problematic for some individuals with cognitive
impairment or dementia. Namely, one recent study reported decreased efficiency of HDL
cholesterol among those with AD (Camponova et al., 2017).
High non-HDL cholesterol. Among men only, those with high non-HDL cholesterol
evidenced significantly slower processing speed than those without high non-HDL cholesterol.
The relationship between processing speed and low-density lipoprotein [LDL] cholesterol, on the
other hand, did not reach statistical significance for either gender.
Non-HDL cholesterol is calculated by subtracting HDL cholesterol from total cholesterol,
which yields an estimate of cholesterol concentration among all atherogenic lipoproteins: LDL
cholesterol, very-low density lipoprotein (VLDL) cholesterol, intermediate-density lipoprotein
(IDL) cholesterol, and lipoprotein (a) [Lp(a)] cholesterol (Virani, 2011). Therefore, non-HDL
cholesterol is a more comprehensive measure of atherogenic lipoproteins than LDL cholesterol.
Although LDL cholesterol is the current primary target for treatment of dyslipidemia,
many doctors have argued for the use of non-HDL cholesterol in place of, or in addition to, LDL
cholesterol in clinical practice on the basis that it is more predictive of cardiovascular risk than
LDL cholesterol or, at the least, adds additional value (Rana, Boekholdt, Kastelein, & Shah,
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2012; van Deventer et al., 2011; Virani, 2011). Nevertheless, LDL cholesterol continues to
receive greater attention than non-HDL cholesterol in the empirical literature, and, not
surprisingly, there are numerous published studies that include information on the relationship
between LDL cholesterol and cognition but very few, if any, that address the relationship
between non-HDL cholesterol and cognition. Results from the present study provide support to
the value of studying non-HDL cholesterol.
Because LDL cholesterol comprises a large portion of non-HDL cholesterol, empirical
findings regarding the relationship between LDL cholesterol and cognition are briefly described
here. Concerning the present study, mean difference in DSST score between groups with and
without high LDL cholesterol was not statistically significant but did show a trend toward
significance, suggesting lower processing speed in those with high LDL cholesterol. This
relationship was stronger among men than women but, again, did not reach statistical
significance when analyses were limited to men. In regard to the literature to date, the
relationship between processing speed and LDL cholesterol level in older adults is not well
established, but one recent study of older adults found that greater variability in LDL cholesterol
readings across study visits was associated with worse processing speed and other aspects of
cognition, as well as lower cerebral blood flow and greater white matter hyperintensity (WMH)
load (Smit et al., 2016). The findings on the relationship between LDL cholesterol and other
cognitive domains have been mixed. For example, one recent study of older adults with
cardiovascular risk factors found higher LDL cholesterol to be related to worse performance on a
working memory task, whereas another recent study of healthy middle-aged and older aged
adults found LDL cholesterol to be associated with better episodic memory (Leritz, McGlinchey,
Salat, Milberg, 2016; Meusel et al., 2017).
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High triglycerides. Among women only, those with high triglycerides evidenced
significantly faster processing speed than those without high triglycerides. This relationship was
surprising, as high triglyceride level is considered to be a biomarker of cardiovascular disease
(CVD) risk, though it should be noted that triglyceride itself is not directly atherogenic (Miller et
al., 2011). There have been few published studies on the relationship between current
triglyceride levels and processing speed in older adults to date. One such study failed to find a
statistically significant relationship between processing speed and triglycerides, but this study did
not report on sex-specific relationships (van den Kommer, Dik, Comijs, Jonker, & Deeg, 2012).
More research is needed in this area to determine whether this is a stable finding and, if so, to
explore the nature of this relationship. Reasons for such a relationship are unclear, though the
authors of a prospective study that found a relationship between high triglyceride levels and
decreased risk of AD in women hypothesized that this finding may reflect a survival bias
(Ancelin et al., 2013). Findings on the relationship between triglycerides and other cognitive
domains among older adults have been mixed (Parthasarathy et al., 2014; van den Kommer et al.,
2012).
Hypothesis 12 Discussion
The hypotheses that risk of first stroke, as indicated by score on a modified version of the
Framingham Stroke Risk Profile (FSRP), and risk of CVD onset, as indicated by score on a
modified version of the Framingham Risk Score (FRS) for general CVD, would each be
inversely associated with DSST score was supported by the data. Scores reflecting risk of first
stroke and risk of CVD onset each showed a statistically significant weak inverse relationship
with DSST score. Findings indicate that, among this nationally representative cross-sectional
sample of young-old adults, processing speed tends to decrease as risk of first stroke or risk of
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CVD onset increases. Although only weak relationships were found, results suggest the
potential impact of stroke and CVD risk factors on processing speed in young-old adults without
history of stroke or CVD. They also suggest the possibility that some cognitive decline or
impairment may be present in these individuals prior to first stroke or CVD onset.
Of course, because these equations were designed to predict risk for first stroke or onset
of CVD rather than processing speed or other aspects of cognition, some of their components
may not be optimal when the goal is to predict current processing speed in young-old adults.
FRS for general CVD, for example, takes total cholesterol into account, whereas the present
study did not support the utility of total cholesterol in predicting processing speed in the youngold adult population.
Hypothesis 13 Discussion
The hypothesis that there would be a significant positive correlation between usual gait
speed and processing speed after controlling for BMI was supported by the data. Therefore,
although walking speed has been found to be slower among obese older adults compared to their
normal weight counterparts, BMI does not explain the association between slower walking speed
and slower processing speed in young-old adults (Xu, Houston, Gropper, & Zizza, 2009).
Results from the present study are consistent with those from another recent study that found
lower processing speed to be a major contributor to slower gait speed after controlling for other
cognitive domains, age, BMI, and other potential confounds in late-middle aged and older adults
(Killane et al., 2014).
The finding that gait speed decelerates faster in the years preceding mild cognitive
impairment (MCI) diagnosis in affected individuals compared to the normal cognitive aging
population suggests the role of shared pathological processes of organic etiology in the
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relationship between slowed gait speed and cognitive decline (Albers et al., 2015; Buracchio,
Dodge, Howieson, Wasserman, & Kaye, 2010; Kikkert, Vuillerme, van Campen, Hortobagyi, &
Lamoth, 2016). For example, cerebral white matter hyperintensities (WMHs), which are areas of
abnormal change in white matter found on head computerized tomography (CT) and brain
magnetic resonance imaging (MRI) scans that reflect changes in interstitial fluid mobility and
water content, demyelination, and/or axonal damage, are increasingly common with age and are
associated with vascular risk factors, stroke, and dementia (Wardlaw, Valdés Hernández, &
Muñoz-Maniega, 2015). WMHs are believed to be causally related to slowed gait speed and
reductions in the cognitive domains of processing speed and executive functioning in affected
individuals depending on their size, location, and total volume (Wakefield et al., 2010). It has
been hypothesized that WMHs can impact gait speed directly through disrupting mobility-related
pathways or indirectly through disrupting pathways important for executive functions
(Bolandzadeh et al., 2014). Likewise, it can be hypothesized that slower processing of
visuospatial information may contribute to slower gait speed. The finding from a recent study
that performance on the DSST significantly mediates the relationship between WMHs and gait
speed supports these hypotheses, as the DSST is a measure of processing speed that has also
been shown to reflect visual scanning ability and executive functioning (Bolandzadeh et al.,
2014; Davis & Pierson, 2012; Joy et al., 2003).
Final Model Discussion
It had been reasoned that bodily states caused by obesity that tend to be present even
among otherwise healthy obese individuals (e.g., increased adipokines, low grade inflammation)
might contribute to worsened processing speed above and beyond that of diagnosed diseases,
disorders, and medical events for which obesity has been shown to often have a contributory role
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(e.g., T2DM, stroke). Additionally, it was thought that these obesity-related bodily states (e.g.,
increased adipokines, low grade inflammation) might have a differential impact on cognition
according to magnitude and duration of exposure. Persistent obesity was conceptualized as a
way of identifying long duration of exposure to these bodily states.
Results of the present study’s final model suggest that vascular health history mediates
the relationship between persistent obesity and processing speed among adults aged 65–74;
however, no evidence for the direct contribution of persistent obesity to current processing speed
was found. Likewise, results of Hypothesis 7 analyses did not provide evidence for persistent
obesity being related to processing speed to a greater extent than obesity in late middle-age.
Taken together, results of the present study do not provide support for the cumulative impact of
obesity during young adulthood and late middle-age on processing speed in young-old adults.
One possible explanation for this finding may be that the brain is more vulnerable to the effects
of obesity-related bodily states (e.g., increased adipokines, low grade inflammation) during late
middle-age than during young adulthood. Additionally, the recent finding that the low grade
systemic inflammation associated with obesity tends to impair the blood brain barrier only in
those with already diseased brains would also support the lack of importance of obesity in young
adulthood relative to obesity in late middle-age (Elwood, Lim, Naveed, & Galea, 2017).
Consistent with this idea, it may be the case that those who are obese when preclinical dementia
begins experience more rapid decline.
Limitations of the Present Study
The present study had several limitations. As a non-experimental, cross-sectional study,
causality of processing speed cannot be inferred. Longitudinal data would have provided many
advantages, including the opportunity for collection and analysis of repeated cognitive tests and

195
biochemistry data. The use of retrospective pretests (e.g., self-report of weight ten years ago,
self-report of weight at age 25) did allow for investigation of associations between weight
trajectory and other variables, but reliance on these retrospective pretests may have been
problematic with regard to their accuracy. For example, one recent study of older adults found
that 20 year retrospectively recalled weights tend to underestimate both 20-year prior assessed
weights and 20 year prior self-reported weights by an average of 4.2 ± 13.0 and 1.2 ± 11.5
pounds, respectively (Dahl & Reynolds, 2013). Another limitation of the present study was the
use of only one measure of processing speed. Cognitive tests are rarely able to measure one
domain in isolation. Given that the DSST primarily reflects graphomotor speed, perceptual
speed, visual scanning ability, and executive functioning, results need to be interpreted within
this specific context. Moreover, the present study was limited by the low number of participants
in some of the weight trajectory groups, which prevented some planned analyses from being run.
Finally, the present study would have benefitted from the inclusion of weight data at time points
between young adulthood and late middle-age. More specifically, the present study assumed that
the combined presence of obesity in young adulthood and late middle-age was generally
consistent with a state of “persistent obesity” throughout that time; however, this assumption
may not be fair, as weight can fluctuate considerably over time.
Conclusions and Recommendations for Future Research
The present study did not provide evidence for the cumulative impact of obesity during
young adulthood and late middle-age on processing speed in young-old adults. In contrast, it
highlighted the link between slower processing speed and the weight trajectory pattern of obesity
in late middle-age coupled with the absence of obesity in both young adulthood and young-old
adulthood. That being said, results should be interpreted with caution due to study limitations,
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especially because the low number of participants in some of the weight trajectory groups
prevented the processing speed outcomes of those groups from being investigated. Future
studies that use similarly large sample sizes but analyze more recent data would be less likely to
encounter the same problem given the history of obesity prevalence trends in the United States.
An indirect effect of persistent obesity during young adulthood and late middle-age on
processing speed in young-old adults through vascular health history was identified by the
present study, but there was no evidence for a direct effect. It may be the case that persistent
obesity does not have a direct effect on processing speed in young adulthood; however,
limitations in the present study prevent this conclusion from being drawn. Future research
should include weight data at time points between young adulthood and late middle-age in order
to more accurately classify individuals as persistently obese throughout that time period. In
addition, future studies should strive to use measured weights rather than self-reported weights,
as this would improve the accuracy of the collected weight data and, by extension, would likely
improve the accuracy of weight category classification. Moreover, future studies should include
a measure of processing speed at baseline to investigate the relationship between weight
trajectory and change in processing speed as well as to investigate the possibility that slower
baseline processing speed predicts subsequent weight patterns.
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Appendix A: Demographics Questionnaire
RIAGENDR – Gender

RIDAGEYR - Age at Screening
RIDRETH1 - Race/Ethnicity – Recode
Mexican American
Other Hispanic
Non-Hispanic White
Non-Hispanic Black
Other Race - Including Multi-Racial

DMDEDUC2 - Education Level - Adults 20+
Less Than 9th Grade
9-11th Grade (Includes 12th grade with no diploma)
High School Grad/GED or Equivalent
Some College or AA degree
College Graduate or above

DMDMARTL - Marital Status
Married
Widowed
Divorced
Separated
Never married
Living with partner

DMDHHSIZ - Total number of people in the Household

INDHHINC - Annual Household Income
$ 0 to $ 4,999
$ 5,000 to $ 9,999
$10,000 to $14,999
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$15,000 to $19,999
$20,000 to $24,999
$25,000 to $34,999
$35,000 to $44,999
$45,000 to $54,999
$55,000 to $64,999
$65,000 to $74,999
$75,000 and Over
Over $20,000
Under $20,000

249
Appendix B: Occupation Questionnaire

OCQ150 - Type of work done last week
English Text:
(SP Interview Version) In this part of the survey I will ask you questions about
{your/SP's} work experience. Which of the following {were you/was SP} doing last
week . . .
Working at a job or business,
With a job or business but not at work,
Looking for work, or
Not working at a job or business?

OCQ180 - Hours worked last week at all jobs
English Text:
How many hours did {you/SP} work last week at all jobs or businesses?

OCQ210 - Usually work 35 or more hours per week
English Text:
{Do you/Does SP} usually work 35 hours or more per week in total at all jobs or
businesses?
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Appendix C: Weight History Questionnaire

WHD010 - Current self-reported height (inches)
English Text:
These next questions ask about {your/SP's} height and weight at different times in
{your/his/her} life. How tall {are you/is SP} without shoes?
WHD020 - Current self-reported weight (pounds)
English Text:
How much {do you/does SP} weigh without clothes or shoes?
WHQ030 - How do you consider your weight
English Text:
{Do you/Does SP} consider {your/his/her}self now to be . . .
Overweight,
Underweight, or
About the right weight?
Refused
Don't know

WHD040 - Like to weigh more, less or same
English Text:
Would {you/SP} like to weigh . . .
More,
Less, or
Stay about the same?
Refused
Don't know

WHD050 - Self-reported weight-1 yr ago (pounds)
English Text:
How much did {you/SP} weigh a year ago?
WHD060 - Weight change intentional
English Text:
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Was the change between {your/SP's} current weight and {your/his/her} weight a year
ago intentional?
WHQ070 - Tried to lose weight in past year
English Text:
During the past 12 months, {have you/has SP} tried to lose weight?
WHQ090 - Tried not to gain weight in past year
English Text:
During the past 12 months, {have you/has SP} done anything to keep from gaining
weight?
WHD110 - Self-reported weight-10 yrs ago (pounds)
English Text:
How much did {you/SP} weigh 10 years ago? [If you don't know {your/his/her} exact
weight, please make your best guess.]
English Instructions:
ENTER WEIGHT IN POUNDS OR KILOGRAMS. IF PREGNANT, ASK FOR
WEIGHT BEFORE PREGNANCY.

WHD120 - Self-reported weight - age 25 (pounds)
English Text:
How much did {you/SP} weigh at age 25? [If you don't know {your/his/her} exact
weight, please make your best guess.]
English Instructions:
IF PREGNANT, ASK FOR WEIGHT BEFORE PREGNANCY.
WHD130 - Self-reported height - age 25 (inches)
English Text:
How tall {were you/was SP} at age 25? [If you don't know {your/his/her} exact height,
please make your best guess.]
WHD140 - Self-reported greatest weight (pounds)
English Text:
Up to the present time, what is the most {you have/SP has} ever weighed?
WHD150 - Age when heaviest weight
English Text:
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How old {were you/was SP} then? [If you don't know {your/his/her} exact age, please
make your best guess.]
WHD160 - Least self-reported weight since 18(lbs)
English Text:
What is the least {you/SP} ever weighed since {you were/s/he was} 18?
English Instructions:
DO NOT INCLUDE WEIGHT DURING PREGNANCY.
WHD170 - Age when lightest weight
English Text:
How old {were you/was SP} then? [If you don't know {your/his/her} exact age, please
make your best guess.]
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Appendix D: Blood Pressure Questionnaire

BPQ020 - Ever told you had high blood pressure
English Text:
{Have you/Has SP} ever been told by a doctor or other health professional that
{you/s/he} had hypertension, also called high blood pressure?

BPQ030 - Told had high blood pressure - 2+ times
English Text:
{Were you/Was SP} told on 2 or more different visits that {you/s/he} had hypertension,
also called high blood pressure?

BPQ050A - Now taking prescribed medicine (for hypertension)
English Text:
HELP AVAILABLE (Are you/Is SP) now taking prescribed medicine
BPQ080 - Doctor told you - high cholesterol level
English Text:
{Have you/Has SP} ever been told by a doctor or other health professional that
{your/his/her} blood cholesterol level was high?

BPQ100D - Now taking prescribed medicine (for cholesterol)
English Text:
(Are you/Is SP) now following this advice to take prescribed medicine?
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Appendix E: Diabetes Questionnaire

DIQ010 - Doctor told you have diabetes
English Text:
The next questions are about specific medical conditions. {Other than during pregnancy,
{have you/has SP}/{Have you/Has SP}} ever been told by a doctor or health professional
that {you have/{he/she/SP} has} diabetes or sugar diabetes?
DIQ040Q - Number of years of age
English Text:
How old {was SP/were you} when a doctor or other health professional first told
{you/him/her} that {you/he/she} had diabetes or sugar diabetes?
DIQ050 - Taking insulin now
English Text:
{Is SP/Are you} now taking insulin
DIQ060Q - Number of mos/yrs taking insulin
English Text:
For how long {have you/has SP} been taking insulin?
DIQ060U - Unit of measure (month/year)
English Instructions:
ENTER UNIT (months or years)
DIQ070 - Take diabetic pills to lower blood sugar
English Text:
{Is SP/Are you} now taking diabetic pills to lower {{his/her}/your} blood sugar? These are
sometimes called oral agents or oral hypoglycemic agents.
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Appendix F: Medical Conditions Questionnaire Variables

MCQ010 - Ever been told you have asthma
English Text:
Has a doctor or other health professional ever told {you/SP} that {you have/s/he/SP has}
asthma?
Code or Value Value Description
1
Yes
2
No
7
Refused
9
Don't know

MCQ040 - Had asthma attack in past year
English Text:
During the past 12 months, {have you/has SP} had an episode of asthma or an asthma
attack?
MCQ050 - Emergency care visit for asthma/past yr
English Text:
[During the past 12 months], {have you/has SP} had to visit an emergency room or
urgent care center because of asthma?
MCQ053 - Taking treatment for anemia/past 3 mos
English Text:
During the past 3 months, {have you/has SP} been on treatment for anemia, sometimes
called "tired blood" or "low blood"? [Include diet, iron pills, iron shots, transfusions as
treatment.]
MCQ160B – MCQ160L
English Text:
Has a doctor or other health professional ever told {you/SP} that {you/s/he} . . .had
{condition}?
MCQ160B - Ever told had congestive heart failure
MCQ160C - Ever told you had coronary heart disease
MCQ160D - Ever told you had angina/angina pectoris
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MCQ160E - Ever told you had heart attack
MCQ160F - Ever told you had a stroke
MCQ160G - Ever told you had emphysema
MCQ160I - Ever told you had thyroid disease
MCQ160K - Ever told you had chronic bronchitis
MCQ160L - Ever told you had any liver condition
MCQ170I - Do you still have thyroid disease
English Text:
{Do you/Does SP} still . . . have another thyroid disease?
Code or Value Value Description
1
Yes
2
No
7
Refused
9
Don't know

MCQ170K - Do you still have chronic bronchitis
English Text:
{Do you/Does SP} still . . . have chronic bronchitis?
MCQ170L - Do you still have a liver condition
English Text:
{Do you/Does SP} still . . . have any kind of liver condition?
MCQ180B- MCQ180L – Age when first told had {condition}
English Text:
How old {were you/was SP} when {you were/s/he was} first told {you/s/he} . . .had
{condition}?
MCQ180B - Age when told you had heart failure
MCQ180C - Age when told had coronary heart disease
MCQ180D - Age when told you had angina pectoris
MCQ180E - Age when told you had heart attack
MCQ180F - Age when told you had a stroke
MCQ180G - Age when told you had emphysema
MCQ180I - Age when told you had thyroid disease
MCQ180K - Age when told you had chronic bronchitis
MCQ180L - Age when told you had a liver condition
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MCQ220 - Ever told you had cancer or malignancy
English Text:
{Have you/Has SP} ever been told by a doctor or other health professional that
{you/s/he} had cancer or a malignancy of any kind?
MCQ230A- MCQ230C - What kind of cancer
English Text:
What kind of cancer was it?
English Instructions:
ENTER UP TO 3 KINDS.
MCQ240A –MCQ240DD - Age cancer diagnosed
English Text:
How old {were you/was SP} when {TYPE OF CANCER/cancer} was first diagnosed?
MCQ250B - Blood relatives have Alzheimer's
English Text:
Including living and deceased, were any of {SP's/ your} biological that is, blood relatives
including grandparents, parents, brothers, sisters ever told by a health professional that
they had . . .Alzheimer's disease?
MCQ260BA- MC260BF – Which Blood relatives have Alzheimer's
English Text:
Which biological [blood] family member?
English Instructions:
CODE ALL THAT APPLY
MCQ260BA - Blood relative-Alzheimer's-mother*
MCQ260BB - Blood relative-Alzheimer's-father*
MCQ260BC - Blood relative-Alzheimer's-mom's mother*
MCQ260BD - Blood relative-Alzheimer's-mom's father*
MCQ260BE - Blood relative-Alzheimer's-dad's mother*
MCQ260BF - Blood relative-Alzheimer's-dad's father*
*Categories are either endorsed or missing
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Appendix G: Kidney Conditions Questionnaire
KIQ020 - Ever told you had weak/failing kidneys
English Text:
{Have you/Has SP} ever been told by a doctor or other health professional that
{you/s/he} had weak or failing kidneys? Do not include kidney stones, bladder
infections, or incontinence.
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Appendix H: Physical Activity Questionnaire
PAQ180 - Avg level of physical activity each day
English Text:
Please tell me which of these four sentences best describes {your/SP's} usual daily
activities? [Daily activities may include {your/his/her} work, housework if {you are/s/he
is} a homemaker, going to and attending classes if {you are/s/he is} a student, and what
{you/s/he} normally {do/does} throughout a typical day if {you are/he/she is} a retiree or
unemployed.] . . .
{you sit/he/she sits} during the day and {do/does} not walk about very much.
{you stand or walk/he/she stands or walks} about a lot during the day, but {do/does}not have to
carry or lift things very often
{you/he/she} lift(s) light load or {have/has} to climb stairs or hills often.
{you/he/she} {do/does} heavy work or {carry/carries} heavy loads.

PAD200 - Vigorous activity over past 30 days
The next questions are about physical activities including exercise, sports, and physically
active hobbies that {you/SP} may have done in {your/his/her} leisure time or at school
over the past 30 days. First I will ask you about vigorous activities that cause heavy
sweating or large increases in breathing or heart rate. Then I will ask you about moderate
activities that cause only light sweating or a slight to moderate increase in breathing or
heart rate. Over the past 30 days, did {you/SP} do any vigorous activities for at least 10
minutes that caused heavy sweating, or large increases in breathing or heart rate? Some
examples are running, lap swimming, aerobics classes or fast bicycling.
Yes
No
Unable to do activity

PAD320 - Moderate activity over past 30 days
[Over the past 30 days], did {you/SP} do moderate activities for at least 10 minutes that
cause only light sweating or a slight to moderate increase in breathing or heart rate?
Some examples are brisk walking, bicycling for pleasure, golf, and dancing.
Yes
No
Unable to do activity
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PAD440 - Muscle strengthening activities
Over the past 30 days, did {you/SP} do any physical activities specifically designed to
strengthen {your/his/her} muscles such as lifting weights, push-ups or sit-ups? Include all
such activities even if you have mentioned them before.
PAD460 - Number of times past 30 days
[Over the past 30 days], how often did {you/SP} do these physical activities? [Activities
designed to strengthen {your/his/her} muscles such as lifting weights, push-ups or situps.]
PAQ500 - Activity comparison last mo - last yr
How does the amount of activity that you reported {for SP} for the past 30 days compare
with {your/his/her} physical activity for the past 12 months? Over the past 30 days,
{were you/was he/she} . . .
more active
less active, or
About the same?

PAQ540 - Compare activity with 10 years ago
Compared with {yourself/himself/herself} 10 years ago, would you say that {you are/SP
is} . . .
More active now,
Less active now, or
About the same?
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Appendix I: Physical Activity Individual Activities File

PADACTIV - Leisure time activity
English Text:
[Over the past 30 days], what {vigorous/moderate} activities did {you/SP} do?
English Instructions:
CODE ALL THAT APPLY.
Code or Value
Value Description
10
AEROBICS
11
BASEBALL
12
BASKETBALL
13
BICYCLING
14
BOWLING
15
DANCE
16
FISHING
17
FOOTBALL
18
GARDENING
19
GOLF
20
HIKING
21
HOCKEY
22
HUNTING
23
JOGGING
24
KAYAKING
25
PUSH-UPS
26
RACQUETBALL
27
ROLLERBLADING
28
ROWING
29
RUNNING
30
SIT-UPS
31
SKATING
32
SKIING - CROSS COUNTRY
33
SKIING - DOWNHILL
34
SOCCER
35
SOFTBALL
36
STAIR CLIMBING
37
STRETCHING
38
SWIMMING
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Code or Value
Value Description
39
TENNIS
40
TREADMILL
41
VOLLEYBALL
42
WALKING
43
WEIGHT LIFTING
44
YARD WORK
50
BOXING
51
FRISBEE
52
HORSEBACK RIDING
53
MARTIAL ARTS
54
WRESTLING
55
YOGA
56
CHEERLEADING AND GYMNASTICS
57
CHILDREN'S GAMES (E.G. DODGEBALL, KICKBALL)
58
ROPE JUMPING
59
SKATEBOARDING
60
SURFING
61
TRAMPOLINE JUMPING
71
OTHER
For each of the above that are coded, the following questions are asked:
PADLEVEL - Activity level
English Text:
Reported intensity level of activity
Code or Value Value Description
1
MODERATE
2
VIGOROUS

PADTIMES - # of times did activity in past 30 days
English Text:
[Over the past 30 day], how often did {you/SP} do {activity}?

PADDURAT - Average duration of activity (minutes)
English Text:
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[Over the past 30 days], on average about how long did {you/SP} do {activity} each
time?

PADMETS - MET score for activity (calculated from above information)
English Text:
Metabolic equivalent(MET) intensity level for activity.

264
Appendix J: Diet Behavior and Nutrition
DBD270c - Helping of fruit/fruit juices eaten/day
English Text:
On an average day, how many helpings of the following kinds of foods {do you/does
SP}eat? Fruits or fruit juices.
English Instructions:
RESPONDENT SHOULD DEFINE 'HELPING'.

DBD270d - Helping of vegetables eaten/day
English Text:
On an average day, how many helpings of the following kinds of foods {do you/does
SP}eat? Vegetables, including vegetable salads.
English Instructions:
RESPONDENT SHOULD DEFINE 'HELPING’
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Appendix K: Smoking Questionnaire

SMQ020 - Smoked at least 100 cigarettes in life
English Text:
These next questions are about cigarette smoking and other tobacco use. {Have you/Has
SP} smoked at least 100 cigarettes in {your/his/her} entire life?

SMD030 - Age started smoking cigarettes regularly
English Text:
How old {were you/was SP} when {you/s/he} first started to smoke cigarettes fairly
regularly?

SMQ040 - Do you now smoke cigarettes
English Text:
{Do you/Does SP} now smoke cigarettes . .
Every day,
Some days, or
Not at all?

SMQ050Q - How long since quit smoking cigarettes (if do not smoke currently)
English Text:
How long has it been since {you/SP} quit smoking cigarettes?
SMQ050U - Unit of measure (day/week/month/year)
Weeks
Months
Years

SMD055 - Age last smoked cigarettes regularly
English Text:
How old {were you/was SP} when {you/s/he} last smoked cigarettes {fairly regularly}?
SMD057 - # cigarettes smoked per day when quit
English Text:
At that time, about how many cigarettes did {you/SP} usually smoke per day?
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SMD070 - # cigarettes smoked per day now
English Text:
On average, how many cigarettes {do you/does SP} now smoke per day?
SMD075 - How many years smoked this amount
English Text:
For about how many years {have you/has SP} smoked this amount?
SMD080 - # days smoked cigs during past 30 days
English Text:
On how many of the past 30 days did {you/SP} smoke a cigarette?
SMD090 - Avg # cigarettes/day during past 30 days
English Text:
During the past 30 days, on the days that {you/SP} smoked, about how many cigarettes
did {you/s/he} smoke per day?
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Appendix L: Alcohol Use History Questionnaire
ALQ100 - Had at least 12 alcohol drinks/1 yr?
English Text:
The next questions are about drinking alcoholic beverages. Included are liquor (such as
whiskey or gin), beer, wine, wine coolers, and any other type of alcoholic beverage. In
any one year, {have you/has SP} had at least 12 drinks of any type of alcoholic beverage?
By a drink, I mean a 12 oz. beer, a 4 oz. glass of wine, or an ounce of liquor.
ALQ110 - Had at least 12 alcohol drinks/lifetime?
English Text:
In {your/SP's} entire life, {have you/has he/ has she} had at least 12 drinks of any type of
alcoholic beverage?
ALQ120Q - How often drink alcohol over past 12 mos
English Text:
In the past 12 months, how often did {you/SP} drink any type of alcoholic beverage?
PROBE: How many days per week, per month, or per year did {you/SP} drink?
ALQ130 - Avg # alcoholic drinks/day -past 12 mos
English Text:
In the past 12 months, on those days that {you/SP} drank alcoholic beverages, on the
average, how many drinks did {you/he/she} have?
ALQ140Q - #days have 5 or more drinks/past 12 mos
English Text:
In the past 12 months, on how many days did {you/SP} have 5 or more drinks of any
alcoholic beverage? PROBE: How many days per week, per month, or per year did
{you/SP} have 5 or more drinks in a single day?
ALQ150 - Ever have 5 or more drinks every day?
English Text:
Was there ever a time or times in {your/SP's} life when {you/he/she} drank 5 or more
drinks of any kind of alcoholic beverage almost every day?
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Appendix M: IRB Exempt Letter

269
Appendix N: Consent Form

